|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
* C-alpha coords only
|
|
|
|
|
|
|
|
|
|
Enzyme class:
|
|
Chains A, M:
E.C.?
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
| |
|
DOI no:
|
Nature
329:506-512
(1987)
|
|
PubMed id:
|
|
|
|
|
|
| |
|
Structure of the human class I histocompatibility antigen, HLA-A2.
|
|
P.J.Bjorkman,
M.A.Saper,
B.Samraoui,
W.S.Bennett,
J.L.Strominger,
D.C.Wiley.
|
|
|
|
|
| |
ABSTRACT
|
|
|
|
| |
|
|
The class I histocompatibility antigen from human cell membranes has two
structural motifs: the membrane-proximal end of the glycoprotein contains two
domains with immunoglobulin-folds that are paired in a novel manner, and the
region distal from the membrane is a platform of eight antiparallel beta-strands
topped by alpha-helices. A large groove between the alpha-helices provides a
binding site for processed foreign antigens. An unknown 'antigen' is found in
this site in crystals of purified HLA-A2.
|
|
|
|
|
|
| |
Selected figure(s)
|
|
|
|
| |
|
|
|
|
|
|
Figure 2.
Fig 2. Schematic representation of the structure of HLA-A2.
|
|
Figure 6.
Fig 6. Van der Waals surface representation of the top of the HLA-A2 molecules
(a) showing the deep groove identified as the antigen recognition site ans the
electron density (b) found in this site in crystals of HLA-A2.
|
|
|
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nature
(1987,
329,
506-512)
copyright 1987.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
|
| |
PubMed id
|
|
Reference
|
|
|
|
|
|
W.A.Hendrickson
(2013).
Evolution of diffraction methods for solving crystal structures.
|
| |
Acta Crystallogr A,
69,
51-59.
|
|
|
|
|
|
|
L.Kjer-Nielsen,
O.Patel,
A.J.Corbett,
J.Le Nours,
B.Meehan,
L.Liu,
M.Bhati,
Z.Chen,
L.Kostenko,
R.Reantragoon,
N.A.Williamson,
A.W.Purcell,
N.L.Dudek,
M.J.McConville,
R.A.O'Hair,
G.N.Khairallah,
D.I.Godfrey,
D.P.Fairlie,
J.Rossjohn,
and
J.McCluskey
(2012).
MR1 presents microbial vitamin B metabolites to MAIT cells.
|
| |
Nature,
491,
717-723.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
C.Yanover,
and
P.Bradley
(2011).
Large-scale characterization of peptide-MHC binding landscapes with structural simulations.
|
| |
Proc Natl Acad Sci U S A,
108,
6981-6986.
|
|
|
|
|
|
|
F.Fogolari,
A.Corazza,
N.Varini,
M.Rotter,
D.Gumral,
L.Codutti,
E.Rennella,
P.Viglino,
V.Bellotti,
and
G.Esposito
(2011).
Molecular dynamics simulation of β(2) -microglobulin in denaturing and stabilizing conditions.
|
| |
Proteins,
79,
986.
|
|
|
|
|
|
|
K.Domanska,
S.Vanderhaegen,
V.Srinivasan,
E.Pardon,
F.Dupeux,
J.A.Marquez,
S.Giorgetti,
M.Stoppini,
L.Wyns,
V.Bellotti,
and
J.Steyaert
(2011).
Atomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic beta2-microglobulin variant.
|
| |
Proc Natl Acad Sci U S A,
108,
1314-1319.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
R.M.McMahon,
L.Friis,
C.Siebold,
M.A.Friese,
L.Fugger,
and
E.Y.Jones
(2011).
Structure of HLA-A*0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosis.
|
| |
Acta Crystallogr D Biol Crystallogr,
67,
447-454.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
S.Infantes,
E.Lorente,
J.J.Cragnolini,
M.Ramos,
R.García,
M.Jiménez,
S.Iborra,
M.Del Val,
and
D.López
(2011).
Unusual viral ligand with alternative interactions is presented by HLA-Cw4 in human respiratory syncytial virus-infected cells.
|
| |
Immunol Cell Biol,
89,
558-565.
|
|
|
|
|
|
|
S.Kang,
J.E.Yang,
J.Kim,
M.Ahn,
H.J.Koo,
M.Kim,
Y.S.Lee,
and
S.R.Paik
(2011).
Removal of intact β2-microglobulin at neutral ph by using seed-conjugated polymer beads prepared with β2-microglobulin-derived peptide (58-67).
|
| |
Biotechnol Prog,
27,
521-529.
|
|
|
|
|
|
|
A.Theodossis,
C.Guillonneau,
A.Welland,
L.K.Ely,
C.S.Clements,
N.A.Williamson,
A.I.Webb,
J.A.Wilce,
R.J.Mulder,
M.A.Dunstone,
P.C.Doherty,
J.McCluskey,
A.W.Purcell,
S.J.Turner,
and
J.Rossjohn
(2010).
Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.
|
| |
Proc Natl Acad Sci U S A,
107,
5534-5539.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
D.Gómez,
P.Conejeros,
S.H.Marshall,
and
S.Consuegra
(2010).
MHC evolution in three salmonid species: a comparison between class II alpha and beta genes.
|
| |
Immunogenetics,
62,
531-542.
|
|
|
|
|
|
|
H.C.Miller,
F.Allendorf,
and
C.H.Daugherty
(2010).
Genetic diversity and differentiation at MHC genes in island populations of tuatara (Sphenodon spp.).
|
| |
Mol Ecol,
19,
3894-3908.
|
|
|
|
|
|
|
H.Möhwald
(2010).
Future challenges in colloid and interfacial science.
|
| |
Colloid Polym Sci,
288,
123-131.
|
|
|
|
|
|
|
H.Mohd-Padil,
K.Tajul-Arifin,
and
A.Mohd-Adnan
(2010).
Characterization of the functional domain of β2-microglobulin from the Asian seabass, Lates calcarifer.
|
| |
PLoS One,
5,
e13159.
|
|
|
|
|
|
|
H.N.Eisen,
and
A.K.Chakraborty
(2010).
Evolving concepts of specificity in immune reactions.
|
| |
Proc Natl Acad Sci U S A,
107,
22373-22380.
|
|
|
|
|
|
|
L.G.Spurgin,
and
D.S.Richardson
(2010).
How pathogens drive genetic diversity: MHC, mechanisms and misunderstandings.
|
| |
Proc Biol Sci,
277,
979-988.
|
|
|
|
|
|
|
M.Ahn,
S.Kang,
H.J.Koo,
J.H.Lee,
Y.S.Lee,
and
S.R.Paik
(2010).
Nanoporous protein matrix made of amyloid fibrils of β2-microglobulin.
|
| |
Biotechnol Prog,
26,
1759-1764.
|
|
|
|
|
|
|
P.C.Doherty
(2010).
The glittering prizes.
|
| |
Nat Immunol,
11,
875-878.
|
|
|
|
|
|
|
S.I.Yoon,
M.Hong,
G.W.Han,
and
I.A.Wilson
(2010).
Crystal structure of soluble MD-1 and its interaction with lipid IVa.
|
| |
Proc Natl Acad Sci U S A,
107,
10990-10995.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
S.Wang,
R.Buchli,
J.Schiller,
J.Gao,
R.S.VanGundy,
W.H.Hildebrand,
and
D.D.Eckels
(2010).
Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity.
|
| |
World J Gastroenterol,
16,
1953-1969.
|
|
|
|
|
|
|
X.C.Li,
and
M.Raghavan
(2010).
Structure and function of major histocompatibility complex class I antigens.
|
| |
Curr Opin Organ Transplant,
15,
499-504.
|
|
|
|
|
|
|
A.Averdam,
B.Petersen,
C.Rosner,
J.Neff,
C.Roos,
M.Eberle,
F.Aujard,
C.Münch,
W.Schempp,
M.Carrington,
T.Shiina,
H.Inoko,
F.Knaust,
P.Coggill,
H.Sehra,
S.Beck,
L.Abi-Rached,
R.Reinhardt,
and
L.Walter
(2009).
A novel system of polymorphic and diverse NK cell receptors in primates.
|
| |
PLoS Genet,
5,
e1000688.
|
|
|
|
|
|
|
A.Ziegler,
C.A.Müller,
R.A.Böckmann,
and
B.Uchanska-Ziegler
(2009).
Low-affinity peptides and T-cell selection.
|
| |
Trends Immunol,
30,
53-60.
|
|
|
|
|
|
|
C.Vandiedonck,
and
J.C.Knight
(2009).
The human Major Histocompatibility Complex as a paradigm in genomics research.
|
| |
Brief Funct Genomic Proteomic,
8,
379-394.
|
|
|
|
|
|
|
E.Rennella,
A.Corazza,
F.Fogolari,
P.Viglino,
S.Giorgetti,
M.Stoppini,
V.Bellotti,
and
G.Esposito
(2009).
Equilibrium unfolding thermodynamics of beta2-microglobulin analyzed through native-state H/D exchange.
|
| |
Biophys J,
96,
169-179.
|
|
|
|
|
|
|
E.Thorsby
(2009).
A short history of HLA.
|
| |
Tissue Antigens,
74,
101-116.
|
|
|
|
|
|
|
H.C.Miller,
J.A.Moore,
N.J.Nelson,
and
C.H.Daugherty
(2009).
Influence of major histocompatibility complex genotype on mating success in a free-ranging reptile population.
|
| |
Proc Biol Sci,
276,
1695-1704.
|
|
|
|
|
|
|
H.V.Siddle,
J.E.Deakin,
P.Coggill,
E.Hart,
Y.Cheng,
E.S.Wong,
J.Harrow,
S.Beck,
and
K.Belov
(2009).
MHC-linked and un-linked class I genes in the wallaby.
|
| |
BMC Genomics,
10,
310.
|
|
|
|
|
|
|
J.Huang,
K.Makabe,
M.Biancalana,
A.Koide,
and
S.Koide
(2009).
Structural basis for exquisite specificity of affinity clamps, synthetic binding proteins generated through directed domain-interface evolution.
|
| |
J Mol Biol,
392,
1221-1231.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
J.Nunoya,
T.Nakashima,
A.Kawana-Tachikawa,
K.Kiyotani,
Y.Ito,
K.Sugimura,
and
A.Iwamoto
(2009).
Short communication: generation of recombinant monoclonal antibodies against an immunodominant HLA-A*2402-restricted HIV type 1 CTL epitope.
|
| |
AIDS Res Hum Retroviruses,
25,
897-904.
|
|
|
|
|
|
|
J.Visser,
J.Rozing,
A.Sapone,
K.Lammers,
and
A.Fasano
(2009).
Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms.
|
| |
Ann N Y Acad Sci,
1165,
195-205.
|
|
|
|
|
|
|
K.E.Routledge,
G.G.Tartaglia,
G.W.Platt,
M.Vendruscolo,
and
S.E.Radford
(2009).
Competition between intramolecular and intermolecular interactions in an amyloid-forming protein.
|
| |
J Mol Biol,
389,
776-786.
|
|
|
|
|
|
|
K.L.Johnson,
I.G.Ovsyannikova,
C.J.Mason,
H.R.Bergen,
and
G.A.Poland
(2009).
Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development.
|
| |
Vaccine,
28,
38-47.
|
|
|
|
|
|
|
L.A.Baxter-Lowe,
M.Maiers,
S.R.Spellman,
M.D.Haagenson,
T.Wang,
M.Fernandez-Vina,
S.G.Marsh,
M.Horowitz,
and
C.K.Hurley
(2009).
HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States.
|
| |
Biol Blood Marrow Transplant,
15,
971-981.
|
|
|
|
|
|
|
M.A.Mena,
J.A.Rodríguez-Navarro,
and
J.G.de Yébenes
(2009).
The multiple mechanisms of amyloid deposition: the role of parkin.
|
| |
Prion,
3,
5.
|
|
|
|
|
|
|
M.F.Calabrese,
and
A.D.Miranker
(2009).
Metal binding sheds light on mechanisms of amyloid assembly.
|
| |
Prion,
3,
1-4.
|
|
|
|
|
|
|
M.Promerová,
T.Albrecht,
and
J.Bryja
(2009).
Extremely high MHC class I variation in a population of a long-distance migrant, the Scarlet Rosefinch (Carpodacus erythrinus).
|
| |
Immunogenetics,
61,
451-461.
|
|
|
|
|
|
|
N.H.Heegaard
(2009).
beta(2)-microglobulin: from physiology to amyloidosis.
|
| |
Amyloid,
16,
151-173.
|
|
|
|
|
|
|
R.Palankar,
A.G.Skirtach,
O.Kreft,
M.Bédard,
M.Garstka,
K.Gould,
H.Möhwald,
G.B.Sukhorukov,
M.Winterhalter,
and
S.Springer
(2009).
Controlled intracellular release of peptides from microcapsules enhances antigen presentation on MHC class I molecules.
|
| |
Small,
5,
2168-2176.
|
|
|
|
|
|
|
S.A.Richman,
D.H.Aggen,
M.L.Dossett,
D.L.Donermeyer,
P.M.Allen,
P.D.Greenberg,
and
D.M.Kranz
(2009).
Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain ValphaVbeta fragments.
|
| |
Mol Immunol,
46,
902-916.
|
|
|
|
|
|
|
S.Singh,
G.K.Sonkar,
and
U.Singh
(2009).
Association of various inflammatory diseases with human leukocyte antigens B27, B7, Bw4 and Bw6 in patients with SSA.
|
| |
Rheumatol Int,
29,
1013-1016.
|
|
|
|
|
|
|
S.X.Xu,
W.H.Ren,
S.Z.Li,
F.W.Wei,
K.Y.Zhou,
and
G.Yang
(2009).
Sequence polymorphism and evolution of three cetacean MHC genes.
|
| |
J Mol Evol,
69,
260-275.
|
|
|
|
|
|
|
T.Ninkovic,
L.Kinarsky,
K.Engelmann,
V.Pisarev,
S.Sherman,
O.J.Finn,
and
F.G.Hanisch
(2009).
Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes.
|
| |
Mol Immunol,
47,
131-140.
|
|
|
|
|
|
|
V.Thammavongsa,
M.Schaefer,
T.Filzen,
K.L.Collins,
M.Carrington,
N.Bangia,
and
M.Raghavan
(2009).
Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503.
|
| |
Immunogenetics,
61,
703-716.
|
|
|
|
|
|
|
Y.Kim,
K.Kang,
I.Kim,
Y.J.Lee,
C.Oh,
J.Ryoo,
E.Jeong,
and
K.Ahn
(2009).
Molecular mechanisms of MHC class I-antigen processing: redox considerations.
|
| |
Antioxid Redox Signal,
11,
907-936.
|
|
|
|
|
|
|
Y.Serov,
G.Hommel-Berrey,
and
A.Lobashevsky
(2009).
Identification of a novel HLA-A*680202 allele by sequence-based typing in an African American individual.
|
| |
Tissue Antigens,
74,
435-437.
|
|
|
|
|
|
|
Y.Xiao,
X.Y.Zhou,
N.Liu,
Z.X.Zhang,
and
J.P.Cai
(2009).
Identification of a novel allele HLA-A*2489 by sequence-based typing in a Chinese individual.
|
| |
Tissue Antigens,
74,
249-250.
|
|
|
|
|
|
|
A.Aureli,
T.Del Beato,
F.Papola,
D.Adorno,
and
D.Piancatelli
(2008).
A new HLA-A allele identified in a leukemic patient attending hematopoietic cell transplantation: A*2318.
|
| |
Tissue Antigens,
71,
568-569.
|
|
|
|
|
|
|
C.S.Parry
(2008).
Flanking p10 contribution and sequence bias in matrix based epitope prediction: revisiting the assumption of independent binding pockets.
|
| |
BMC Struct Biol,
8,
44.
|
|
|
|
|
|
|
D.Wang,
and
Z.Zhang
(2008).
Characterization of the novel allele HLA-B*4075.
|
| |
Tissue Antigens,
71,
251-252.
|
|
|
|
|
|
|
F.Mohammed,
M.Cobbold,
A.L.Zarling,
M.Salim,
G.A.Barrett-Wilt,
J.Shabanowitz,
D.F.Hunt,
V.H.Engelhard,
and
B.E.Willcox
(2008).
Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self.
|
| |
Nat Immunol,
9,
1236-1243.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
H.Zhu,
D.Zhao,
X.Han,
J.Sun,
W.Da,
L.Yu,
and
C.Gao
(2008).
Identification of a new HLA-Cw*07 allele, HLA-Cw*0743, from a Chinese hematopoietic stem cell donor.
|
| |
Int J Hematol,
88,
321-323.
|
|
|
|
|
|
|
K.Antwi,
M.Mahar,
R.Srikanth,
M.R.Olbris,
J.F.Tyson,
and
R.W.Vachet
(2008).
Cu(II) organizes beta-2-microglobulin oligomers but is released upon amyloid formation.
|
| |
Protein Sci,
17,
748-759.
|
|
|
|
|
|
|
M.F.Calabrese,
C.M.Eakin,
J.M.Wang,
and
A.D.Miranker
(2008).
A regulatable switch mediates self-association in an immunoglobulin fold.
|
| |
Nat Struct Mol Biol,
15,
965-971.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
M.Kamoun,
J.H.Holmes,
A.K.Israni,
J.D.Kearns,
V.Teal,
W.P.Yang,
S.E.Rosas,
M.M.Joffe,
H.Li,
and
H.I.Feldman
(2008).
HLA-A amino acid polymorphism and delayed kidney allograft function.
|
| |
Proc Natl Acad Sci U S A,
105,
18883-18888.
|
|
|
|
|
|
|
M.Saitakis,
A.Dellaporta,
and
E.Gizeli
(2008).
Measurement of two-dimensional binding constants between cell-bound major histocompatibility complex and immobilized antibodies with an acoustic biosensor.
|
| |
Biophys J,
95,
4963-4971.
|
|
|
|
|
|
|
P.Marrack,
J.P.Scott-Browne,
S.Dai,
L.Gapin,
and
J.W.Kappler
(2008).
Evolutionarily conserved amino acids that control TCR-MHC interaction.
|
| |
Annu Rev Immunol,
26,
171-203.
|
|
|
|
|
|
|
R.F.Furlong,
and
Z.Yang
(2008).
Diversifying and purifying selection in the peptide binding region of DRB in mammals.
|
| |
J Mol Evol,
66,
384-394.
|
|
|
|
|
|
|
R.Kelsch,
T.M.Binder,
and
W.Sibrowski
(2008).
Identification of the novel allele HLA-A*9237 in peripheral blood of a bone marrow donor.
|
| |
Tissue Antigens,
71,
480-481.
|
|
|
|
|
|
|
A.Heinold,
M.Bauer,
S.Scherer,
G.Opelz,
and
T.H.Tran
(2007).
Characterization of a new HLA-B allele, HLA-B*5312, and re-evaluation of the published sequences of the untranslated regions of HLA-B*35 and HLA-B*53.
|
| |
Tissue Antigens,
70,
319-323.
|
|
|
|
|
|
|
A.J.McMichael,
and
A.J.McMichael
(2007).
From influenza to HIV--and back?
|
| |
Nat Immunol,
8,
1149-1151.
|
|
|
|
|
|
|
A.Kienast,
M.Preuss,
M.Winkler,
and
T.P.Dick
(2007).
Redox regulation of peptide receptivity of major histocompatibility complex class I molecules by ERp57 and tapasin.
|
| |
Nat Immunol,
8,
864-872.
|
|
|
|
|
|
|
B.Ay,
M.Streitz,
P.Boisguerin,
A.Schlosser,
C.C.Mahrenholz,
S.D.Schuck,
F.Kern,
and
R.Volkmer
(2007).
Sorting and pooling strategy: a novel tool to map a virus proteome for CD8 T-cell epitopes.
|
| |
Biopolymers,
88,
64-75.
|
|
|
|
|
|
|
B.Bodey
(2007).
Thymic reticulo-epithelial cells: key cells of neuroendocrine regulation.
|
| |
Expert Opin Biol Ther,
7,
939-949.
|
|
|
|
|
|
|
C.Li,
and
Q.Wu
(2007).
Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes.
|
| |
BMC Evol Biol,
7,
69.
|
|
|
|
|
|
|
D.Masopust,
V.Vezys,
E.J.Wherry,
and
R.Ahmed
(2007).
A brief history of CD8 T cells.
|
| |
Eur J Immunol,
37,
S103-S110.
|
|
|
|
|
|
|
E.Garino,
J.Miertus,
M.Berrino,
F.Bertinetto,
P.Caropreso,
V.Gay,
G.Mazzola,
F.Tondat,
V.Frecer,
S.Miertus,
and
A.Amoroso
(2007).
Molecular aspects of a novel HLA-A*02 allele (A*0297): the first HLA class I allele mutated at codon 232.
|
| |
Tissue Antigens,
69,
342-347.
|
|
|
|
|
|
|
E.J.Adams,
Z.S.Juo,
R.T.Venook,
M.J.Boulanger,
H.Arase,
L.L.Lanier,
and
K.C.Garcia
(2007).
Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors.
|
| |
Proc Natl Acad Sci U S A,
104,
10128-10133.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
J.Carey,
S.Lindman,
M.Bauer,
and
S.Linse
(2007).
Protein reconstitution and three-dimensional domain swapping: benefits and constraints of covalency.
|
| |
Protein Sci,
16,
2317-2333.
|
|
|
|
|
|
|
J.H.Kessler,
and
C.J.Melief
(2007).
Identification of T-cell epitopes for cancer immunotherapy.
|
| |
Leukemia,
21,
1859-1874.
|
|
|
|
|
|
|
J.M.Dijkstra,
T.Katagiri,
K.Hosomichi,
K.Yanagiya,
H.Inoko,
M.Ototake,
T.Aoki,
K.Hashimoto,
and
T.Shiina
(2007).
A third broad lineage of major histocompatibility complex (MHC) class I in teleost fish; MHC class II linkage and processed genes.
|
| |
Immunogenetics,
59,
305-321.
|
|
|
|
|
|
|
J.Mans,
K.Natarajan,
A.Balbo,
P.Schuck,
D.Eikel,
S.Hess,
H.Robinson,
H.Simic,
S.Jonjic,
C.T.Tiemessen,
and
D.H.Margulies
(2007).
Cellular expression and crystal structure of the murine cytomegalovirus major histocompatibility complex class I-like glycoprotein, m153.
|
| |
J Biol Chem,
282,
35247-35258.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
J.Moscoso,
J.I.Serrano-Vela,
B.Perez-Saborido,
E.Moreno,
and
A.Arnaiz-Villena
(2007).
A novel HLA-G allele (HLA-G*0108) with an alpha-3 domain amino acid change.
|
| |
Tissue Antigens,
70,
171-173.
|
|
|
|
|
|
|
J.Wischhusen,
A.Waschbisch,
and
H.Wiendl
(2007).
Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
|
| |
Semin Cancer Biol,
17,
459-468.
|
|
|
|
|
|
|
L.Teyton
(2007).
The saga of MHC-bound peptides: a renaissance for antigen presentation?
|
| |
J Clin Invest,
117,
3164-3166.
|
|
|
|
|
|
|
M.Lee,
C.Kistler,
T.B.Hartmann,
F.Li,
R.Dummer,
E.Dippel,
N.Booken,
C.D.Klemke,
D.Schadendorf,
and
S.B.Eichmüller
(2007).
Immunoscreening of a cutaneous T-cell lymphoma library for plasma membrane proteins.
|
| |
Cancer Immunol Immunother,
56,
783-795.
|
|
|
|
|
|
|
M.Provenzano,
S.Selleri,
P.Jin,
E.Wang,
R.Werden,
S.Slezak,
S.D.Adams,
M.C.Panelli,
S.F.Leitman,
D.F.Stroncek,
and
F.M.Marincola
(2007).
Comprehensive epitope mapping of the Epstein-Barr virus latent membrane protein-2 in normal, non tumor-bearing individuals.
|
| |
Cancer Immunol Immunother,
56,
1047-1063.
|
|
|
|
|
|
|
N.E.Elamin,
M.I.Elbashir,
I.M.Elkhidir,
G.Elghazali,
R.Blasczyk,
and
P.A.Horn
(2007).
Identification of four new HLA-Cw alleles in the Sudanese population.
|
| |
Tissue Antigens,
69,
270-272.
|
|
|
|
|
|
|
P.Contini,
M.R.Zocchi,
I.Pierri,
A.Albarello,
and
A.Poggi
(2007).
In vivo apoptosis of CD8(+) lymphocytes in acute myeloid leukemia patients: involvement of soluble HLA-I and Fas ligand.
|
| |
Leukemia,
21,
253-260.
|
|
|
|
|
|
|
R.W.Hoffman
(2007).
T cells and the loss of immunologic tolerance in Sjögren's syndrome and systemic lupus erythematosus.
|
| |
Arthritis Rheum,
56,
3180-3182.
|
|
|
|
|
|
|
S.Vucetic,
H.Xie,
L.M.Iakoucheva,
C.J.Oldfield,
A.K.Dunker,
Z.Obradovic,
and
V.N.Uversky
(2007).
Functional anthology of intrinsic disorder. 2. Cellular components, domains, technical terms, developmental processes, and coding sequence diversities correlated with long disordered regions.
|
| |
J Proteome Res,
6,
1899-1916.
|
|
|
|
|
|
|
S.Xu,
P.Sun,
K.Zhou,
and
G.Yang
(2007).
Sequence variability at three MHC loci of finless porpoises (Neophocaena phocaenoides).
|
| |
Immunogenetics,
59,
581-592.
|
|
|
|
|
|
|
S.Y.Choo
(2007).
The HLA system: genetics, immunology, clinical testing, and clinical implications.
|
| |
Yonsei Med J,
48,
11-23.
|
|
|
|
|
|
|
S.Yoon,
J.Y.Baek,
S.S.Hur,
O.J.Kwon,
and
K.Kwack
(2007).
Identification of a novel HLA-B*58 allele, B*5813, by sequence-based typing of DNA from Korean baby cord blood.
|
| |
Tissue Antigens,
69,
366-367.
|
|
|
|
|
|
|
W.Lutz
(2007).
Pas de deux: Natural Killer Receptors and MHC Class I Ligands in Primates.
|
| |
Curr Genomics,
8,
51-57.
|
|
|
|
|
|
|
Y.H.Chien,
and
Y.Konigshofer
(2007).
Antigen recognition by gammadelta T cells.
|
| |
Immunol Rev,
215,
46-58.
|
|
|
|
|
|
|
Y.Sun,
F.Kong,
S.Ren,
F.Yuan,
F.Liang,
N.Liu,
L.Jin,
and
Y.Xi
(2007).
Severe acute graft-vs-host disease in a patient with acute monocytic leukemia having a recombination event between HLA-A/B loci from a multiple recombinant family.
|
| |
Tissue Antigens,
70,
499-505.
|
|
|
|
|
|
|
Y.Suzuki
(2007).
Inferring natural selection operating on conservative and radical substitution at single amino acid sites.
|
| |
Genes Genet Syst,
82,
341-360.
|
|
|
|
|
|
|
A.Aureli,
D.Piancatelli,
G.Ozzella,
G.Liberatore,
A.Piazza,
and
D.Adorno
(2006).
B*3812: a new HLA-B38 variant identified by sequence-based typing.
|
| |
Tissue Antigens,
68,
91-93.
|
|
|
|
|
|
|
A.Kosmopoulou,
M.Vlassi,
A.Stavrakoudis,
C.Sakarellos,
and
M.Sakarellos-Daitsiotis
(2006).
T-cell epitopes of the La/SSB autoantigen: prediction based on the homology modeling of HLA-DQ2/DQ7 with the insulin-B peptide/HLA-DQ8 complex.
|
| |
J Comput Chem,
27,
1033-1044.
|
|
|
|
|
|
|
A.Suri,
J.J.Walters,
M.G.Levisetti,
M.L.Gross,
and
E.R.Unanue
(2006).
Identification of naturally processed peptides bound to the class I MHC molecule H-2Kd of normal and TAP-deficient cells.
|
| |
Eur J Immunol,
36,
544-557.
|
|
|
|
|
|
|
B.Park,
S.Lee,
E.Kim,
K.Cho,
S.R.Riddell,
S.Cho,
and
K.Ahn
(2006).
Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing.
|
| |
Cell,
127,
369-382.
|
|
|
|
|
|
|
C.M.Eakin,
A.J.Berman,
and
A.D.Miranker
(2006).
A native to amyloidogenic transition regulated by a backbone trigger.
|
| |
Nat Struct Mol Biol,
13,
202-208.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
C.N.Baxevanis,
N.N.Sotiriadou,
A.D.Gritzapis,
P.A.Sotiropoulou,
S.A.Perez,
N.T.Cacoullos,
and
M.Papamichail
(2006).
Immunogenic HER-2/neu peptides as tumor vaccines.
|
| |
Cancer Immunol Immunother,
55,
85-95.
|
|
|
|
|
|
|
C.S.Clements,
M.A.Dunstone,
W.A.Macdonald,
J.McCluskey,
and
J.Rossjohn
(2006).
Specificity on a knife-edge: the alphabeta T cell receptor.
|
| |
Curr Opin Struct Biol,
16,
787-795.
|
|
|
|
|
|
|
C.Thilo,
P.Berglund,
S.E.Applequist,
J.W.Yewdell,
H.G.Ljunggren,
and
A.Achour
(2006).
Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2.
|
| |
J Biol Chem,
281,
8950-8957.
|
|
|
|
|
|
|
D.K.Cole,
P.J.Rizkallah,
F.Gao,
N.I.Watson,
J.M.Boulter,
J.I.Bell,
M.Sami,
G.F.Gao,
and
B.K.Jakobsen
(2006).
Crystal structure of HLA-A*2402 complexed with a telomerase peptide.
|
| |
Eur J Immunol,
36,
170-179.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
E.Huchard,
G.Cowlishaw,
M.Raymond,
M.Weill,
and
L.A.Knapp
(2006).
Molecular study of Mhc-DRB in wild chacma baboons reveals high variability and evidence for trans-species inheritance.
|
| |
Immunogenetics,
58,
805-816.
|
|
|
|
|
|
|
E.Martinez-Hackert,
N.Anikeeva,
S.A.Kalams,
B.D.Walker,
W.A.Hendrickson,
and
Y.Sykulev
(2006).
Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes.
|
| |
J Biol Chem,
281,
20205-20212.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
E.R.Unanue,
and
E.R.Unanue
(2006).
From antigen processing to peptide-MHC binding.
|
| |
Nat Immunol,
7,
1277-1279.
|
|
|
|
|
|
|
F.Liu,
S.Wang,
Y.Ye,
H.Zhang,
Y.Zhang,
and
W.Chen
(2006).
Identification and functional perspective of a novel HLA-A allele: A*0279.
|
| |
Immunogenetics,
58,
339-346.
|
|
|
|
|
|
|
H.Kudat,
G.Telci,
A.B.Sozen,
F.Oguz,
V.Akkaya,
M.Ozcan,
D.Atilgan,
M.Carin,
and
O.Guven
(2006).
The role of HLA molecules in susceptibility to chronic rheumatic heart disease.
|
| |
Int J Immunogenet,
33,
41-44.
|
|
|
|
|
|
|
H.S.Yun,
J.Y.Baek,
S.S.Hur,
O.J.Kwon,
and
K.Kwack
(2006).
Identification of a novel HLA-A*02 allele, A*0287, in the cord blood of a Korean baby.
|
| |
Tissue Antigens,
67,
167-168.
|
|
|
|
|
|
|
I.G.Ovsyannikova,
N.Dhiman,
R.M.Jacobson,
and
G.A.Poland
(2006).
Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines.
|
| |
Expert Rev Vaccines,
5,
33-43.
|
|
|
|
|
|
|
J.L.Strominger,
and
J.L.Strominger
(2006).
The tortuous journey of a biochemist to immunoland and what he found there.
|
| |
Annu Rev Immunol,
24,
1.
|
|
|
|
|
|
|
J.M.Dijkstra,
I.Kiryu,
Y.Yoshiura,
A.Kumánovics,
M.Kohara,
N.Hayashi,
and
M.Ototake
(2006).
Polymorphism of two very similar MHC class Ib loci in rainbow trout (Oncorhynchus mykiss).
|
| |
Immunogenetics,
58,
152-167.
|
|
|
|
|
|
|
J.Racape,
F.Connan,
J.Hoebeke,
J.Choppin,
and
J.G.Guillet
(2006).
Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation.
|
| |
Proc Natl Acad Sci U S A,
103,
18208-18213.
|
|
|
|
|
|
|
J.Y.Baek,
Y.Y.Cha,
Y.S.Heo,
K.Kwack,
and
O.J.Kwon
(2006).
Identification of a novel HLA-B*51 allele, HLA-B*5137, in the Korean population.
|
| |
Tissue Antigens,
67,
254-255.
|
|
|
|
|
|
|
L.L.Jones,
S.E.Brophy,
A.J.Bankovich,
L.A.Colf,
N.A.Hanick,
K.C.Garcia,
and
D.M.Kranz
(2006).
Engineering and characterization of a stabilized alpha1/alpha2 module of the class I major histocompatibility complex product Ld.
|
| |
J Biol Chem,
281,
25734-25744.
|
|
|
|
|
|
|
M.Kihara,
E.Chatani,
K.Iwata,
K.Yamamoto,
T.Matsuura,
A.Nakagawa,
H.Naiki,
and
Y.Goto
(2006).
Conformation of amyloid fibrils of beta2-microglobulin probed by tryptophan mutagenesis.
|
| |
J Biol Chem,
281,
31061-31069.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
N.Gouin,
A.M.Wright,
K.B.Miska,
Z.E.Parra,
P.B.Samollow,
M.L.Baker,
and
R.D.Miller
(2006).
Modo-UG, a marsupial nonclassical MHC class I locus.
|
| |
Immunogenetics,
58,
396-406.
|
|
|
|
|
|
|
N.J.Deng,
L.Yan,
D.Singh,
and
P.Cieplak
(2006).
Molecular basis for the Cu2+ binding-induced destabilization of beta2-microglobulin revealed by molecular dynamics simulation.
|
| |
Biophys J,
90,
3865-3879.
|
|
|
|
|
|
|
N.Mehra,
and
G.Kaur
(2006).
HLA genetics and disease with particular reference to Type 1 diabetes and HIV infection in Asian Indians.
|
| |
Expert Rev Clin Immunol,
2,
901-913.
|
|
|
|
|
|
|
P.J.Bjorkman
(2006).
Finding the groove.
|
| |
Nat Immunol,
7,
787-789.
|
|
|
|
|
|
|
P.Tripathi,
S.Naik,
and
S.Agrawal
(2006).
HLA-E and immunobiology of pregnancy.
|
| |
Tissue Antigens,
67,
207-213.
|
|
|
|
|
|
|
R.Olson,
C.Dulac,
and
P.J.Bjorkman
(2006).
MHC homologs in the nervous system--they haven't lost their groove.
|
| |
Curr Opin Neurobiol,
16,
351-357.
|
|
|
|
|
|
|
S.Bernales,
F.R.Papa,
and
P.Walter
(2006).
Intracellular signaling by the unfolded protein response.
|
| |
Annu Rev Cell Dev Biol,
22,
487-508.
|
|
|
|
|
|
|
S.Frison,
E.Longhi,
A.Espadas de Arias,
E.Andreini,
F.Poli,
and
M.Scalamogna
(2006).
Characterization of the novel allele HLA-B*3710.
|
| |
Tissue Antigens,
67,
173-174.
|
|
|
|
|
|
|
S.H.Hwang,
Y.S.Lim,
O.J.Kwon,
Y.S.Heo,
and
H.B.Oh
(2006).
Structural aspects of the B*3564 molecule, a novel HLA-B*35 allele identified by sequence-based typing.
|
| |
Tissue Antigens,
68,
90-91.
|
|
|
|
|
|
|
S.Viatte,
P.M.Alves,
and
P.Romero
(2006).
Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles.
|
| |
Immunol Cell Biol,
84,
318-330.
|
|
|
|
|
|
|
T.F.Tang,
L.Hou,
B.Tu,
W.Y.Hwang,
A.E.Yeoh,
J.Ng,
and
C.K.Hurley
(2006).
Identification of nine new HLA class I alleles in volunteers from the Singapore stem cell donor registries.
|
| |
Tissue Antigens,
68,
518-520.
|
|
|
|
|
|
|
T.Suda,
T.Tsunoda,
N.Uchida,
T.Watanabe,
S.Hasegawa,
S.Satoh,
S.Ohgi,
Y.Furukawa,
Y.Nakamura,
and
H.Tahara
(2006).
Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray.
|
| |
Cancer Sci,
97,
411-419.
|
|
|
|
|
|
|
V.Cerundolo,
and
H.de la Salle
(2006).
Description of HLA class I- and CD8-deficient patients: Insights into the function of cytotoxic T lymphocytes and NK cells in host defense.
|
| |
Semin Immunol,
18,
330-336.
|
|
|
|
|
|
|
Y.Watanabe,
N.Aoyama,
T.Sakai,
D.Shirasaka,
S.Maekawa,
K.Kuroda,
C.Wambura,
T.Tamura,
Y.Nose,
and
M.Kasuga
(2006).
HLA-DQB1 locus and gastric cancer in Helicobacter pylori infection.
|
| |
J Gastroenterol Hepatol,
21,
420-424.
|
|
|
|
|
|
|
Y.Y.Cha,
J.Y.Baek,
Y.S.Heo,
K.Kwack,
and
O.J.Kwon
(2006).
A novel identification of HLA-B*07 allele, HLA-B*0743, in the Korean population.
|
| |
Tissue Antigens,
67,
172-173.
|
|
|
|
|
|
|
Y.Zhang,
E.Baig,
and
D.B.Williams
(2006).
Functions of ERp57 in the folding and assembly of major histocompatibility complex class I molecules.
|
| |
J Biol Chem,
281,
14622-14631.
|
|
|
|
|
|
|
B.Franke,
T.S.Galloway,
and
T.J.Wilkin
(2005).
Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies.
|
| |
Diabetes Metab Res Rev,
21,
395-415.
|
|
|
|
|
|
|
D.Piancatelli,
T.D.Beato,
F.Papola,
A.Aureli,
A.Fioroni,
A.Canossi,
E.Mastrangelo,
G.Liberatore,
A.Tessitore,
and
D.Adorno
(2005).
Identification of a novel HLA-A*02 allele, A*027401*.
|
| |
Tissue Antigens,
66,
138-140.
|
|
|
|
|
|
|
H.Ishida,
K.Tanabe,
M.Furusawa,
T.Ishizuka,
T.Hayashi,
T.Tokumoto,
N.Miyamoto,
H.Shirakawa,
H.Shimmura,
T.Shimizu,
and
H.Toma
(2005).
Evaluation of flow cytometric panel reactive antibody in renal transplant recipients - examination of 238 cases of renal transplantation.
|
| |
Transpl Int,
18,
163-168.
|
|
|
|
|
|
|
J.A.López de Castro
(2005).
HLA-B27: portraying immunodominant viral epitopes.
|
| |
Eur J Immunol,
35,
336-340.
|
|
|
|
|
|
|
K.Hoelsch,
I.Lenggeler,
W.Pfannes,
H.Knabe,
H.G.Klein,
and
A.Woelpl
(2005).
Routine HLA-B genotyping with PCR-sequence-specific oligonucleotides detects a B*52 variant (B*5206).
|
| |
Tissue Antigens,
65,
488-492.
|
|
|
|
|
|
|
K.L.Johnson,
I.G.Ovsyannikova,
B.J.Madden,
G.A.Poland,
and
D.C.Muddiman
(2005).
Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus.
|
| |
J Am Soc Mass Spectrom,
16,
1812-1817.
|
|
|
|
|
|
|
M.Kihara,
E.Chatani,
M.Sakai,
K.Hasegawa,
H.Naiki,
and
Y.Goto
(2005).
Seeding-dependent maturation of beta2-microglobulin amyloid fibrils at neutral pH.
|
| |
J Biol Chem,
280,
12012-12018.
|
|
|
|
|
|
|
M.Sachdev,
R.Sankaranarayanan,
P.Reddanna,
K.Thangaraj,
and
L.Singh
(2005).
Major histocompatibility complex class I polymorphism in Asiatic lions.
|
| |
Tissue Antigens,
66,
9.
|
|
|
|
|
|
|
O.J.Kwon,
S.H.Hwang,
S.S.Hur,
M.N.Lee,
and
H.B.Oh
(2005).
Novel HLA-Cw*01 allele, Cw*010203, identified by sequence-based typing*.
|
| |
Tissue Antigens,
66,
240-241.
|
|
|
|
|
|
|
O.J.Kwon,
S.H.Hwang,
Y.S.Heo,
S.S.Hur,
and
H.B.Oh
(2005).
Structural aspect of B*4811 molecule, a novel HLA-B*48 allele identified by sequence-based typing.
|
| |
Tissue Antigens,
66,
707-709.
|
|
|
|
|
|
|
O.J.Kwon,
S.H.Hwang,
Y.S.Heo,
S.S.Hur,
M.N.Lee,
and
H.B.Oh
(2005).
Novel HLA-A*11 allele, A*1120, identified by sequence-based typing.
|
| |
Tissue Antigens,
66,
141-144.
|
|
|
|
|
|
|
S.C.Meredith
(2005).
Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
|
| |
Ann N Y Acad Sci,
1066,
181-221.
|
|
|
|
|
|
|
S.H.Hwang,
C.H.Cha,
O.J.Kwon,
Y.S.Heo,
S.S.Hur,
M.N.Lee,
and
H.B.Oh
(2005).
Novel HLA-Cw*06 allele, Cw*0612, identified by sequence-based typing.
|
| |
Tissue Antigens,
66,
330-331.
|
|
|
|
|
|
|
S.H.Hwang,
H.B.Oh,
S.S.Hur,
M.N.Lee,
S.A.Hong,
and
O.J.Kwon
(2005).
Novel HLA-A*31 allele, A*3111 identified by sequence-based typing.
|
| |
Tissue Antigens,
66,
145-147.
|
|
|
|
|
|
|
S.Krishnakumar,
S.A.Lakshmi,
V.Pusphparaj,
A.Iyer,
D.Abhyankar,
and
J.Biswas
(2005).
Human leukocyte class I antigen and beta2-microglobulin expression in conjunctival dysplasia, carcinoma in situ, and squamous cell carcinoma.
|
| |
Cornea,
24,
337-341.
|
|
|
|
|
|
|
S.Madurga,
I.Belda,
X.Llorà,
and
E.Giralt
(2005).
Design of enhanced agonists through the use of a new virtual screening method: application to peptides that bind class I major histocompatibility complex (MHC) molecules.
|
| |
Protein Sci,
14,
2069-2079.
|
|
|
|
|
|
|
T.Blicher,
J.S.Kastrup,
S.Buus,
and
M.Gajhede
(2005).
High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide.
|
| |
Acta Crystallogr D Biol Crystallogr,
61,
1031-1040.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
T.Elliott,
and
A.Williams
(2005).
The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex.
|
| |
Immunol Rev,
207,
89-99.
|
|
|
|
|
|
|
T.Raine,
and
R.Allen
(2005).
MHC-I recognition by receptors on myelomonocytic cells: new tricks for old dogs?
|
| |
Bioessays,
27,
542-550.
|
|
|
|
|
|
|
T.V.Lebedeva,
M.Ohashi,
A.Huang,
S.Vasconcellos,
S.Flesch,
and
N.Yu
(2005).
Emerging new alleles suggest high diversity of HLA-C locus.
|
| |
Tissue Antigens,
65,
101-106.
|
|
|
|
|
|
|
Y.Ohhashi,
M.Kihara,
H.Naiki,
and
Y.Goto
(2005).
Ultrasonication-induced amyloid fibril formation of beta2-microglobulin.
|
| |
J Biol Chem,
280,
32843-32848.
|
|
|
|
|
|
|
A.D.Miranker
(2004).
Unzipping the mysteries of amyloid fiber formation.
|
| |
Proc Natl Acad Sci U S A,
101,
4335-4336.
|
|
|
|
|
|
|
A.I.Webb,
M.A.Dunstone,
W.Chen,
M.I.Aguilar,
Q.Chen,
H.Jackson,
L.Chang,
L.Kjer-Nielsen,
T.Beddoe,
J.McCluskey,
J.Rossjohn,
and
A.W.Purcell
(2004).
Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue.
|
| |
J Biol Chem,
279,
23438-23446.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
A.J.Borysik,
P.Read,
D.R.Little,
R.H.Bateman,
S.E.Radford,
and
A.E.Ashcroft
(2004).
Separation of beta2-microglobulin conformers by high-field asymmetric waveform ion mobility spectrometry (FAIMS) coupled to electrospray ionisation mass spectrometry.
|
| |
Rapid Commun Mass Spectrom,
18,
2229-2234.
|
|
|
|
|
|
|
A.J.Borysik,
S.E.Radford,
and
A.E.Ashcroft
(2004).
Co-populated conformational ensembles of beta2-microglobulin uncovered quantitatively by electrospray ionization mass spectrometry.
|
| |
J Biol Chem,
279,
27069-27077.
|
|
|
|
|
|
|
C.Hirsch,
S.Misaghi,
D.Blom,
M.E.Pacold,
and
H.L.Ploegh
(2004).
Yeast N-glycanase distinguishes between native and non-native glycoproteins.
|
| |
EMBO Rep,
5,
201-206.
|
|
|
|
|
|
|
D.Zanuy,
K.Gunasekaran,
B.Ma,
H.H.Tsai,
C.J.Tsai,
and
R.Nussinov
(2004).
Insights into amyloid structural formation and assembly through computational approaches.
|
| |
Amyloid,
11,
143-161.
|
|
|
|
|
|
|
E.Longhi,
S.Frison,
F.Poli,
A.Espadas de Arias,
C.Zanuso,
E.Guizzardi,
and
M.Scalamogna
(2004).
Identification of two new HLA-B alleles, HLA-B*0732 and HLA-B*5809, by sequence-based typing.
|
| |
Tissue Antigens,
63,
273-278.
|
|
|
|
|
|
|
E.Simpson,
and
P.Medawar
(2004).
Reminiscences of Sir Peter Medawar: in hope of antigen-specific transplantation tolerance.
|
| |
Am J Transplant,
4,
1937-1940.
|
|
|
|
|
|
|
G.Chapman,
C.Kennedy,
W.D.Greville,
R.Dodd,
J.Hersee,
A.Taverniti,
T.Le,
R.Wallace,
A.Kennedy,
and
H.Dunckley
(2004).
Identification of new HLA-C alleles by polymerase chain reaction-sequence specific oligonucleotide typing: Cw*0314 and Cw*1511*.
|
| |
Tissue Antigens,
64,
506-508.
|
|
|
|
|
|
|
G.J.Laundy,
B.A.Bradley,
B.M.Rees,
M.Younie,
and
J.M.Hows
(2004).
Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia.
|
| |
Transfusion,
44,
814-825.
|
|
|
|
|
|
|
H.Dunckley,
R.Dodd,
W.D.Greville,
J.Hersee,
T.Le,
A.Taverniti,
R.Wallace,
J.Strickland,
J.P.Hogbin,
J.Truong,
and
Z.M.Velickovic
(2004).
A new HLA-B allele, B*1565, identified in three unrelated samples.
|
| |
Tissue Antigens,
63,
584-586.
|
|
|
|
|
|
|
H.S.Park,
J.H.Choi,
and
K.W.Lee
(2004).
Identification of a novel HLA-B*55 variant (B*5513) from a Korean family.
|
| |
Tissue Antigens,
64,
96-98.
|
|
|
|
|
|
|
J.Dausset
(2004).
An interview with Jean Dausset.
|
| |
Am J Transplant,
4,
4-7.
|
|
|
|
|
|
|
J.Deisenhofer,
and
H.Michel
(2004).
The photosynthetic reaction centre from the purple bacterium Rhodopseudomonas viridis.
|
| |
Biosci Rep,
24,
323-361.
|
|
|
|
|
|
|
J.E.García-Ortiz,
S.T.Cox,
L.Sandoval-Ramirez,
A.M.Little,
S.G.Marsh,
J.A.Madrigal,
and
J.R.Argüello
(2004).
A novel HLA-A allele: A*0257.
|
| |
Tissue Antigens,
63,
85-87.
|
|
|
|
|
|
|
J.Hersee,
R.Dodd,
W.D.Greville,
G.Chapman,
A.Taverniti,
T.Le,
R.Wallace,
A.Kennedy,
and
H.Dunckley
(2004).
Detection of a novel HLA-A allele by polymerase chain reaction-sequence-specific oligonucleotide typing: HLA-A*0252.
|
| |
Tissue Antigens,
63,
587-588.
|
|
|
|
|
|
|
J.Villanueva,
M.Hoshino,
H.Katou,
J.Kardos,
K.Hasegawa,
H.Naiki,
and
Y.Goto
(2004).
Increase in the conformational flexibility of beta 2-microglobulin upon copper binding: a possible role for copper in dialysis-related amyloidosis.
|
| |
Protein Sci,
13,
797-809.
|
|
|
|
|
|
|
L.Smallwood,
and
A.G.Baxter
(2004).
On lawnmowers and lay-down misères.
|
| |
Immunology,
111,
252-253.
|
|
|
|
|
|
|
M.Zhou,
Y.Xu,
Z.Lou,
D.K.Cole,
X.Li,
Y.Liu,
P.Tien,
Z.Rao,
and
G.F.Gao
(2004).
Complex assembly, crystallization and preliminary X-ray crystallographic studies of MHC H-2Kd complexed with an HBV-core nonapeptide.
|
| |
Acta Crystallogr D Biol Crystallogr,
60,
1473-1475.
|
|
|
|
|
|
|
R.C.Hillig,
M.Hülsmeyer,
W.Saenger,
K.Welfle,
R.Misselwitz,
H.Welfle,
C.Kozerski,
A.Volz,
B.Uchanska-Ziegler,
and
A.Ziegler
(2004).
Thermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association.
|
| |
J Biol Chem,
279,
652-663.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
R.D.Emes,
S.A.Beatson,
C.P.Ponting,
and
L.Goodstadt
(2004).
Evolution and comparative genomics of odorant- and pheromone-associated genes in rodents.
|
| |
Genome Res,
14,
591-602.
|
|
|
|
|
|
|
R.Dodd,
J.Hersee,
W.D.Greville,
G.Chapman,
A.Taverniti,
T.Le,
R.Wallace,
A.Kennedy,
and
H.Dunckley
(2004).
New HLA-B alleles detected by polymerase chain reaction-sequence-specific oligonucleotide typing: HLA-B*0725, B*0728, and B*3808.
|
| |
Tissue Antigens,
63,
598-599.
|
|
|
|
|
|
|
R.Horton,
L.Wilming,
V.Rand,
R.C.Lovering,
E.A.Bruford,
V.K.Khodiyar,
M.J.Lush,
S.Povey,
C.C.Talbot,
M.W.Wright,
H.M.Wain,
J.Trowsdale,
A.Ziegler,
and
S.Beck
(2004).
Gene map of the extended human MHC.
|
| |
Nat Rev Genet,
5,
889-899.
|
|
|
|
|
|
|
R.N.Germain
(2004).
An innately interesting decade of research in immunology.
|
| |
Nat Med,
10,
1307-1320.
|
|
|
|
|
|
|
S.Frison,
L.Crespiatico,
E.Longhi,
E.Guizzardi,
F.Poli,
and
M.Scalamogna
(2004).
HLA-B*1819, a novel HLA-B allele identified by sequence-based typing.
|
| |
Tissue Antigens,
63,
592-594.
|
|
|
|
|
|
|
S.Kundu,
and
C.G.Faulkes
(2004).
Patterns of MHC selection in African mole-rats, family Bathyergidae: the effects of sociality and habitat.
|
| |
Proc Biol Sci,
271,
273-278.
|
|
|
|
|
|
|
V.Apostolopoulos,
and
E.Lazoura
(2004).
Noncanonical peptides in complex with MHC class I.
|
| |
Expert Rev Vaccines,
3,
151-162.
|
|
|
|
|
|
|
W.S.Wong,
Z.Yang,
N.Goldman,
and
R.Nielsen
(2004).
Accuracy and power of statistical methods for detecting adaptive evolution in protein coding sequences and for identifying positively selected sites.
|
| |
Genetics,
168,
1041-1051.
|
|
|
|
|
|
|
W.T.Swelsen,
C.E.Voorter,
and
E.M.van den Berg-Loonen
(2004).
Ambiguities of human leukocyte antigen-B resolved by sequence-based typing of exons 1, 4, and 5.
|
| |
Tissue Antigens,
63,
248-254.
|
|
|
|
|
|
|
Y.Ohhashi,
K.Hasegawa,
H.Naiki,
and
Y.Goto
(2004).
Optimum amyloid fibril formation of a peptide fragment suggests the amyloidogenic preference of beta2-microglobulin under physiological conditions.
|
| |
J Biol Chem,
279,
10814-10821.
|
|
|
|
|
|
|
A.Garcia-Lora,
I.Algarra,
and
F.Garrido
(2003).
MHC class I antigens, immune surveillance, and tumor immune escape.
|
| |
J Cell Physiol,
195,
346-355.
|
|
|
|
|
|
|
A.Han,
F.Pan,
J.C.Stroud,
H.D.Youn,
J.O.Liu,
and
L.Chen
(2003).
Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2.
|
| |
Nature,
422,
730-734.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
A.W.Purcell,
W.Zeng,
N.A.Mifsud,
L.K.Ely,
W.A.Macdonald,
and
D.C.Jackson
(2003).
Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design.
|
| |
J Pept Sci,
9,
255-281.
|
|
|
|
|
|
|
D.Garrigan,
and
P.W.Hedrick
(2003).
Perspective: detecting adaptive molecular polymorphism: lessons from the MHC.
|
| |
Evolution Int J Org Evolution,
57,
1707-1722.
|
|
|
|
|
|
|
E.S.Jordanova,
S.A.Riemersma,
K.Philippo,
E.Schuuring,
and
P.M.Kluin
(2003).
Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system.
|
| |
Int J Cancer,
103,
393-398.
|
|
|
|
|
|
|
F.Poli,
L.Crespiatico,
S.Frison,
E.Longhi,
E.Marlianici,
and
M.Scalamogna
(2003).
HLA-B*5808, a new HLA-B allele characterized by sequence based typing.
|
| |
Tissue Antigens,
62,
551-553.
|
|
|
|
|
|
|
H.Nojima,
M.Takeda-Shitaka,
Y.Kurihara,
K.Kamiya,
and
H.Umeyama
(2003).
Dynamic flexibility of a peptide-binding groove of human HLA-DR1 class II MHC molecules: normal mode analysis of the antigen peptide-class II MHC complex.
|
| |
Chem Pharm Bull (Tokyo),
51,
923-928.
|
|
|
|
|
|
|
J.H.Wang,
and
M.J.Eck
(2003).
Assembling atomic resolution views of the immunological synapse.
|
| |
Curr Opin Immunol,
15,
286-293.
|
|
|
|
|
|
|
J.H.Zhou,
S.Ferencik,
V.Rebmann,
D.L.Yang,
M.Lu,
M.Roggendorf,
and
H.Grosse-Wilde
(2003).
Molecular genetic and biochemical analysis of woodchuck (Marmota monax) MHC class I polymorphism.
|
| |
Tissue Antigens,
61,
240-248.
|
|
|
|
|
|
|
K.Ogata,
A.Jaramillo,
W.Cohen,
J.P.Briand,
F.Connan,
J.Choppin,
S.Muller,
and
S.J.Wodak
(2003).
Automatic sequence design of major histocompatibility complex class I binding peptides impairing CD8+ T cell recognition.
|
| |
J Biol Chem,
278,
1281-1290.
|
|
|
|
|
|
|
M.G.Clemente,
S.De Virgiliis,
J.S.Kang,
R.Macatagney,
M.P.Musu,
M.R.Di Pierro,
S.Drago,
M.Congia,
and
A.Fasano
(2003).
Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function.
|
| |
Gut,
52,
218-223.
|
|
|
|
|
|
|
M.I.Ivanova,
M.Gingery,
L.J.Whitson,
and
D.Eisenberg
(2003).
Role of the C-terminal 28 residues of beta2-microglobulin in amyloid fibril formation.
|
| |
Biochemistry,
42,
13536-13540.
|
|
|
|
|
|
|
M.L.Diegel,
F.Chen,
R.Laus,
T.J.Graddis,
and
D.Vidovic
(2003).
Major histocompatibility complex class I-restricted presentation of protein antigens without prior intracellular processing.
|
| |
Scand J Immunol,
58,
1-8.
|
|
|
|
|
|
|
P.S.Heeger
(2003).
T-cell allorecognition and transplant rejection: a summary and update.
|
| |
Am J Transplant,
3,
525-533.
|
|
|
|
|
|
|
S.Nishiguchi,
S.Kaneshiro,
M.Tanaka,
M.Enomoto,
T.Akihiro,
D.Habu,
T.Takeda,
K.Fujino,
T.Tanaka,
Y.Yano,
and
S.Shiomi
(2003).
Association of HLA alleles with response (especially biochemical response) to interferon therapy in Japanese patients with chronic hepatitis C.
|
| |
J Interferon Cytokine Res,
23,
135-141.
|
|
|
|
|
|
|
S.Zuccotti,
C.Rosano,
P.Mangione,
V.Bellotti,
and
M.Bolognesi
(2003).
Preliminary crystallographic characterization of the human beta2 microglobulin His31Tyr mutant in a tetrameric assembly.
|
| |
Acta Crystallogr D Biol Crystallogr,
59,
1270-1272.
|
|
|
|
|
|
|
T.Ban,
D.Hamada,
K.Hasegawa,
H.Naiki,
and
Y.Goto
(2003).
Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence.
|
| |
J Biol Chem,
278,
16462-16465.
|
|
|
|
|
|
|
T.Chiba,
Y.Hagihara,
T.Higurashi,
K.Hasegawa,
H.Naiki,
and
Y.Goto
(2003).
Amyloid fibril formation in the context of full-length protein: effects of proline mutations on the amyloid fibril formation of beta2-microglobulin.
|
| |
J Biol Chem,
278,
47016-47024.
|
|
|
|
|
|
|
W.T.Swelsen,
C.E.Voorter,
and
E.M.van den Berg-Loonen
(2003).
Polymorphism of intron 4 in HLA-A, -B and -C genes.
|
| |
Tissue Antigens,
61,
475-483.
|
|
|
|
|
|
|
A.L.Hughes
(2002).
Natural selection and the diversification of vertebrate immune effectors.
|
| |
Immunol Rev,
190,
161-168.
|
|
|
|
|
|
|
B.J.McFarland,
and
C.Beeson
(2002).
Binding interactions between peptides and proteins of the class II major histocompatibility complex.
|
| |
Med Res Rev,
22,
168-203.
|
|
|
|
|
|
|
C.Lee,
J.H.Chang,
H.S.Lee,
and
Y.Cho
(2002).
Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor.
|
| |
Genes Dev,
16,
3199-3212.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
C.M.Eakin,
J.D.Knight,
C.J.Morgan,
M.A.Gelfand,
and
A.D.Miranker
(2002).
Formation of a copper specific binding site in non-native states of beta-2-microglobulin.
|
| |
Biochemistry,
41,
10646-10656.
|
|
|
|
|
|
|
D.Feldman,
J.Kearns,
J.Wu,
S.Bassinger,
G.D.Montoya,
M.McKeen,
S.Birkos,
T.M.Williams,
and
M.Kamoun
(2002).
Identification and sequencing of HLA-B*0714 and B*2718 alleles and novel exon 1 sequences of B*0709 and B*2714 alleles in potential bone marrow donors.
|
| |
Tissue Antigens,
59,
426-429.
|
|
|
|
|
|
|
D.K.Langat,
and
J.S.Hunt
(2002).
Do nonhuman primates comprise appropriate experimental models for studying the function of human leukocyte antigen-G?
|
| |
Biol Reprod,
67,
1367-1374.
|
|
|
|
|
|
|
D.P.Hong,
M.Gozu,
K.Hasegawa,
H.Naiki,
and
Y.Goto
(2002).
Conformation of beta 2-microglobulin amyloid fibrils analyzed by reduction of the disulfide bond.
|
| |
J Biol Chem,
277,
21554-21560.
|
|
|
|
|
|
|
E.R.Unanue
(2002).
Perspective on antigen processing and presentation.
|
| |
Immunol Rev,
185,
86.
|
|
|
|
|
|
|
G.Verdone,
A.Corazza,
P.Viglino,
F.Pettirossi,
S.Giorgetti,
P.Mangione,
A.Andreola,
M.Stoppini,
V.Bellotti,
and
G.Esposito
(2002).
The solution structure of human beta2-microglobulin reveals the prodromes of its amyloid transition.
|
| |
Protein Sci,
11,
487-499.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
H.A.Elsner,
and
R.Blasczyk
(2002).
Sequence similarity matching: proposal of a structure-based rating system for bone marrow transplantation.
|
| |
Eur J Immunogenet,
29,
229-236.
|
|
|
|
|
|
|
H.Katou,
T.Kanno,
M.Hoshino,
Y.Hagihara,
H.Tanaka,
T.Kawai,
K.Hasegawa,
H.Naiki,
and
Y.Goto
(2002).
The role of disulfide bond in the amyloidogenic state of beta(2)-microglobulin studied by heteronuclear NMR.
|
| |
Protein Sci,
11,
2218-2229.
|
|
|
|
|
|
|
H.Nojima,
M.Takeda-Shitaka,
Y.Kurihara,
M.Adachi,
S.Yoneda,
K.Kamiya,
and
H.Umeyama
(2002).
Dynamic characteristics of a peptide-binding groove of human HLA-A2 class I MHC molecules: normal mode analysis of the antigen peptide-class I MHC complex.
|
| |
Chem Pharm Bull (Tokyo),
50,
1209-1214.
|
|
|
|
|
|
|
I.A.Doytchinova,
and
D.R.Flower
(2002).
Quantitative approaches to computational vaccinology.
|
| |
Immunol Cell Biol,
80,
270-279.
|
|
|
|
|
|
|
I.A.Doytchinova,
and
D.R.Flower
(2002).
Physicochemical explanation of peptide binding to HLA-A*0201 major histocompatibility complex: a three-dimensional quantitative structure-activity relationship study.
|
| |
Proteins,
48,
505-518.
|
|
|
|
|
|
|
K.A.Smith
(2002).
Medical immunology: a new journal for a new subspecialty.
|
| |
Med Immunol,
1,
1.
|
|
|
|
|
|
|
K.Suzuki,
R.Inoue,
H.Sakaguchi,
M.Aoki,
Z.Kato,
H.Kaneko,
S.Matsushita,
and
N.Kondo
(2002).
The correlation between ovomucoid-derived peptides, human leucocyte antigen class II molecules and T cell receptor-complementarity determining region 3 compositions in patients with egg-white allergy.
|
| |
Clin Exp Allergy,
32,
1223-1230.
|
|
|
|
|
|
|
M.B.Oldstone,
and
M.B.Oldstone
(2002).
Travels along the viral-immunobiology highway.
|
| |
Immunol Rev,
185,
54-68.
|
|
|
|
|
|
|
M.G.Rudolph,
and
I.A.Wilson
(2002).
The specificity of TCR/pMHC interaction.
|
| |
Curr Opin Immunol,
14,
52-65.
|
|
|
|
|
|
|
M.Hoshino,
H.Katou,
Y.Hagihara,
K.Hasegawa,
H.Naiki,
and
Y.Goto
(2002).
Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange.
|
| |
Nat Struct Biol,
9,
332-336.
|
|
|
|
|
|
|
M.Przemeck,
H.A.Elsner,
S.Sel,
L.T.Pastucha,
and
R.Blasczyk
(2002).
HLA-B*4431: a new HLA-B variant with a complex ancestral history involving HLA-B*44, B*40 and B*07 alleles.
|
| |
Tissue Antigens,
60,
91-94.
|
|
|
|
|
|
|
N.H.Heegaard,
P.Roepstorff,
S.G.Melberg,
and
M.H.Nissen
(2002).
Cleaved beta 2-microglobulin partially attains a conformation that has amyloidogenic features.
|
| |
J Biol Chem,
277,
11184-11189.
|
|
|
|
|
|
|
S.Wu,
C.Y.Lai,
S.M.Lai,
S.P.Chen,
F.C.Chou,
Y.M.Shiao,
and
C.S.Huang
(2002).
Point mutation in the alpha helix of the HLA-C alpha2 domain generates a novel HLA-C allele,HLA-Cw*0106, in a Han Chinese individual in Taiwan.
|
| |
Tissue Antigens,
59,
433-435.
|
|
|
|
|
|
|
T.M.Williams,
J.Wu,
S.Bassinger,
D.Feldman,
S.Birkos,
J.Kearns,
and
M.Kamoun
(2002).
New HLA-B alleles identified and sequences extended in potential bone marrow donors: B*5804, B*4418, B*1558, and B*4805.
|
| |
Tissue Antigens,
60,
186-188.
|
|
|
|
|
|
|
V.Brusic,
N.Petrovsky,
G.Zhang,
and
V.B.Bajic
(2002).
Prediction of promiscuous peptides that bind HLA class I molecules.
|
| |
Immunol Cell Biol,
80,
280-285.
|
|
|
|
|
|
|
V.J.McParland,
A.P.Kalverda,
S.W.Homans,
and
S.E.Radford
(2002).
Structural properties of an amyloid precursor of beta(2)-microglobulin.
|
| |
Nat Struct Biol,
9,
326-331.
|
|
|
|
|
|
|
W.T.Swelsen,
C.E.Voorter,
and
E.M.van den Berg-Loonen
(2002).
Sequence analysis of exons 1, 2, 3, 4 and 5 of the HLA-B5/35 cross-reacting group.
|
| |
Tissue Antigens,
60,
224-234.
|
|
|
|
|
|
|
A.V.Romphruk,
T.K.Naruse,
A.Romphruk,
H.Kawata,
C.Puapairoj,
J.K.Kulski,
C.Leelayuwat,
and
H.Inoko
(2001).
Diversity of MICA (PERB11.1) and HLA haplotypes in Northeastern Thais.
|
| |
Tissue Antigens,
58,
83-89.
|
|
|
|
|
|
|
C.B.Carpenter
(2001).
Why do we reject grafts?
|
| |
Heart Dis,
3,
270-275.
|
|
|
|
|
|
|
D.P.Smith,
and
S.E.Radford
(2001).
Role of the single disulphide bond of beta(2)-microglobulin in amyloidosis in vitro.
|
| |
Protein Sci,
10,
1775-1784.
|
|
|
|
|
|
|
E.Maverakis,
P.van den Elzen,
and
E.E.Sercarz
(2001).
Self-reactive T cells and degeneracy of T cell recognition: evolving concepts-from sequence homology to shape mimicry and TCR flexibility.
|
| |
J Autoimmun,
16,
201-209.
|
|
|
|
|
|
|
F.Chiti,
E.De Lorenzi,
S.Grossi,
P.Mangione,
S.Giorgetti,
G.Caccialanza,
C.M.Dobson,
G.Merlini,
G.Ramponi,
and
V.Bellotti
(2001).
A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis.
|
| |
J Biol Chem,
276,
46714-46721.
|
|
|
|
|
|
|
K.H.Wiesmüller,
B.Fleckenstein,
and
G.Jung
(2001).
Peptide vaccines and peptide libraries.
|
| |
Biol Chem,
382,
571-579.
|
|
|
|
|
|
|
M.B.Oldstone,
H.Lewicki,
D.Homann,
C.Nguyen,
S.Julien,
and
J.E.Gairin
(2001).
Common antiviral cytotoxic t-lymphocyte epitope for diverse arenaviruses.
|
| |
J Virol,
75,
6273-6278.
|
|
|
|
|
|
|
M.Larché
(2001).
Inhibition of human T-cell responses by allergen peptides.
|
| |
Immunology,
104,
377-382.
|
|
|
|
|
|
|
N.Matsumoto,
M.Mitsuki,
K.Tajima,
W.M.Yokoyama,
and
K.Yamamoto
(2001).
The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand.
|
| |
J Exp Med,
193,
147-158.
|
|
|
|
|
|
|
P.Cano,
and
B.Fan
(2001).
A geometric and algebraic view of MHC-peptide complexes and their binding properties.
|
| |
BMC Struct Biol,
1,
2.
|
|
|
|
|
|
|
P.Kourilsky,
and
N.Fazilleau
(2001).
Self peptides and the peptidic self.
|
| |
Int Rev Immunol,
20,
575-591.
|
|
|
|
|
|
|
P.Paul,
D.Thomas,
P.Kawczak,
D.Good,
D.J.Cook,
and
E.J.Ball
(2001).
Resolution of cis-trans ambiguities between HLA-DRB1 alleles using single-strand conformation polymorphisms and sequencing.
|
| |
Tissue Antigens,
57,
300-307.
|
|
|
|
|
|
|
S.L.Lauemøller,
A.Holm,
J.Hilden,
S.Brunak,
M.Holst Nissen,
A.Stryhn,
L.Østergaard Pedersen,
and
S.Buus
(2001).
Quantitative predictions of peptide binding to MHC class I molecules using specificity matrices and anchor-stratified calibrations.
|
| |
Tissue Antigens,
57,
405-414.
|
|
|
|
|
|
|
A.K.Abbas,
and
C.A.Janeway
(2000).
Immunology: improving on nature in the twenty-first century.
|
| |
Cell,
100,
129-138.
|
|
|
|
|
|
|
A.Piazza,
A.Canossi,
O.Buonomo,
M.Di Rocco,
T.Del Beato,
N.Torlone,
A.Felici,
C.Cortini,
C.U.Casciani,
and
D.Adorno
(2000).
HLA class I residue mismatch and renal graft outcome.
|
| |
Transpl Int,
13,
S444-S448.
|
|
|
|
|
|
|
C.C.Deivanayagam,
R.L.Rich,
M.Carson,
R.T.Owens,
S.Danthuluri,
T.Bice,
M.Höök,
and
S.V.Narayana
(2000).
Novel fold and assembly of the repetitive B region of the Staphylococcus aureus collagen-binding surface protein.
|
| |
Structure,
8,
67-78.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
C.E.Voorter,
S.A.van der Vlies,
and
E.M.van den Berg-Loonen
(2000).
Sequence-based typing of HLA-B: the B7 cross-reacting group.
|
| |
Tissue Antigens,
56,
356-362.
|
|
|
|
|
|
|
C.T.Kennedy,
R.Dodd,
T.Le,
R.Wallace,
G.Ng,
W.D.Greville,
A.Kennedy,
A.Taverniti,
J.H.Moses,
N.Clow,
N.Watson,
and
H.Dunckley
(2000).
Routine HLA-B genotyping with PCR-sequence-specific oligonucleotides (PCR-SSO) detects eight new alleles: B*0807, B*0809, B*1551, B*3529, B*3532, B*4025, B*5304 and B*5508.
|
| |
Tissue Antigens,
55,
266-270.
|
|
|
|
|
|
|
D.L.Yang,
M.Lu,
L.J.Hao,
and
M.Roggendorf
(2000).
Molecular cloning and characterization of major histocompatibility complex class I cDNAs from woodchuck (Marmota monax).
|
| |
Tissue Antigens,
55,
548-557.
|
|
|
|
|
|
|
D.Scott,
C.Addey,
P.Ellis,
E.James,
M.J.Mitchell,
N.Saut,
S.Jurcevic,
and
E.Simpson
(2000).
Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens.
|
| |
Immunity,
12,
711-720.
|
|
|
|
|
|
|
D.Tortorella,
B.E.Gewurz,
M.H.Furman,
D.J.Schust,
and
H.L.Ploegh
(2000).
Viral subversion of the immune system.
|
| |
Annu Rev Immunol,
18,
861-926.
|
|
|
|
|
|
|
E.Mallon,
and
C.B.Bunker
(2000).
HIV-associated psoriasis.
|
| |
AIDS Patient Care STDS,
14,
239-246.
|
|
|
|
|
|
|
G.Esposito,
R.Michelutti,
G.Verdone,
P.Viglino,
H.Hernández,
C.V.Robinson,
A.Amoresano,
F.Dal Piaz,
M.Monti,
P.Pucci,
P.Mangione,
M.Stoppini,
G.Merlini,
G.Ferri,
and
V.Bellotti
(2000).
Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation.
|
| |
Protein Sci,
9,
831-845.
|
|
|
|
|
|
|
H.A.Elsner,
A.Wölpl,
S.F.Goldmann,
and
R.Blasczyk
(2000).
Identification of the novel allele HLA-B*1546 which belongs to the serological B72 type: implications for bone marrow transplantation.
|
| |
Tissue Antigens,
55,
83-85.
|
|
|
|
|
|
|
H.A.Elsner,
L.T.Pastucha,
V.Rebmann,
H.Grosse-Wilde,
and
R.Blasczyk
(2000).
Identification of the novel allele HLA-A*6813 in two members of a family of Syrian origin: implications for bone marrow transplantation.
|
| |
Tissue Antigens,
55,
262-265.
|
|
|
|
|
|
|
H.A.Elsner,
and
R.Blasczyk
(2000).
Identification of the novel allele HLA-B*0809 in a Caucasian individual: estimation of allogeneic potential between B*08 variants.
|
| |
Tissue Antigens,
55,
74-77.
|
|
|
|
|
|
|
H.A.Elsner,
and
R.Blasczyk
(2000).
Identification of the novel allele HLA-B*1545: assessment of alloreactivity in case of mismatch with other B*15 alleles.
|
| |
Tissue Antigens,
55,
80-82.
|
|
|
|
|
|
|
H.A.Elsner,
and
R.Blasczyk
(2000).
Increased diversity within the HLA-B*07 group: identification of the two novel alleles B*0709 and B*0710.
|
| |
Tissue Antigens,
56,
371-375.
|
|
|
|
|
|
|
I.Faé,
B.Gleissner,
D.Kriks,
D.Leitner,
and
G.F.Fischer
(2000).
Serological and nucleotide sequence analysis of HLA-A*6812.
|
| |
Tissue Antigens,
56,
276-278.
|
|
|
|
|
|
|
J.M.Blander,
D.B.Sant'Angelo,
K.Bottomly,
and
C.A.Janeway
(2000).
Alteration at a single amino acid residue in the T cell receptor alpha chain complementarity determining region 2 changes the differentiation of naive CD4 T cells in response to antigen from T helper cell type 1 (Th1) to Th2.
|
| |
J Exp Med,
191,
2065-2074.
|
|
|
|
|
|
|
J.Yagüe,
I.Alvarez,
D.Rognan,
M.Ramos,
J.Vázquez,
and
J.A.de Castro
(2000).
An N-acetylated natural ligand of human histocompatibility leukocyte antigen (HLA)-B39. Classical major histocompatibility complex class I proteins bind peptides with a blocked NH(2) terminus in vivo.
|
| |
J Exp Med,
191,
2083-2092.
|
|
|
|
|
|
|
K.Natarajan,
M.W.Sawicki,
D.H.Margulies,
and
R.A.Mariuzza
(2000).
Crystal structure of human CD69: a C-type lectin-like activation marker of hematopoietic cells.
|
| |
Biochemistry,
39,
14779-14786.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
M.P.Bettinotti,
R.D.Norris,
J.A.Hackett,
C.O.Thompson,
T.B.Simonis,
D.Stroncek,
and
F.M.Marincola
(2000).
Frequency of human leukocyte antigen-A 24 alleles in patients with melanoma determined by human leukocyte antigen-A sequence-based typing.
|
| |
J Immunother (1997),
23,
282-287.
|
|
|
|
|
|
|
M.P.Davey,
and
J.T.Rosenbaum
(2000).
The human leukocyte antigen complex and chronic ocular inflammatory disorders.
|
| |
Am J Ophthalmol,
129,
235-243.
|
|
|
|
|
|
|
P.Krausa,
C.Münz,
W.Keilholz,
S.Stevanovic,
E.Y.Jones,
M.Browning,
M.Bunce,
H.G.Rammensee,
and
A.McMichael
(2000).
Definition of peptide binding motifs amongst the HLA-A*30 allelic group.
|
| |
Tissue Antigens,
56,
10-18.
|
|
|
|
|
|
|
P.Parham
(2000).
NK cell receptors: of missing sugar and missing self.
|
| |
Curr Biol,
10,
R195-R197.
|
|
|
|
|
|
|
P.S.Beisser,
J.S.Kloover,
G.E.Grauls,
M.J.Blok,
C.A.Bruggeman,
and
C.Vink
(2000).
The r144 major histocompatibility complex class I-like gene of rat cytomegalovirus is dispensable for both acute and long-term infection in the immunocompromised host.
|
| |
J Virol,
74,
1045-1050.
|
|
|
|
|
|
|
S.A.Scheltinga,
S.M.Lai,
A.W.van der Zwan,
M.G.Tilanus,
and
S.Wu
(2000).
A novel HLA-A24 (A*2420) allele identified in the Atayal tribe of Taiwan.
|
| |
Tissue Antigens,
55,
65-67.
|
|
|
|
|
|
|
T.Kimura,
and
D.E.Griffin
(2000).
The role of CD8(+) T cells and major histocompatibility complex class I expression in the central nervous system of mice infected with neurovirulent Sindbis virus.
|
| |
J Virol,
74,
6117-6125.
|
|
|
|
|
|
|
V.Ghetie,
and
E.S.Ward
(2000).
Multiple roles for the major histocompatibility complex class I- related receptor FcRn.
|
| |
Annu Rev Immunol,
18,
739-766.
|
|
|
|
|
|
|
V.J.McParland,
N.M.Kad,
A.P.Kalverda,
A.Brown,
P.Kirwin-Jones,
M.G.Hunter,
M.Sunde,
and
S.E.Radford
(2000).
Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro.
|
| |
Biochemistry,
39,
8735-8746.
|
|
|
|
|
|
|
Y.Ohta,
K.Okamura,
E.C.McKinney,
S.Bartl,
K.Hashimoto,
and
M.F.Flajnik
(2000).
Primitive synteny of vertebrate major histocompatibility complex class I and class II genes.
|
| |
Proc Natl Acad Sci U S A,
97,
4712-4717.
|
|
|
|
|
|
|
A.Achour,
R.A.Harris,
K.Persson,
J.Sundbäck,
C.L.Sentman,
G.Schneider,
Y.Lindqvist,
and
K.Kärre
(1999).
Murine class I major histocompatibility complex H-2Dd: expression, refolding and crystallization.
|
| |
Acta Crystallogr D Biol Crystallogr,
55,
260-262.
|
|
|
|
|
|
|
A.J.Sant,
C.Beeson,
B.McFarland,
J.Cao,
S.Ceman,
P.W.Bryant,
and
S.Wu
(1999).
Individual hydrogen bonds play a critical role in MHC class II: peptide interactions: implications for the dynamic aspects of class II trafficking and DM-mediated peptide exchange.
|
| |
Immunol Rev,
172,
239-253.
|
|
|
|
|
|
|
B.Fleckenstein,
G.Jung,
and
K.H.Wiesmüller
(1999).
Quantitative analysis of peptide-MHC class II interaction.
|
| |
Semin Immunol,
11,
405-416.
|
|
|
|
|
|
|
B.Sammut,
L.Du Pasquier,
P.Ducoroy,
V.Laurens,
A.Marcuz,
and
A.Tournefier
(1999).
Axolotl MHC architecture and polymorphism.
|
| |
Eur J Immunol,
29,
2897-2907.
|
|
|
|
|
|
|
C.Sweet
(1999).
The pathogenicity of cytomegalovirus.
|
| |
FEMS Microbiol Rev,
23,
457-482.
|
|
|
|
|
|
|
D.M.Davis,
I.Chiu,
M.Fassett,
G.B.Cohen,
O.Mandelboim,
and
J.L.Strominger
(1999).
The human natural killer cell immune synapse.
|
| |
Proc Natl Acad Sci U S A,
96,
15062-15067.
|
|
|
|
|
|
|
G.J.Hämmerling,
A.B.Vogt,
and
H.Kropshofer
(1999).
Antigen processing and presentation--towards the millennium.
|
| |
Immunol Rev,
172,
5-9.
|
|
|
|
|
|
|
J.N.Feder
(1999).
The hereditary hemochromatosis gene (HFE): a MHC class I-like gene that functions in the regulation of iron homeostasis.
|
| |
Immunol Res,
20,
175-185.
|
|
|
|
|
|
|
K.C.Garcia,
L.Teyton,
and
I.A.Wilson
(1999).
Structural basis of T cell recognition.
|
| |
Annu Rev Immunol,
17,
369-397.
|
|
|
|
|
|
|
K.Hashimoto,
K.Okamura,
H.Yamaguchi,
M.Ototake,
T.Nakanishi,
and
Y.Kurosawa
(1999).
Conservation and diversification of MHC class I and its related molecules in vertebrates.
|
| |
Immunol Rev,
167,
81.
|
|
|
|
|
|
|
K.Maenaka,
and
E.Y.Jones
(1999).
MHC superfamily structure and the immune system.
|
| |
Curr Opin Struct Biol,
9,
745-753.
|
|
|
|
|
|
|
M.E.Ressing,
J.H.de Jong,
R.M.Brandt,
J.W.Drijfhout,
W.E.Benckhuijsen,
G.M.Schreuder,
R.Offringa,
W.M.Kast,
and
C.J.Melief
(1999).
Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma.
|
| |
Eur J Immunol,
29,
1292-1303.
|
|
|
|
|
|
|
M.K.Wild,
A.Cambiaggi,
M.H.Brown,
E.A.Davies,
H.Ohno,
T.Saito,
and
P.A.van der Merwe
(1999).
Dependence of T cell antigen recognition on the dimensions of an accessory receptor-ligand complex.
|
| |
J Exp Med,
190,
31-41.
|
|
|
|
|
|
|
M.Raghavan
(1999).
Immunodeficiency due to defective antigen processing: the molecular basis for type 1 bare lymphocyte syndrome.
|
| |
J Clin Invest,
103,
595-596.
|
|
|
|
|
|
|
M.Yeager,
and
A.L.Hughes
(1999).
Evolution of the mammalian MHC: natural selection, recombination, and convergent evolution.
|
| |
Immunol Rev,
167,
45-58.
|
|
|
|
|
|
|
P.R.Smith,
I.E.Morrison,
K.M.Wilson,
N.Fernández,
and
R.J.Cherry
(1999).
Anomalous diffusion of major histocompatibility complex class I molecules on HeLa cells determined by single particle tracking.
|
| |
Biophys J,
76,
3331-3344.
|
|
|
|
|
|
|
Q.R.Fan,
and
D.C.Wiley
(1999).
Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor.
|
| |
J Exp Med,
190,
113-123.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
R.R.Latek,
and
E.R.Unanue
(1999).
Mechanisms and consequences of peptide selection by the I-Ak class II molecule.
|
| |
Immunol Rev,
172,
209-228.
|
|
|
|
|
|
|
S.Buus
(1999).
Description and prediction of peptide-MHC binding: the 'human MHC project'.
|
| |
Curr Opin Immunol,
11,
209-213.
|
|
|
|
|
|
|
S.J.O'Brien,
and
N.Yuhki
(1999).
Comparative genome organization of the major histocompatibility complex: lessons from the Felidae.
|
| |
Immunol Rev,
167,
133-144.
|
|
|
|
|
|
|
T.U.Vogel,
D.T.Evans,
J.A.Urvater,
D.H.O'Connor,
A.L.Hughes,
and
D.I.Watkins
(1999).
Major histocompatibility complex class I genes in primates: co-evolution with pathogens.
|
| |
Immunol Rev,
167,
327-337.
|
|
|
|
|
|
|
A.Bianco,
C.Brock,
C.Zabel,
T.Walk,
P.Walden,
and
G.Jung
(1998).
New synthetic non-peptide ligands for classical major histocompatibility complex class I molecules.
|
| |
J Biol Chem,
273,
28759-28765.
|
|
|
|
|
|
|
A.L.Hughes,
and
M.Yeager
(1998).
Natural selection at major histocompatibility complex loci of vertebrates.
|
| |
Annu Rev Genet,
32,
415-435.
|
|
|
|
|
|
|
A.Olsén,
M.J.Wick,
M.Mörgelin,
and
L.Björck
(1998).
Curli, fibrous surface proteins of Escherichia coli, interact with major histocompatibility complex class I molecules.
|
| |
Infect Immun,
66,
944-949.
|
|
|
|
|
|
|
A.Steinle,
V.Groh,
and
T.Spies
(1998).
Diversification, expression, and gamma delta T cell recognition of evolutionarily distant members of the MIC family of major histocompatibility complex class I-related molecules.
|
| |
Proc Natl Acad Sci U S A,
95,
12510-12515.
|
|
|
|
|
|
|
A.Tournefier,
V.Laurens,
C.Chapusot,
P.Ducoroy,
M.R.Padros,
F.Salvadori,
and
B.Sammut
(1998).
Structure of MHC class I and class II cDNAs and possible immunodeficiency linked to class II expression in the Mexican axolotl.
|
| |
Immunol Rev,
166,
259-277.
|
|
|
|
|
|
|
A.de Jong
(1998).
Contribution of mass spectrometry to contemporary immunology.
|
| |
Mass Spectrom Rev,
17,
311-335.
|
|
|
|
|
|
|
C.A.Scott,
P.A.Peterson,
L.Teyton,
and
I.A.Wilson
(1998).
Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues.
|
| |
Immunity,
8,
319-329.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
D.Tortorella,
C.M.Story,
J.B.Huppa,
E.J.Wiertz,
T.R.Jones,
I.Bacik,
J.R.Bennink,
J.W.Yewdell,
and
H.L.Ploegh
(1998).
Dislocation of type I membrane proteins from the ER to the cytosol is sensitive to changes in redox potential.
|
| |
J Cell Biol,
142,
365-376.
|
|
|
|
|
|
|
E.Mallon,
D.Young,
M.Bunce,
F.M.Gotch,
P.J.Easterbrook,
R.Newson,
and
C.B.Bunker
(1998).
HLA-Cw*0602 and HIV-associated psoriasis.
|
| |
Br J Dermatol,
139,
527-533.
|
|
|
|
|
|
|
E.Rigney,
M.Kojima,
A.Glithero,
and
T.Elliott
(1998).
A soluble major histocompatibility complex class I peptide-binding platform undergoes a conformational change in response to peptide epitopes.
|
| |
J Biol Chem,
273,
14200-14204.
|
|
|
|
|
|
|
E.Simpson
(1998).
Minor transplantation antigens: animal models for human host-versus-graft, graft-versus-host, and graft-versus-leukemia reactions.
|
| |
Transplantation,
65,
611-616.
|
|
|
|
|
|
|
E.Y.Jones,
J.Tormo,
S.W.Reid,
and
D.I.Stuart
(1998).
Recognition surfaces of MHC class I.
|
| |
Immunol Rev,
163,
121-128.
|
|
|
|
|
|
|
I.A.Wilson,
and
P.J.Bjorkman
(1998).
Unusual MHC-like molecules: CD1, Fc receptor, the hemochromatosis gene product, and viral homologs.
|
| |
Curr Opin Immunol,
10,
67-73.
|
|
|
|
|
|
|
I.B.Jakobsen,
X.Gao,
S.Easteal,
and
G.Chelvanayagam
(1998).
Correlating sequence variation with HLA-A allelic families: implications for T cell receptor binding specificities.
|
| |
Immunol Cell Biol,
76,
135-142.
|
|
|
|
|
|
|
J.A.Speir,
K.C.Garcia,
A.Brunmark,
M.Degano,
P.A.Peterson,
L.Teyton,
and
I.A.Wilson
(1998).
Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes.
|
| |
Immunity,
8,
553-562.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
J.Beninga,
K.L.Rock,
and
A.L.Goldberg
(1998).
Interferon-gamma can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase.
|
| |
J Biol Chem,
273,
18734-18742.
|
|
|
|
|
|
|
J.D.Reveille
(1998).
HLA-B27 and the seronegative spondyloarthropathies.
|
| |
Am J Med Sci,
316,
239-249.
|
|
|
|
|
|
|
J.I.Bell
(1998).
Molecular anatomy of the immune response.
|
| |
Immunol Rev,
163,
5.
|
|
|
|
|
|
|
J.N.Feder,
D.M.Penny,
A.Irrinki,
V.K.Lee,
J.A.Lebrón,
N.Watson,
Z.Tsuchihashi,
E.Sigal,
P.J.Bjorkman,
and
R.C.Schatzman
(1998).
The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding.
|
| |
Proc Natl Acad Sci U S A,
95,
1472-1477.
|
|
|
|
|
|
|
J.W.Lewis,
and
T.Elliott
(1998).
Evidence for successive peptide binding and quality control stages during MHC class I assembly.
|
| |
Curr Biol,
8,
717-720.
|
|
|
|
|
|
|
K.Kulig,
D.Nandi,
I.Bacik,
J.J.Monaco,
and
S.Vukmanović
(1998).
Physical and functional association of the major histocompatibility complex class I heavy chain alpha3 domain with the transporter associated with antigen processing.
|
| |
J Exp Med,
187,
865-874.
|
|
|
|
|
|
|
M.Bouvier,
and
D.C.Wiley
(1998).
Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/beta 2m heterodimer.
|
| |
Nat Struct Biol,
5,
377-384.
|
|
|
|
|
|
|
M.F.Flajnik
(1998).
Churchill and the immune system of ectothermic vertebrates.
|
| |
Immunol Rev,
166,
5.
|
|
|
|
|
|
|
M.Feng,
D.Chou,
Y.Liaw,
and
M.Lai
(1998).
Conserved T-cell receptor class II major histocompatibility complex contact detected in a T-lymphocyte population.
|
| |
Immunology,
95,
185-192.
|
|
|
|
|
|
|
M.J.Parker,
C.E.Dempsey,
L.L.Hosszu,
J.P.Waltho,
and
A.R.Clarke
(1998).
Topology, sequence evolution and folding dynamics of an immunoglobulin domain.
|
| |
Nat Struct Biol,
5,
194-198.
|
|
|
|
|
|
|
M.J.Shields,
and
R.K.Ribaudo
(1998).
Mapping of the monoclonal antibody W6/32: sensitivity to the amino terminus of beta2-microglobulin.
|
| |
Tissue Antigens,
51,
567-570.
|
|
|
|
|
|
|
M.J.Shields,
R.Kubota,
W.Hodgson,
S.Jacobson,
W.E.Biddison,
and
R.K.Ribaudo
(1998).
The effect of human beta2-microglobulin on major histocompatibility complex I peptide loading and the engineering of a high affinity variant. Implications for peptide-based vaccines.
|
| |
J Biol Chem,
273,
28010-28018.
|
|
|
|
|
|
|
M.Kemeny,
and
M.Peakman
(1998).
Recent advances. Immunology.
|
| |
BMJ,
316,
600-603.
|
|
|
|
|
|
|
N.Katunuma,
Y.Matsunaga,
A.Matsui,
H.Kakegawa,
K.Endo,
T.Inubushi,
T.Saibara,
Y.Ohba,
and
T.Kakiuchi
(1998).
Novel physiological functions of cathepsins B and L on antigen processing and osteoclastic bone resorption.
|
| |
Adv Enzyme Regul,
38,
235-251.
|
|
|
|
|
|
|
P.J.Fairchild
(1998).
Presentation of antigenic peptides by products of the major histocompatibility complex.
|
| |
J Pept Sci,
4,
182-194.
|
|
|
|
|
|
|
P.J.Leibson
(1998).
Cytotoxic lymphocyte recognition of HLA-E: utilizing a nonclassical window to peer into classical MHC.
|
| |
Immunity,
9,
289-294.
|
|
|
|
|
|
|
R.Busch,
Z.Reich,
D.M.Zaller,
V.Sloan,
and
E.D.Mellins
(1998).
Secondary structure composition and pH-dependent conformational changes of soluble recombinant HLA-DM.
|
| |
J Biol Chem,
273,
27557-27564.
|
|
|
|
|
|
|
S.Bartl
(1998).
What sharks can tell us about the evolution of MHC genes.
|
| |
Immunol Rev,
166,
317-331.
|
|
|
|
|
|
|
S.Bauer,
S.T.Willie,
T.Spies,
and
R.K.Strong
(1998).
Expression, purification, crystallization and crystallographic characterization of the human MHC class I related protein MICA.
|
| |
Acta Crystallogr D Biol Crystallogr,
54,
451-453.
|
|
|
|
|
|
|
S.Ceman,
S.Wu,
T.S.Jardetzky,
and
A.J.Sant
(1998).
Alteration of a single hydrogen bond between class II molecules and peptide results in rapid degradation of class II molecules after invariant chain removal.
|
| |
J Exp Med,
188,
2139-2149.
|
|
|
|
|
|
|
T.A.Plunkett,
and
D.W.Miles
(1998).
Immunotherapy and breast cancer.
|
| |
Cancer Treat Rev,
24,
55-67.
|
|
|
|
|
|
|
T.L.Chapman,
and
P.J.Bjorkman
(1998).
Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog.
|
| |
J Virol,
72,
460-466.
|
|
|
|
|
|
|
T.M.McCarty,
Z.Yu,
X.Liu,
D.J.Diamond,
and
J.D.Ellenhorn
(1998).
An HLA-restricted, p53 specific immune response from HLA transgenic p53 knockout mice.
|
| |
Ann Surg Oncol,
5,
93-99.
|
|
|
|
|
|
|
V.D.Rao,
S.Misra,
I.V.Boronenkov,
R.A.Anderson,
and
J.H.Hurley
(1998).
Structure of type IIbeta phosphatidylinositol phosphate kinase: a protein kinase fold flattened for interfacial phosphorylation.
|
| |
Cell,
94,
829-839.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
Y.Ghendler,
M.K.Teng,
J.H.Liu,
T.Witte,
J.Liu,
K.S.Kim,
P.Kern,
H.C.Chang,
J.H.Wang,
and
E.L.Reinherz
(1998).
Differential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligands.
|
| |
Proc Natl Acad Sci U S A,
95,
10061-10066.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
Z.Wang,
F.Arienti,
G.Parmiani,
and
S.Ferrone
(1998).
Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells.
|
| |
Eur J Immunol,
28,
2817-2826.
|
|
|
|
|
|
|
Z.Weng,
and
C.DeLisi
(1998).
Toward a predictive understanding of molecular recognition.
|
| |
Immunol Rev,
163,
251-266.
|
|
|
|
|
|
|
A.Kochańska-Dziurowicz,
and
C.Bukowska
(1997).
Estimation of serum beta-2-microglobulin in children with malabsorption disorders syndrome.
|
| |
J Gastroenterol,
32,
312-317.
|
|
|
|
|
|
|
A.L.Hughes,
and
M.Yeager
(1997).
Molecular evolution of the vertebrate immune system.
|
| |
Bioessays,
19,
777-786.
|
|
|
|
|
|
|
A.Müllbacher
(1997).
Hypothesis: MHC class I, rather than just a flagpole for CD8+ T cells is also a protease in its own right.
|
| |
Immunol Cell Biol,
75,
310-317.
|
|
|
|
|
|
|
B.Suárez,
P.Morales,
M.J.Castro,
V.Fernández-Soria,
M.J.Recio,
M.Pérez-Blas,
M.Alvarez,
N.Díaz-Campos,
and
A.Arnaiz-Villena
(1997).
Mhc-E polymorphism in Pongidae primates: the same allele is found in two different species.
|
| |
Tissue Antigens,
50,
695-698.
|
|
|
|
|
|
|
C.I.Brändén,
and
J.Deisenhofer
(1997).
Proteins.
|
| |
Curr Opin Struct Biol,
7,
819-820.
|
|
|
|
|
|
|
C.Vilches,
M.Bunce,
R.de Pablo,
A.K.Murray,
C.A.McIntyre,
and
M.Kreisler
(1997).
Complete coding regions of two novel HLA-B alleles detected by phototyping (PCR-SSP) in the British caucasoid population: B*5108 and B*5002.
|
| |
Tissue Antigens,
50,
38-41.
|
|
|
|
|
|
|
C.Vilches,
M.Bunce,
R.de Pablo,
M.E.Moreno,
S.Puente,
L.Sanz,
and
M.Kreisler
(1997).
The novel HLA-Cw*1802 allele is associated with B*5703 in the Bubi population from Equatorial Guinea.
|
| |
Tissue Antigens,
49,
644-648.
|
|
|
|
|
|
|
D.J.Leahy
(1997).
Implications of atomic-resolution structures for cell adhesion.
|
| |
Annu Rev Cell Dev Biol,
13,
363-393.
|
|
|
|
|
|
|
D.M.Lepley,
W.E.Gillanders,
N.B.Myers,
R.A.Robinson,
K.W.Beisel,
J.L.Wisecarver,
S.J.Pirruccello,
D.R.Lee,
T.H.Hansen,
and
R.J.Rubocki
(1997).
Biochemical and functional characterization of soluble multivalent MHC L(d)/Fc gamma 1 and L(d)/Fc mu chimeric proteins loaded with specific peptides.
|
| |
Transplantation,
63,
765-774.
|
|
|
|
|
|
|
D.M.Sintasath,
M.Bei,
N.Steiner,
J.Ng,
S.Alosco,
J.D.Hegland,
and
C.K.Hurley
(1997).
Analysis of HLA-A and -B serologic typing of bone marrow registry donors using polymerase chain reaction with sequence-specific oligonucleotide probes and DNA sequencing.
|
| |
Tissue Antigens,
50,
366-371.
|
|
|
|
|
|
|
E.Mallon,
M.Bunce,
F.Wojnarowska,
and
K.Welsh
(1997).
HLA-CW*0602 is a susceptibility factor in type I psoriasis, and evidence Ala-73 is increased in male type I psoriatics.
|
| |
J Invest Dermatol,
109,
183-186.
|
|
|
|
|
|
|
E.Y.Jones
(1997).
MHC class I and class II structures.
|
| |
Curr Opin Immunol,
9,
75-79.
|
|
|
|
|
|
|
E.Z.Wolpert,
M.Petersson,
B.J.Chambers,
J.K.Sandberg,
R.Kiessling,
H.G.Ljunggren,
and
K.Kärre
(1997).
Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells.
|
| |
Proc Natl Acad Sci U S A,
94,
11496-11501.
|
|
|
|
|
|
|
G.K.Balendiran,
J.C.Solheim,
A.C.Young,
T.H.Hansen,
S.G.Nathenson,
and
J.C.Sacchettini
(1997).
The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide.
|
| |
Proc Natl Acad Sci U S A,
94,
6880-6885.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
H.Wang,
K.Tokunaga,
T.Akaza,
K.Tadokoro,
Y.Shibata,
and
T.Juji
(1997).
Identification of HLA-C alleles using PCR-single-strand-conformation polymorphism and direct sequencing.
|
| |
Tissue Antigens,
49,
134-140.
|
|
|
|
|
|
|
H.Wang,
K.Tokunaga,
T.Akaza,
Y.Shibata,
and
T.Juji
(1997).
A novel allele, Cw*1702 with serological Cw2 specificity.
|
| |
Tissue Antigens,
49,
183-185.
|
|
|
|
|
|
|
J.M.Pattison,
and
A.M.Krensky
(1997).
New insights into mechanisms of allograft rejection.
|
| |
Am J Med Sci,
313,
257-263.
|
|
|
|
|
|
|
K.Okamura,
M.Ototake,
T.Nakanishi,
Y.Kurosawa,
and
K.Hashimoto
(1997).
The most primitive vertebrates with jaws possess highly polymorphic MHC class I genes comparable to those of humans.
|
| |
Immunity,
7,
777-790.
|
|
|
|
|
|
|
M.A.Batalia,
and
E.J.Collins
(1997).
Peptide binding by class I and class II MHC molecules.
|
| |
Biopolymers,
43,
281-302.
|
|
|
|
|
|
|
M.Alvarez,
J.Martinez-Laso,
P.Varela,
N.Diaz-Campos,
E.Gomez-Casado,
G.Vargas-Alarcon,
C.Garcia-Torre,
and
A.Arnaiz-Villena
(1997).
High polymorphism of Mhc-E locus in non-human primates: alleles with identical exon 2 and 3 are found in two different species.
|
| |
Tissue Antigens,
49,
160-167.
|
|
|
|
|
|
|
M.P.Davenport,
K.J.Smith,
D.Barouch,
S.W.Reid,
W.M.Bodnar,
A.C.Willis,
D.F.Hunt,
and
A.V.Hill
(1997).
HLA class I binding motifs derived from random peptide libraries differ at the COOH terminus from those of eluted peptides.
|
| |
J Exp Med,
185,
367-371.
|
|
|
|
|
|
|
M.Wang,
S.M.Stepkowski,
J.Yu,
M.Wang,
and
B.D.Kahan
(1997).
Localization of cryptic tolerogenic epitopes in the alpha1-helical region of the RT1.Au alloantigen.
|
| |
Transplantation,
63,
1373-1379.
|
|
|
|
|
|
|
N.M.Valiante,
K.Lienert,
H.G.Shilling,
B.J.Smits,
and
P.Parham
(1997).
Killer cell receptors: keeping pace with MHC class I evolution.
|
| |
Immunol Rev,
155,
155-164.
|
|
|
|
|
|
|
O.Mandelboim,
H.T.Reyburn,
E.G.Sheu,
M.Vales-Gomez,
D.M.Davis,
L.Pazmany,
and
J.L.Strominger
(1997).
The binding site of NK receptors on HLA-C molecules.
|
| |
Immunity,
6,
341-350.
|
|
|
|
|
|
|
P.E.Jensen
(1997).
Peptide binding and antigen presentation by class II histocompatibility glycoproteins.
|
| |
Biopolymers,
43,
303-322.
|
|
|
|
|
|
|
P.Parham,
K.L.Arnett,
E.J.Adams,
A.M.Little,
K.Tees,
L.D.Barber,
S.G.Marsh,
T.Ohta,
T.Markow,
and
M.L.Petzl-Erler
(1997).
Episodic evolution and turnover of HLA-B in the indigenous human populations of the Americas.
|
| |
Tissue Antigens,
50,
219-232.
|
|
|
|
|
|
|
Q.Hu,
C.R.Bazemore Walker,
C.Girao,
J.T.Opferman,
J.Sun,
J.Shabanowitz,
D.F.Hunt,
and
P.G.Ashton-Rickardt
(1997).
Specific recognition of thymic self-peptides induces the positive selection of cytotoxic T lymphocytes.
|
| |
Immunity,
7,
221-231.
|
|
|
|
|
|
|
R.C.Burnett,
S.A.DeRose,
J.L.Wagner,
and
R.Storb
(1997).
Molecular analysis of six dog leukocyte antigen class I sequences including three complete genes, two truncated genes and one full-length processed gene.
|
| |
Tissue Antigens,
49,
484-495.
|
|
|
|
|
|
|
S.H.Seo,
L.Wang,
R.Smith,
and
E.W.Collisson
(1997).
The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection.
|
| |
J Virol,
71,
7889-7894.
|
|
|
|
|
|
|
S.K.Mendiratta,
W.D.Martin,
S.Hong,
A.Boesteanu,
S.Joyce,
and
L.Van Kaer
(1997).
CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4.
|
| |
Immunity,
6,
469-477.
|
|
|
|
|
|
|
S.M.Weenink,
and
A.M.Gautam
(1997).
Antigen presentation by MHC class II molecules.
|
| |
Immunol Cell Biol,
75,
69-81.
|
|
|
|
|
|
|
T.Binder,
J.Wehling,
D.Huhn,
and
R.Blasczyk
(1997).
Increased diversity within the HLA-A*66 group: implications for matching in unrelated bone marrow transplantation.
|
| |
Tissue Antigens,
50,
77-82.
|
|
|
|
|
|
|
T.N.Bullock,
A.E.Patterson,
L.L.Franlin,
E.Notidis,
and
L.C.Eisenlohr
(1997).
Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression.
|
| |
J Exp Med,
186,
1051-1058.
|
|
|
|
|
|
|
T.Witte,
A.Smolyar,
R.Spoerl,
E.C.Goyarts,
S.G.Nathenson,
E.L.Reinherz,
and
H.C.Chang
(1997).
Major histocompatibility complex recognition by immune receptors: differences among T cell receptor versus antibody interactions with the VSV8/H-2Kb complex.
|
| |
Eur J Immunol,
27,
227-233.
|
|
|
|
|
|
|
W.P.Trymbulak,
and
R.A.Zeff
(1997).
Mutants of human beta2-microglobulin map an immunodominant epitope within the three-stranded beta-pleated sheet.
|
| |
Transplantation,
64,
640-645.
|
|
|
|
|
|
|
X.Gao,
S.Lester,
B.Matheson,
B.Boettcher,
and
J.McCluskey
(1997).
Three newly identified A*24 alleles: A*2406, A*2413 and A*2414.
|
| |
Tissue Antigens,
50,
192-196.
|
|
|
|
|
|
|
Y.Kurosawa,
and
K.Hashimoto
(1997).
How did the primordial T cell receptor and MHC molecules function initially?
|
| |
Immunol Cell Biol,
75,
193-196.
|
|
|
|
|
|
|
Z.Reich,
J.D.Altman,
J.J.Boniface,
D.S.Lyons,
H.Kozono,
G.Ogg,
C.Morgan,
and
M.M.Davis
(1997).
Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparison to class I proteins.
|
| |
Proc Natl Acad Sci U S A,
94,
2495-2500.
|
|
|
|
|
|
|
A.Gilman,
J.J.Auger,
L.Terry,
N.Flomenberg,
and
L.A.Baxter-Lowe
(1996).
HLA-B14 subtypes and their influence on allorecognition.
|
| |
Tissue Antigens,
47,
253-256.
|
|
|
|
|
|
|
A.Kikuchi,
T.Sakaguchi,
K.Miwa,
Y.Takamiya,
H.G.Rammensee,
Y.Kaneko,
and
M.Takiguchi
(1996).
Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket.
|
| |
Immunogenetics,
43,
268-276.
|
|
|
|
|
|
|
A.L.Peace-Brewer,
L.G.Tussey,
M.Matsui,
G.Li,
D.G.Quinn,
and
J.A.Frelinger
(1996).
A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL.
|
| |
Immunity,
4,
505-514.
|
|
|
|
|
|
|
A.M.Krensky,
and
C.Clayberger
(1996).
Structure of HLA molecules and immunosuppressive effects of HLA derived peptides.
|
| |
Int Rev Immunol,
13,
173-185.
|
|
|
|
|
|
|
A.Marozzi,
R.Meneveri,
C.De Santis,
P.Robbioni,
E.Molteni,
A.Beretta,
A.G.Siccardi,
and
E.Ginelli
(1996).
Expression of distinct conformations of free HLA-Cw4 heavy chains in transfected neuroblastoma cells.
|
| |
Immunogenetics,
43,
289-295.
|
|
|
|
|
|
|
A.Stryhn,
L.O.Pedersen,
T.Romme,
C.B.Holm,
A.Holm,
and
S.Buus
(1996).
Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding.
|
| |
Eur J Immunol,
26,
1911-1918.
|
|
|
|
|
|
|
A.Stryhn,
P.S.Andersen,
L.O.Pedersen,
A.Svejgaard,
A.Holm,
C.J.Thorpe,
L.Fugger,
S.Buus,
and
J.Engberg
(1996).
Shared fine specificity between T-cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex.
|
| |
Proc Natl Acad Sci U S A,
93,
10338-10342.
|
|
|
|
|
|
|
A.von Bonin,
S.Plaga,
H.Ruh,
S.Hebbelmann,
U.Pflugfelder,
S.Martin,
and
H.U.Weltzien
(1996).
Analysis of major histocompatibility complex class I-restricted hapten recognition by mutation of the V-J joining of T cell receptor alpha chains.
|
| |
Eur J Immunol,
26,
179-186.
|
|
|
|
|
|
|
C.A.Nelson,
N.J.Viner,
and
E.R.Unanue
(1996).
Appreciating the complexity of MHC class II peptide binding: lysozyme peptide and I-Ak.
|
| |
Immunol Rev,
151,
81.
|
|
|
|
|
|
|
C.K.Hurley,
N.Steiner,
R.J.Hoyer,
E.Menchaca,
W.Mitton,
T.Simonis,
R.J.Hartzman,
A.H.Johnson,
and
J.Ng
(1996).
Novel HLA-B alleles, B*8201, B*3515 and B*5106, add to the complexity of serologic identification of HLA types.
|
| |
Tissue Antigens,
47,
179-187.
|
|
|
|
|
|
|
C.Kisker,
H.Schindelin,
B.E.Alber,
J.G.Ferry,
and
D.C.Rees
(1996).
A left-hand beta-helix revealed by the crystal structure of a carbonic anhydrase from the archaeon Methanosarcina thermophila.
|
| |
EMBO J,
15,
2323-2330.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
C.Robadey,
H.J.Wallny,
and
S.Demotz
(1996).
Cell type-specific processing of the I-Ed-restricted hen egg lysozyme determinant 107-116.
|
| |
Eur J Immunol,
26,
1656-1659.
|
|
|
|
|
|
|
C.de Santis,
P.Robbioni,
R.Longhi,
E.Carrow,
A.G.Siccardi,
and
A.Beretta
(1996).
Role of HLA class I in HIV type 1-induced syncytium formation.
|
| |
AIDS Res Hum Retroviruses,
12,
1031-1040.
|
|
|
|
|
|
|
D.B.Sant'Angelo,
G.Waterbury,
P.Preston-Hurlburt,
S.T.Yoon,
R.Medzhitov,
S.C.Hong,
and
C.A.Janeway
(1996).
The specificity and orientation of a TCR to its peptide-MHC class II ligands.
|
| |
Immunity,
4,
367-376.
|
|
|
|
|
|
|
D.H.Fremont,
W.A.Rees,
and
H.Kozono
(1996).
Biophysical studies of T-cell receptors and their ligands.
|
| |
Curr Opin Immunol,
8,
93.
|
|
|
|
|
|
|
E.D.Ferguson,
B.M.Dutia,
W.R.Hein,
and
J.Hopkins
(1996).
The sheep CD1 gene family contains at least four CD1B homologues.
|
| |
Immunogenetics,
44,
86-96.
|
|
|
|
|
|
|
F.Lara-Ochoa,
J.C.Almagro,
E.Vargas-Madrazo,
and
I.Mendez
(1996).
Frequency analysis of amino acids in the recognition regions of T-cell receptors.
|
| |
Biosystems,
39,
77-85.
|
|
|
|
|
|
|
G.J.Kersh,
and
P.M.Allen
(1996).
Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands.
|
| |
J Exp Med,
184,
1259-1268.
|
|
|
|
|
|
|
G.R.Crabtree,
and
S.L.Schreiber
(1996).
Three-part inventions: intracellular signaling and induced proximity.
|
| |
Trends Biochem Sci,
21,
418-422.
|
|
|
|
|
|
|
H.Eriksson
(1996).
Proteolytic cleavage of MHC class I by complement C1-esterases--an overlooked mechanism?
|
| |
Immunotechnology,
2,
163-168.
|
|
|
|
|
|
|
H.G.Ljunggren,
R.Glas,
J.K.Sandberg,
and
K.Kärre
(1996).
Reactivity and specificity of CD8+ T cells in mice with defects in the MHC class I antigen-presenting pathway.
|
| |
Immunol Rev,
151,
123-148.
|
|
|
|
|
|
|
H.S.Lillehoj,
and
J.M.Trout
(1996).
Avian gut-associated lymphoid tissues and intestinal immune responses to Eimeria parasites.
|
| |
Clin Microbiol Rev,
9,
349-360.
|
|
|
|
|
|
|
I.A.York,
and
K.L.Rock
(1996).
Antigen processing and presentation by the class I major histocompatibility complex.
|
| |
Annu Rev Immunol,
14,
369-396.
|
|
|
|
|
|
|
J.A.Bradley
(1996).
Indirect T cell recognition in allograft rejection.
|
| |
Int Rev Immunol,
13,
245-255.
|
|
|
|
|
|
|
J.Estaquier,
C.Boutillon,
B.Georges,
J.C.Ameisen,
A.Tartar,
and
C.Auriault
(1996).
A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.
|
| |
J Pept Sci,
2,
165-175.
|
|
|
|
|
|
|
J.N.Feder,
A.Gnirke,
W.Thomas,
Z.Tsuchihashi,
D.A.Ruddy,
A.Basava,
F.Dormishian,
R.Domingo,
M.C.Ellis,
A.Fullan,
L.M.Hinton,
N.L.Jones,
B.E.Kimmel,
G.S.Kronmal,
P.Lauer,
V.K.Lee,
D.B.Loeb,
F.A.Mapa,
E.McClelland,
N.C.Meyer,
G.A.Mintier,
N.Moeller,
T.Moore,
E.Morikang,
C.E.Prass,
L.Quintana,
S.M.Starnes,
R.C.Schatzman,
K.J.Brunke,
D.T.Drayna,
N.J.Risch,
B.R.Bacon,
and
R.K.Wolff
(1996).
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.
|
| |
Nat Genet,
13,
399-408.
|
|
|
|
|
|
|
J.W.Fabre
(1996).
The role of polymorphic donor peptides in allograft recognition and rejection.
|
| |
Immunol Rev,
154,
21-43.
|
|
|
|
|
|
|
J.Zhang,
and
G.C.Walker
(1996).
Identification of elements of the peptide binding site of DnaK by peptide cross-linking.
|
| |
J Biol Chem,
271,
19668-19674.
|
|
|
|
|
|
|
K.J.Smith,
S.W.Reid,
D.I.Stuart,
A.J.McMichael,
E.Y.Jones,
and
J.I.Bell
(1996).
An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501.
|
| |
Immunity,
4,
203-213.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
K.J.Smith,
S.W.Reid,
K.Harlos,
A.J.McMichael,
D.I.Stuart,
J.I.Bell,
and
E.Y.Jones
(1996).
Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53.
|
| |
Immunity,
4,
215-228.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
K.Lienert,
G.Russ,
S.Lester,
G.Bennett,
X.Gao,
and
J.McCluskey
(1996).
Stable inheritance of an HLA-"blank" phenotype associated with a structural mutation in the HLA-A*0301 gene.
|
| |
Tissue Antigens,
48,
187-191.
|
|
|
|
|
|
|
K.Prilliman,
N.Steiner,
M.Ellexson,
D.Stewart,
M.Lau,
P.Terasaki,
C.Hurley,
and
W.Hildebrand
(1996).
Novel alleles HLA-B*7802 and B*51022: evidence for convergency in the HLA-B5 family.
|
| |
Tissue Antigens,
47,
49-57.
|
|
|
|
|
|
|
L.J.Ausubel,
C.K.Kwan,
A.Sette,
V.Kuchroo,
and
D.A.Hafler
(1996).
Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones.
|
| |
Proc Natl Acad Sci U S A,
93,
15317-15322.
|
|
|
|
|
|
|
L.Lin,
K.Tokunaga,
H.Tanaka,
F.Nakajima,
T.Imanishi,
K.Kashiwase,
M.Bannai,
S.Mizuno,
T.Akaza,
K.Tadokoro,
Y.Shibata,
and
T.Juji
(1996).
Further molecular diversity in the HLA-B15 group.
|
| |
Tissue Antigens,
47,
265-274.
|
|
|
|
|
|
|
L.Zerva,
B.Cizman,
N.K.Mehra,
S.K.Alahari,
R.Murali,
C.M.Zmijewski,
M.Kamoun,
and
D.S.Monos
(1996).
Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy.
|
| |
J Exp Med,
183,
829-836.
|
|
|
|
|
|
|
M.A.Ossevoort,
M.L.De Bruijn,
K.J.Van Veen,
W.M.Kast,
and
C.J.Melief
(1996).
Peptide specificity of alloreactive CD4 positive T lymphocytes directed against a major histocompatibility complex class I disparity.
|
| |
Transplantation,
62,
1485-1491.
|
|
|
|
|
|
|
M.D.Crew,
L.M.Bates,
C.A.Douglass,
and
J.L.York
(1996).
Expressed Peromyscus maniculatus (Pema) MHC class I genes: evolutionary implications and the identification of a gene encoding a Qa1-like antigen.
|
| |
Immunogenetics,
44,
177-185.
|
|
|
|
|
|
|
M.Ellexson,
D.Stewart,
P.Chrétien,
L.Zhang,
and
W.Hildebrand
(1996).
Description of a modified sequencing strategy and the molecular characterization of HLA-B*8201.
|
| |
Tissue Antigens,
47,
438-441.
|
|
|
|
|
|
|
M.L.Dustin,
L.M.Ferguson,
P.Y.Chan,
T.A.Springer,
and
D.E.Golan
(1996).
Visualization of CD2 interaction with LFA-3 and determination of the two-dimensional dissociation constant for adhesion receptors in a contact area.
|
| |
J Cell Biol,
132,
465-474.
|
|
|
|
|
|
|
M.Saleem,
K.Gustafsson,
and
J.W.Fabre
(1996).
Attempts to demonstrate indirect T cell allorecognition of donor MHC peptides in transplant patients.
|
| |
Immunol Lett,
54,
21-24.
|
|
|
|
|
|
|
M.Wang,
S.M.Stepkowski,
M.E.Wang,
L.Tian,
X.Qu,
Y.Tu,
G.He,
and
B.D.Kahan
(1996).
Induction of specific allograft immunity by soluble class I MHC heavy chain protein produced in a baculovirus expression system.
|
| |
Transplantation,
61,
448-457.
|
|
|
|
|
|
|
M.Yeager,
and
A.L.Hughes
(1996).
Interallelic recombination has not played a major role in the history of the HLA-C locus.
|
| |
Immunogenetics,
44,
128-133.
|
|
|
|
|
|
|
N.P.Restifo,
F.M.Marincola,
Y.Kawakami,
J.Taubenberger,
J.R.Yannelli,
and
S.A.Rosenberg
(1996).
Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.
|
| |
J Natl Cancer Inst,
88,
100-108.
|
|
|
|
|
|
|
N.Zavazava,
F.Fandrich,
K.A.Ott,
A.Freese,
and
K.Turnewitsch
(1996).
Rat MHC class I peptides are immunogenic.
|
| |
Transpl Int,
9,
S337-S339.
|
|
|
|
|
|
|
P.Krausa,
and
M.J.Browning
(1996).
HLA-A2 polymorphism and immune functions.
|
| |
Eur J Immunogenet,
23,
261-274.
|
|
|
|
|
|
|
P.Parham
(1996).
Presentation of HLA class I-derived peptides: potential involvement in allorecognition and HLA-B27-associated arthritis.
|
| |
Immunol Rev,
154,
137-154.
|
|
|
|
|
|
|
P.Parham
(1996).
Functions for MHC class I carbohydrates inside and outside the cell.
|
| |
Trends Biochem Sci,
21,
427-433.
|
|
|
|
|
|
|
R.Blasczyk,
J.Wehling,
D.Onaldi-Mohr,
V.Rebmann,
D.Chandanayingyong,
and
H.Grosse-Wilde
(1996).
Structural definition of the A*74 group: implications for matching in bone marrow transplantation with alternative donors.
|
| |
Tissue Antigens,
48,
205-209.
|
|
|
|
|
|
|
R.E.Bontrop,
N.Otting,
H.Niphuis,
R.Noort,
V.Teeuwsen,
and
J.L.Heeney
(1996).
The role of major histocompatibility complex polymorphisms on SIV infection in rhesus macaques.
|
| |
Immunol Lett,
51,
35-38.
|
|
|
|
|
|
|
R.N.German,
F.Castellino,
R.Han,
C.Reis e Sousa,
P.Romagnoli,
S.Sadegh-Nasseri,
and
G.M.Zhong
(1996).
Processing and presentation of endocytically acquired protein antigens by MHC class II and class I molecules.
|
| |
Immunol Rev,
151,
5.
|
|
|
|
|
|
|
R.R.Ghobrial,
T.Hamashima,
M.E.Wang,
M.Wang,
S.M.Stepkowski,
and
B.D.Kahan
(1996).
Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules.
|
| |
Transplantation,
62,
1002-1010.
|
|
|
|
|
|
|
R.S.Wells,
and
P.Parham
(1996).
A novel recombinant HLA-B*39 allele (B*3910) in a South African Zulu.
|
| |
Tissue Antigens,
48,
595-597.
|
|
|
|
|
|
|
S.Alberti
(1996).
A high affinity T cell receptor?
|
| |
Immunol Cell Biol,
74,
292-297.
|
|
|
|
|
|
|
S.Joyce,
and
S.G.Nathenson
(1996).
Alloreactivity, antigen recognition and T-cell selection: three diverse T-cell recognition problems with a common solution.
|
| |
Immunol Rev,
154,
59.
|
|
|
|
|
|
|
S.Kaveri,
T.Vassilev,
V.Hurez,
R.Lengagne,
C.Lefranc,
S.Cot,
P.Pouletty,
D.Glotz,
and
M.D.Kazatchkine
(1996).
Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.
|
| |
J Clin Invest,
97,
865-869.
|
|
|
|
|
|
|
S.Szmania,
and
L.A.Baxter-Lowe
(1996).
Nucleotide sequence for HLA-A*2608 which encodes glutamine at codon 156.
|
| |
Tissue Antigens,
48,
210-212.
|
|
|
|
|
|
|
S.Szmania,
P.Gasque-Carter,
and
L.A.Baxter-Lowe
(1996).
Nucleotide sequence for HLA-A*0221 which encodes a novel HLA class I polymorphic residue.
|
| |
Tissue Antigens,
48,
720-724.
|
|
|
|
|
|
|
S.W.Reid,
S.McAdam,
K.J.Smith,
P.Klenerman,
C.A.O'Callaghan,
K.Harlos,
B.K.Jakobsen,
A.J.McMichael,
J.I.Bell,
D.I.Stuart,
and
E.Y.Jones
(1996).
Antagonist HIV-1 Gag peptides induce structural changes in HLA B8.
|
| |
J Exp Med,
184,
2279-2286.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
T.N.Bullock,
and
L.C.Eisenlohr
(1996).
Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames.
|
| |
J Exp Med,
184,
1319-1329.
|
|
|
|
|
|
|
W.A.Hendrickson
(1996).
Production of crystallizable fragments of membrane proteins.
|
| |
J Bioenerg Biomembr,
28,
35-40.
|
|
|
|
|
|
|
X.Gao,
and
B.Matheson
(1996).
A novel HLA-A*24 (A*2410) identified in a Javanese population.
|
| |
Tissue Antigens,
48,
711-713.
|
|
|
|
|
|
|
Y.Higashi,
N.Kamikawaji,
H.Suko,
and
M.Ando
(1996).
Analysis of HLA alleles in Japanese patients with cirrhosis due to chronic hepatitis C.
|
| |
J Gastroenterol Hepatol,
11,
241-246.
|
|
|
|
|
|
|
Y.Shimabukuro,
S.Murakami,
and
H.Okada
(1996).
Antigen-presenting-cell function of interferon gamma-treated human gingival fibroblasts.
|
| |
J Periodontal Res,
31,
217-228.
|
|
|
|
|
|
|
Y.Yang,
P.Sempé,
and
P.A.Peterson
(1996).
Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation.
|
| |
Immunol Res,
15,
208-233.
|
|
|
|
|
|
|
A.A.Beharka,
J.J.Iandolo,
S.K.Chapes,
and
B.S.Spooner
(1995).
Staphylococcal enterotoxins bind H-2Db molecules on macrophages.
|
| |
Proc Natl Acad Sci U S A,
92,
6294-6298.
|
|
|
|
|
|
|
A.Campos-Neto,
L.Soong,
J.L.Cordova,
D.Sant'Angelo,
Y.A.Skeiky,
N.H.Ruddle,
S.G.Reed,
C.Janeway,
and
D.McMahon-Pratt
(1995).
Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages.
|
| |
J Exp Med,
182,
1423-1433.
|
|
|
|
|
|
|
A.Oxenius,
M.F.Bachmann,
P.G.Ashton-Rickardt,
S.Tonegawa,
R.M.Zinkernagel,
and
H.Hengartner
(1995).
Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system.
|
| |
Eur J Immunol,
25,
3402-3411.
|
|
|
|
|
|
|
C.D.Katayama,
F.J.Eidelman,
A.Duncan,
F.Hooshmand,
and
S.M.Hedrick
(1995).
Predicted complementarity determining regions of the T cell antigen receptor determine antigen specificity.
|
| |
EMBO J,
14,
927-938.
|
|
|
|
|
|
|
C.Ostermeier,
S.Iwata,
B.Ludwig,
and
H.Michel
(1995).
Fv fragment-mediated crystallization of the membrane protein bacterial cytochrome c oxidase.
|
| |
Nat Struct Biol,
2,
842-846.
|
|
|
|
|
|
|
C.R.Wang,
A.R.Castaño,
P.A.Peterson,
C.Slaughter,
K.F.Lindahl,
and
J.Deisenhofer
(1995).
Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3.
|
| |
Cell,
82,
655-664.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
D.Barouch,
P.Krausa,
J.Bodmer,
M.J.Browning,
and
A.J.McMichael
(1995).
Identification of a novel HLA-A2 subtype, HLA-A*0216.
|
| |
Immunogenetics,
41,
388.
|
|
|
|
|
|
|
D.Barouch,
T.Friede,
S.Stevanović,
L.Tussey,
K.Smith,
S.Rowland-Jones,
V.Braud,
A.McMichael,
and
H.G.Rammensee
(1995).
HLA-A2 subtypes are functionally distinct in peptide binding and presentation.
|
| |
J Exp Med,
182,
1847-1856.
|
|
|
|
|
|
|
E.A.Nalefski,
K.T.Shaw,
and
A.Rao
(1995).
An ion pair in class II major histocompatibility complex heterodimers critical for surface expression and peptide presentation.
|
| |
J Biol Chem,
270,
22351-22360.
|
|
|
|
|
|
|
E.J.Adams,
A.M.Little,
K.L.Arnett,
J.E.McAuley,
R.C.Williams,
and
P.Parham
(1995).
Three new HLA-B alleles found in Mexican-Americans.
|
| |
Tissue Antigens,
46,
414-416.
|
|
|
|
|
|
|
E.K.Bikoff,
R.N.Germain,
and
E.J.Robertson
(1995).
Allelic differences affecting invariant chain dependency of MHC class II subunit assembly.
|
| |
Immunity,
2,
301-310.
|
|
|
|
|
|
|
E.Mottez,
P.Langlade-Demoyen,
H.Gournier,
F.Martinon,
J.Maryanski,
P.Kourilsky,
and
J.P.Abastado
(1995).
Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic.
|
| |
J Exp Med,
181,
493-502.
|
|
|
|
|
|
|
E.Nössner,
and
P.Parham
(1995).
Species-specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules.
|
| |
J Exp Med,
181,
327-337.
|
|
|
|
|
|
|
F.M.Marincola,
P.Shamamian,
L.Rivoltini,
M.Salgaller,
J.Cormier,
N.P.Restifo,
T.B.Simonis,
D.Venzon,
D.E.White,
and
D.R.Parkinson
(1995).
HLA associations in the antitumor response against malignant melanoma.
|
| |
J Immunother Emphasis Tumor Immunol,
18,
242-252.
|
|
|
|
|
|
|
F.W.Schwaiger,
and
J.T.Epplen
(1995).
Exonic MHC-DRB polymorphisms and intronic simple repeat sequences: Janus' faces of DNA sequence evolution.
|
| |
Immunol Rev,
143,
199-224.
|
|
|
|
|
|
|
H.C.Borbe,
G.Stuber,
R.Wagner,
H.Wolf,
and
S.Modrow
(1995).
Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
|
| |
J Pept Sci,
1,
109-123.
|
|
|
|
|
|
|
H.Cheroutre,
H.R.Holcombe,
S.Tangri,
A.R.Castaño,
M.Teitell,
J.E.Miller,
S.Cardell,
C.Benoist,
D.Mathis,
and
W.D.Huse
(1995).
Antigen-presenting function of the TL antigen and mouse CD1 molecules.
|
| |
Immunol Rev,
147,
31-52.
|
|
|
|
|
|
|
H.J.Hoffmann,
T.J.Kristensen,
T.G.Jensen,
B.Graugaard,
and
L.U.Lamm
(1995).
Antigenic characteristics and cDNA sequences of HLA-B73.
|
| |
Eur J Immunogenet,
22,
231-240.
|
|
|
|
|
|
|
J.C.Solheim,
J.R.Cook,
and
T.H.Hansen
(1995).
Conformational changes induced in the MHC class I molecule by peptide and beta 2-microglobulin.
|
| |
Immunol Res,
14,
200-217.
|
|
|
|
|
|
|
J.E.Fulton,
E.L.Thacker,
L.D.Bacon,
and
H.D.Hunt
(1995).
Functional analysis of avian class I (BFIV) glycoproteins by epitope tagging and mutagenesis in vitro.
|
| |
Eur J Immunol,
25,
2069-2076.
|
|
|
|
|
|
|
J.E.Gumperz,
and
P.Parham
(1995).
The enigma of the natural killer cell.
|
| |
Nature,
378,
245-248.
|
|
|
|
|
|
|
J.E.Gumperz,
V.Litwin,
J.H.Phillips,
L.L.Lanier,
and
P.Parham
(1995).
The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
|
| |
J Exp Med,
181,
1133-1144.
|
|
|
|
|
|
|
J.R.Tame,
E.J.Dodson,
G.Murshudov,
C.F.Higgins,
and
A.J.Wilkinson
(1995).
The crystal structures of the oligopeptide-binding protein OppA complexed with tripeptide and tetrapeptide ligands.
|
| |
Structure,
3,
1395-1406.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
J.S.Haurum,
L.Tan,
G.Arsequell,
P.Frodsham,
A.C.Lellouch,
P.A.Moss,
R.A.Dwek,
A.J.McMichael,
and
T.Elliott
(1995).
Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition.
|
| |
Eur J Immunol,
25,
3270-3276.
|
|
|
|
|
|
|
K.Udaka,
K.H.Wiesmüller,
S.Kienle,
G.Jung,
and
P.Walden
(1995).
Tolerance to amino acid variations in peptides binding to the major histocompatibility complex class I protein H-2Kb.
|
| |
J Biol Chem,
270,
24130-24134.
|
|
|
|
|
|
|
K.Udaka,
K.H.Wiesmüller,
S.Kienle,
G.Jung,
and
P.Walden
(1995).
Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries.
|
| |
J Exp Med,
181,
2097-2108.
|
|
|
|
|
|
|
L.G.Tussey,
S.Rowland-Jones,
T.S.Zheng,
M.J.Androlewicz,
P.Cresswell,
J.A.Frelinger,
and
A.J.McMichael
(1995).
Different MHC class I alleles compete for presentation of overlapping viral epitopes.
|
| |
Immunity,
3,
65-77.
|
|
|
|
|
|
|
L.M.Mylin,
R.H.Bonneau,
J.D.Lippolis,
and
S.S.Tevethia
(1995).
Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen.
|
| |
J Virol,
69,
6665-6677.
|
|
|
|
|
|
|
L.O.Pedersen,
A.Stryhn,
T.L.Holter,
M.Etzerodt,
J.Gerwien,
M.H.Nissen,
H.C.Thøgersen,
and
S.Buus
(1995).
The interaction of beta 2-microglobulin (beta 2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse beta 2m.
|
| |
Eur J Immunol,
25,
1609-1616.
|
|
|
|
|
|
|
L.R.Wedderburn,
S.J.Searle,
A.R.Rees,
J.R.Lamb,
and
M.J.Owen
(1995).
Mapping T cell recognition: the identification of a T cell receptor residue critical to the specific interaction with an influenza hemagglutinin peptide.
|
| |
Eur J Immunol,
25,
1654-1662.
|
|
|
|
|
|
|
M.B.Oldstone,
H.Lewicki,
P.Borrow,
D.Hudrisier,
and
J.E.Gairin
(1995).
Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection.
|
| |
J Virol,
69,
7423-7429.
|
|
|
|
|
|
|
M.D.Lairmore,
A.M.DiGeorge,
S.F.Conrad,
A.V.Trevino,
R.B.Lal,
and
P.T.Kaumaya
(1995).
Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.
|
| |
J Virol,
69,
6077-6089.
|
|
|
|
|
|
|
M.Kuwana,
Y.Okano,
J.Kaburaki,
K.Tsuji,
and
H.Inoko
(1995).
Major histocompatibility complex class II gene associations with anti-U1 small nuclear ribonucleoprotein antibody. Relationship to immunoreactivity with individual constituent proteins.
|
| |
Arthritis Rheum,
38,
396-405.
|
|
|
|
|
|
|
M.L.Fahnestock,
J.L.Johnson,
R.M.Feldman,
J.M.Neveu,
W.S.Lane,
and
P.J.Bjorkman
(1995).
The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides.
|
| |
Immunity,
3,
583-590.
|
|
|
|
|
|
|
M.Lusti-Narasimhan,
C.A.Power,
B.Allet,
S.Alouani,
K.B.Bacon,
J.J.Mermod,
A.E.Proudfoot,
and
T.N.Wells
(1995).
Mutation of Leu25 and Val27 introduces CC chemokine activity into interleukin-8.
|
| |
J Biol Chem,
270,
2716-2721.
|
|
|
|
|
|
|
M.P.Belich,
and
J.Trowsdale
(1995).
Proteasome and class I antigen processing and presentation.
|
| |
Mol Biol Rep,
21,
53-56.
|
|
|
|
|
|
|
M.P.Pistillo,
D.Bini,
S.Pozzi,
and
G.B.Ferrara
(1995).
A cytotoxic human monoclonal antibody that can discriminate HLA-A*3002 from HLA-A*3001 subtypes.
|
| |
Tissue Antigens,
46,
327-329.
|
|
|
|
|
|
|
M.Ramos,
J.M.Postigo,
C.Vilches,
Z.Layrisse,
and
J.A.Lopez de Castro
(1995).
Primary structure of a novel HLA-B39 allele (B*3909) from the Warao Indians of Venezuela. Further evidence for local HLA-B diversification in South America.
|
| |
Tissue Antigens,
46,
401-404.
|
|
|
|
|
|
|
N.Lee,
A.R.Malacko,
A.Ishitani,
M.C.Chen,
J.Bajorath,
H.Marquardt,
and
D.E.Geraghty
(1995).
The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association.
|
| |
Immunity,
3,
591-600.
|
|
|
|
|
|
|
P.A.Moss,
and
J.I.Bell
(1995).
Sequence analysis of the human alpha beta T-cell receptor CDR3 region.
|
| |
Immunogenetics,
42,
10-18.
|
|
|
|
|
|
|
P.A.van der Merwe,
P.N.McNamee,
E.A.Davies,
A.N.Barclay,
and
S.J.Davis
(1995).
Topology of the CD2-CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells.
|
| |
Curr Biol,
5,
74-84.
|
|
|
|
|
|
|
P.Krausa,
D.Barouch,
J.G.Bodmer,
A.V.Hill,
C.Mason,
A.J.McMichael,
and
M.J.Browning
(1995).
Characterization of a novel HLA-A2 variant, A*0214, by ARMS-PCR and DNA sequencing.
|
| |
Immunogenetics,
41,
50.
|
|
|
|
|
|
|
P.Krausa,
M.Brywka,
D.Savage,
K.M.Hui,
M.Bunce,
J.L.Ngai,
D.L.Teo,
Y.W.Ong,
D.Barouch,
and
C.E.Allsop
(1995).
Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations.
|
| |
Tissue Antigens,
45,
223-231.
|
|
|
|
|
|
|
P.Parham,
E.J.Adams,
and
K.L.Arnett
(1995).
The origins of HLA-A,B,C polymorphism.
|
| |
Immunol Rev,
143,
141-180.
|
|
|
|
|
|
|
R.Blasczyk,
J.Wehling,
M.Pässler,
U.Hahn,
D.Huhn,
and
A.Salama
(1995).
A novel HLA-A30 allele (A*3004) identified by single-strand conformation polymorphism analysis and confirmed by solid-phase sequencing.
|
| |
Tissue Antigens,
46,
322-326.
|
|
|
|
|
|
|
R.Blasczyk,
J.Wehling,
U.Hahn,
N.Schwella,
D.Huhn,
and
A.Salama
(1995).
Identification of a novel HLA-A33 subtype (A*3303) and correction of the A*3301 sequence.
|
| |
Tissue Antigens,
45,
348-352.
|
|
|
|
|
|
|
R.D.Pettersen,
K.Hestdal,
N.Lee,
D.E.Geraghty,
E.T.Valø,
S.O.Lie,
and
G.Gaudernack
(1995).
RG1, a new murine monoclonal antibody recognizing a "supertypic" determinant on HLA-A molecules.
|
| |
Tissue Antigens,
45,
203-212.
|
|
|
|
|
|
|
R.Fukuda,
S.Satoh,
X.T.Nguyen,
Y.Uchida,
N.Kohge,
S.Akagi,
S.Ikeda,
M.Watanabe,
and
S.Fukumoto
(1995).
Expression rate of cytokine mRNA in the liver of chronic hepatitis C: comparison with chronic hepatitis B.
|
| |
J Gastroenterol,
30,
41-47.
|
|
|
|
|
|
|
R.König,
X.Shen,
and
R.N.Germain
(1995).
Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation.
|
| |
J Exp Med,
182,
779-787.
|
|
|
|
|
|
|
R.Martin,
and
H.F.McFarland
(1995).
Multiple sclerosis: are HLA class I molecules involved in disease pathogenesis?
|
| |
Ann Neurol,
38,
137-139.
|
|
|
|
|
|
|
R.N.Germain
(1995).
The biochemistry and cell biology of antigen presentation by MHC class I and class II molecules. Implications for development of combination vaccines.
|
| |
Ann N Y Acad Sci,
754,
114-125.
|
|
|
|
|
|
|
R.Sun,
S.E.Shepherd,
S.S.Geier,
C.T.Thomson,
J.M.Sheil,
and
S.G.Nathenson
(1995).
Evidence that the antigen receptors of cytotoxic T lymphocytes interact with a common recognition pattern on the H-2Kb molecule.
|
| |
Immunity,
3,
573-582.
|
|
|
|
|
|
|
S.J.Davis,
E.A.Davies,
A.N.Barclay,
S.Daenke,
D.L.Bodian,
E.Y.Jones,
D.I.Stuart,
T.D.Butters,
R.A.Dwek,
and
P.A.van der Merwe
(1995).
Ligand binding by the immunoglobulin superfamily recognition molecule CD2 is glycosylation-independent.
|
| |
J Biol Chem,
270,
369-375.
|
|
|
|
|
|
|
S.K.Salgar,
H.W.Kunz,
and
T.J.Gill
(1995).
Expression of the rat MHC class I gene in the human B lymphoblastoid cell line Hmy 2 CIR.
|
| |
Eur J Immunogenet,
22,
479-483.
|
|
|
|
|
|
|
S.Mikko,
and
L.Andersson
(1995).
Low major histocompatibility complex class II diversity in European and North American moose.
|
| |
Proc Natl Acad Sci U S A,
92,
4259-4263.
|
|
|
|
|
|
|
S.Sartoris,
and
R.S.Accolla
(1995).
Transcriptional regulation of MHC class II genes.
|
| |
Int J Clin Lab Res,
25,
71-78.
|
|
|
|
|
|
|
T.L.Garber,
L.M.Butler,
E.A.Trachtenberg,
H.A.Erlich,
O.Rickards,
G.De Stefano,
and
D.I.Watkins
(1995).
HLA-B alleles of the Cayapa of Ecuador: new B39 and B15 alleles.
|
| |
Immunogenetics,
42,
19-27.
|
|
|
|
|
|
|
Y.Beck,
L.Satz,
Y.Takamiya,
S.Nakayama,
L.Ling,
Y.Ishikawa,
T.Nagao,
H.Uchida,
K.Tokunaga,
and
C.Müller
(1995).
Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules.
|
| |
J Exp Med,
181,
2037-2048.
|
|
|
|
|
|
|
Y.Becker
(1995).
An analysis of the role of skin Langerhans cells (LC) in the cytoplasmic processing of HIV-1 peptides after "peplotion" transepidermal transfer and HLA class I presentation to CD8+ CTLs--an approach to immunization of humans.
|
| |
Virus Genes,
9,
133-147.
|
|
|
|
|
|
|
A.A.Beharka,
J.W.Armstrong,
J.J.Iandolo,
S.K.Chapes,
and
B.S.Spooner
(1994).
Binding and activation of major histocompatibility complex class II-deficient macrophages by staphylococcal exotoxins.
|
| |
Infect Immun,
62,
3907-3915.
|
|
|
|
|
|
|
A.AEvarsson,
E.Brazhnikov,
M.Garber,
J.Zheltonosova,
Y.Chirgadze,
S.al-Karadaghi,
L.A.Svensson,
and
A.Liljas
(1994).
Three-dimensional structure of the ribosomal translocase: elongation factor G from Thermus thermophilus.
|
| |
EMBO J,
13,
3669-3677.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
A.Bertoletti,
A.Costanzo,
F.V.Chisari,
M.Levrero,
M.Artini,
A.Sette,
A.Penna,
T.Giuberti,
F.Fiaccadori,
and
C.Ferrari
(1994).
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.
|
| |
J Exp Med,
180,
933-943.
|
|
|
|
|
|
|
A.C.Young,
W.Zhang,
J.C.Sacchettini,
and
S.G.Nathenson
(1994).
The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection.
|
| |
Cell,
76,
39-50.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
A.I.Colovai,
N.Suciu-Foca,
G.E.Baiulescu,
and
P.E.Harris
(1994).
HLA class I self peptides isolated from a T-cell leukemia reveal the allele-specific motif of HLA-B38.
|
| |
Tissue Antigens,
44,
65-72.
|
|
|
|
|
|
|
A.J.Rees
(1994).
The immunogenetics of glomerulonephritis.
|
| |
Kidney Int,
45,
377-383.
|
|
|
|
|
|
|
A.Morita,
T.Takahashi,
E.Stockert,
E.Nakayama,
T.Tsuji,
Y.Matsudaira,
L.J.Old,
and
Y.Obata
(1994).
TL antigen as a transplantation antigen recognized by TL-restricted cytotoxic T cells.
|
| |
J Exp Med,
179,
777-784.
|
|
|
|
|
|
|
A.Morris,
C.Hewitt,
and
S.Young
(1994).
The major histocompatibility complex: its genes and their roles in antigen presentation.
|
| |
Mol Aspects Med,
15,
377-503.
|
|
|
|
|
|
|
B.Catipović,
G.Talluri,
J.Oh,
T.Wei,
X.M.Su,
T.E.Johansen,
M.Edidin,
and
J.P.Schneck
(1994).
Analysis of the structure of empty and peptide-loaded major histocompatibility complex molecules at the cell surface.
|
| |
J Exp Med,
180,
1753-1761.
|
|
|
|
|
|
|
B.Rubin,
J.Arnaud,
S.Caspar-Bauguil,
F.Conte,
and
A.Huchenq
(1994).
Biological function of the extracellular domain of the T-cell receptor constant region.
|
| |
Scand J Immunol,
39,
517-525.
|
|
|
|
|
|
|
B.Schoel,
U.Zügel,
T.Ruppert,
and
S.H.Kaufmann
(1994).
Elongated peptides, not the predicted nonapeptide stimulate a major histocompatibility complex class I-restricted cytotoxic T lymphocyte clone with specificity for a bacterial heat shock protein.
|
| |
Eur J Immunol,
24,
3161-3169.
|
|
|
|
|
|
|
C.L.Verlinde,
and
W.G.Hol
(1994).
Structure-based drug design: progress, results and challenges.
|
| |
Structure,
2,
577-587.
|
|
|
|
|
|
|
C.de Santis,
L.Lopalco,
P.Robbioni,
R.Longhi,
G.Rappocciolo,
A.G.Siccardi,
and
A.Beretta
(1994).
Human antibodies to immunodominant C5 region of HIV-1 gp120 cross-react with HLA class I on activated cells.
|
| |
AIDS Res Hum Retroviruses,
10,
157-162.
|
|
|
|
|
|
|
D.A.Vignali,
and
J.L.Strominger
(1994).
Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor.
|
| |
J Exp Med,
179,
1945-1956.
|
|
|
|
|
|
|
D.Bouzida,
J.Garnier,
R.Brower,
J.Cornette,
and
C.DeLisi
(1994).
Monte Carlo study of the effect of beta 2-microglobulin on the binding cleft of the HLA-A2 complex.
|
| |
Protein Sci,
3,
911-919.
|
|
|
|
|
|
|
E.A.Welsh,
H.H.Clark,
S.Z.Epstein,
J.D.Reveille,
and
M.Duvic
(1994).
Human leukocyte antigen-DQB1*03 alleles are associated with alopecia areata.
|
| |
J Invest Dermatol,
103,
758-763.
|
|
|
|
|
|
|
F.J.Ayala,
A.Escalante,
C.O'Huigin,
and
J.Klein
(1994).
Molecular genetics of speciation and human origins.
|
| |
Proc Natl Acad Sci U S A,
91,
6787-6794.
|
|
|
|
|
|
|
G.Ada
(1994).
Twenty years into the saga of MHC-restriction.
|
| |
Immunol Cell Biol,
72,
447-454.
|
|
|
|
|
|
|
G.V.Glinsky
(1994).
Antigen presentation, aberrant glycosylation and tumor progression.
|
| |
Crit Rev Oncol Hematol,
17,
27-51.
|
|
|
|
|
|
|
G.Wagner,
and
D.F.Wyss
(1994).
Cell surface adhesion receptors.
|
| |
Curr Opin Struct Biol,
4,
841-851.
|
|
|
|
|
|
|
H.E.Liang,
C.C.Chen,
D.L.Chou,
and
M.Z.Lai
(1994).
Flexibility of the T cell receptor repertoire.
|
| |
Eur J Immunol,
24,
1604-1611.
|
|
|
|
|
|
|
I.Callebaut,
D.Portetelle,
A.Burny,
and
J.P.Mornon
(1994).
Identification of functional sites on bovine leukemia virus envelope glycoproteins using structural and immunological data.
|
| |
Eur J Biochem,
222,
405-414.
|
|
|
|
|
|
|
J.A.Todd
(1994).
Lawrence Lecture. The Emperor's new genes: 1993 RD Lawrence Lecture.
|
| |
Diabet Med,
11,
6.
|
|
|
|
|
|
|
J.A.Villadangos,
B.Galocha,
R.García-Hoyo,
D.López,
F.García,
and
J.A.López de Castro
(1994).
Structure of HLA-B27-specific T cell epitopes. Antigen presentation in B*2703 is limited mostly to a subset of the antigenic determinants on B*2705.
|
| |
Eur J Immunol,
24,
2548-2555.
|
|
|
|
|
|
|
J.Alexander,
J.Sidney,
S.Southwood,
J.Ruppert,
C.Oseroff,
A.Maewal,
K.Snoke,
H.M.Serra,
R.T.Kubo,
and
A.Sette
(1994).
Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.
|
| |
Immunity,
1,
751-761.
|
|
|
|
|
|
|
J.B.Rothbard
(1994).
Antigen presentation. One size fits all.
|
| |
Curr Biol,
4,
653-655.
|
|
|
|
|
|
|
J.Estaquier,
H.Gras-Masse,
C.Boutillon,
J.C.Ameisen,
A.Capron,
A.Tartar,
and
C.Auriault
(1994).
The mixotope: a combinatorial peptide library as a T cell and B cell immunogen.
|
| |
Eur J Immunol,
24,
2789-2795.
|
|
|
|
|
|
|
J.F.Miller
(1994).
Burnet oration. The thymus then and now.
|
| |
Immunol Cell Biol,
72,
361-366.
|
|
|
|
|
|
|
J.Ge,
A.Bratlie,
and
K.Hannestad
(1994).
A novel HLA-A determinant recognized by a cytotoxic human hybridoma IgG1 monoclonal antibody (TrJ14).
|
| |
Tissue Antigens,
44,
306-310.
|
|
|
|
|
|
|
J.H.Moses,
H.Tsichti,
P.Donaldson,
P.B.Smith,
N.W.Johnson,
and
J.G.Bodmer
(1994).
HLA and susceptibility to juvenile periodontitis in Afro-Caribbeans.
|
| |
Tissue Antigens,
43,
316-319.
|
|
|
|
|
|
|
J.S.Murray,
D.Ferrandis-Edwards,
C.J.Wolfe,
and
T.Schountz
(1994).
Major histocompatibility complex regulation of T helper functions mapped to a peptide C terminus that controls ligand density.
|
| |
Eur J Immunol,
24,
2337-2344.
|
|
|
|
|
|
|
J.Tormo,
D.Blaas,
N.R.Parry,
D.Rowlands,
D.Stuart,
and
I.Fita
(1994).
Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2.
|
| |
EMBO J,
13,
2247-2256.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
K.Karjalainen
(1994).
High sensitivity, low affinity--paradox of T-cell receptor recognition.
|
| |
Curr Opin Immunol,
6,
9.
|
|
|
|
|
|
|
K.L.Hilyard,
H.Reyburn,
S.Chung,
J.I.Bell,
and
J.L.Strominger
(1994).
Binding of soluble natural ligands to a soluble human T-cell receptor fragment produced in Escherichia coli.
|
| |
Proc Natl Acad Sci U S A,
91,
9057-9061.
|
|
|
|
|
|
|
L.J.Stern,
and
D.C.Wiley
(1994).
Antigenic peptide binding by class I and class II histocompatibility proteins.
|
| |
Structure,
2,
245-251.
|
|
|
|
|
|
|
L.J.Stern,
J.H.Brown,
T.S.Jardetzky,
J.C.Gorga,
R.G.Urban,
J.L.Strominger,
and
D.C.Wiley
(1994).
Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.
|
| |
Nature,
368,
215-221.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
L.Lin,
K.Tokunaga,
Y.Ishikawa,
M.Bannai,
K.Kashiwase,
S.Kuwata,
T.Akaza,
K.Tadokoro,
Y.Shibata,
and
T.Juji
(1994).
Sequence analysis of serological HLA-A11 split antigens, A11.1 and A11.2.
|
| |
Tissue Antigens,
43,
78-82.
|
|
|
|
|
|
|
L.O.Pedersen,
A.S.Hansen,
A.C.Olsen,
J.Gerwien,
M.H.Nissen,
and
S.Buus
(1994).
The interaction between beta 2-microglobulin (beta 2m) and purified class-I major histocompatibility (MHC) antigen.
|
| |
Scand J Immunol,
39,
64-72.
|
|
|
|
|
|
|
L.Olsson,
A.Goldstein,
and
J.Stagsted
(1994).
Regulation of receptor internalization by the major histocompatibility complex class I molecule.
|
| |
Proc Natl Acad Sci U S A,
91,
9086-9090.
|
|
|
|
|
|
|
M.A.Gavin,
B.Dere,
A.G.Grandea,
K.A.Hogquist,
and
M.J.Bevan
(1994).
Major histocompatibility complex class I allele-specific peptide libraries: identification of peptides that mimic an H-Y T cell epitope.
|
| |
Eur J Immunol,
24,
2124-2133.
|
|
|
|
|
|
|
M.F.Flajnik
(1994).
Advances in immunology.
|
| |
Bioessays,
16,
671-675.
|
|
|
|
|
|
|
M.Fridkis-Hareli,
D.Teitelbaum,
E.Gurevich,
I.Pecht,
C.Brautbar,
O.J.Kwon,
T.Brenner,
R.Arnon,
and
M.Sela
(1994).
Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.
|
| |
Proc Natl Acad Sci U S A,
91,
4872-4876.
|
|
|
|
|
|
|
M.H.Feng,
and
M.Z.Lai
(1994).
A peptide binding weakly to the major histocompatibility molecule augments T cell responses.
|
| |
Eur J Immunol,
24,
355-361.
|
|
|
|
|
|
|
M.J.Bijlmakers,
P.Benaroch,
and
H.L.Ploegh
(1994).
Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain.
|
| |
EMBO J,
13,
2699-2707.
|
|
|
|
|
|
|
M.Raghavan,
M.Y.Chen,
L.N.Gastinel,
and
P.J.Bjorkman
(1994).
Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand.
|
| |
Immunity,
1,
303-315.
|
|
|
|
|
|
|
M.Sester,
and
H.G.Burgert
(1994).
Conserved cysteine residues within the E3/19K protein of adenovirus type 2 are essential for binding to major histocompatibility complex antigens.
|
| |
J Virol,
68,
5423-5432.
|
|
|
|
|
|
|
N.Q.Lu
(1994).
A speculative view of immune recognition.
|
| |
Immunol Invest,
23,
53-71.
|
|
|
|
|
|
|
O.Perisic,
P.A.Webb,
P.Holliger,
G.Winter,
and
R.L.Williams
(1994).
Crystal structure of a diabody, a bivalent antibody fragment.
|
| |
Structure,
2,
1217-1226.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
P.Aichele,
D.Kyburz,
P.S.Ohashi,
B.Odermatt,
R.M.Zinkernagel,
H.Hengartner,
and
H.Pircher
(1994).
Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model.
|
| |
Proc Natl Acad Sci U S A,
91,
444-448.
|
|
|
|
|
|
|
P.J.Bjorkman,
and
W.P.Burmeister
(1994).
Structures of two classes of MHC molecules elucidated: crucial differences and similarities.
|
| |
Curr Opin Struct Biol,
4,
852-856.
|
|
|
|
|
|
|
P.M.Allen
(1994).
Peptides in positive and negative selection: a delicate balance.
|
| |
Cell,
76,
593-596.
|
|
|
|
|
|
|
P.Parham,
K.L.Arnett,
E.J.Adams,
L.D.Barber,
J.D.Domena,
D.Stewart,
W.H.Hildebrand,
and
A.M.Little
(1994).
The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles.
|
| |
Tissue Antigens,
43,
302-313.
|
|
|
|
|
|
|
R.A.Colbert,
S.L.Rowland-Jones,
A.J.McMichael,
and
J.A.Frelinger
(1994).
Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703.
|
| |
Immunity,
1,
121-130.
|
|
|
|
|
|
|
R.A.Hughes,
and
A.C.Keat
(1994).
Reiter's syndrome and reactive arthritis: a current view.
|
| |
Semin Arthritis Rheum,
24,
190-210.
|
|
|
|
|
|
|
R.N.Germain
(1994).
MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.
|
| |
Cell,
76,
287-299.
|
|
|
|
|
|
|
R.S.Blumberg,
and
S.P.Balk
(1994).
Intraepithelial lymphocytes and their recognition of non-classical MHC molecules.
|
| |
Int Rev Immunol,
11,
15-30.
|
|
|
|
|
|
|
S.Bahram,
M.Bresnahan,
D.E.Geraghty,
and
T.Spies
(1994).
A second lineage of mammalian major histocompatibility complex class I genes.
|
| |
Proc Natl Acad Sci U S A,
91,
6259-6263.
|
|
|
|
|
|
|
S.Bartl,
and
I.L.Weissman
(1994).
Isolation and characterization of major histocompatibility complex class IIB genes from the nurse shark.
|
| |
Proc Natl Acad Sci U S A,
91,
262-266.
|
|
|
|
|
|
|
S.Joyce,
and
S.G.Nathenson
(1994).
Methods to study peptides associated with MHC class I molecules.
|
| |
Curr Opin Immunol,
6,
24-31.
|
|
|
|
|
|
|
S.N.McAdam,
J.E.Boyson,
X.Liu,
T.L.Garber,
A.L.Hughes,
R.E.Bontrop,
and
D.I.Watkins
(1994).
A uniquely high level of recombination at the HLA-B locus.
|
| |
Proc Natl Acad Sci U S A,
91,
5893-5897.
|
|
|
|
|
|
|
U.Feige,
and
B.S.Polla
(1994).
Hsp70--a multi-gene, multi-structure, multi-function family with potential clinical applications.
|
| |
Experientia,
50,
979-986.
|
|
|
|
|
|
|
W.R.Taylor,
T.P.Flores,
and
C.A.Orengo
(1994).
Multiple protein structure alignment.
|
| |
Protein Sci,
3,
1858-1870.
|
|
|
|
|
|
|
X.Q.Huang,
M.S.Mitchell,
P.E.Liggett,
A.L.Murphree,
and
J.Kan-Mitchell
(1994).
Non-fastidious, melanoma-specific CD8+ cytotoxic T lymphocytes from choroidal melanoma patients.
|
| |
Cancer Immunol Immunother,
38,
399-405.
|
|
|
|
|
|
|
Y.Becker
(1994).
Dengue fever virus and Japanese encephalitis virus synthetic peptides, with motifs to fit HLA class I haplotypes prevalent in human populations in endemic regions, can be used for application to skin Langerhans cells to prime antiviral CD8+ cytotoxic T cells (CTLs)--a novel approach to the protection of humans.
|
| |
Virus Genes,
9,
33-45.
|
|
|
|
|
|
|
Y.Becker
(1994).
Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)--a point of view.
|
| |
Virus Genes,
8,
199-214.
|
|
|
|
|
|
|
Y.Itoh,
K.Ogasawara,
K.Takami,
T.Gotohda,
H.Naruse,
R.A.Good,
and
K.Onoé
(1994).
Determination of amino acids on agretopes of pigeon cytochrome c-related peptides specifically bound to I-A allelic products.
|
| |
Eur J Immunol,
24,
76-83.
|
|
|
|
|
|
|
Y.Obata,
Y.Satta,
K.Moriwaki,
T.Shiroishi,
H.Hasegawa,
T.Takahashi,
and
N.Takahata
(1994).
Structure, function, and evolution of mouse TL genes, nonclassical class I genes of the major histocompatibility complex.
|
| |
Proc Natl Acad Sci U S A,
91,
6589-6593.
|
|
|
|
|
|
|
Y.Shindo,
H.Inoko,
T.Yamamoto,
and
S.Ohno
(1994).
HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410.
|
| |
Br J Ophthalmol,
78,
223-226.
|
|
|
|
|
|
|
Z.Yu,
F.Healy,
D.Valmori,
P.Escobar,
G.Corradin,
and
J.P.Mach
(1994).
Peptide-antibody conjugates for tumour therapy: a MHC-class-II-restricted tetanus toxin peptide coupled to an anti-Ig light chain antibody can induce cytotoxic lysis of a human B-cell lymphoma by specific CD4 T cells.
|
| |
Int J Cancer,
56,
244-248.
|
|
|
|
|
|
|
A.B.Kulkarni,
H.C.Morse,
J.R.Bennink,
J.W.Yewdell,
and
B.R.Murphy
(1993).
Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells.
|
| |
J Virol,
67,
4086-4092.
|
|
|
|
|
|
|
A.Bertoletti,
F.V.Chisari,
A.Penna,
S.Guilhot,
L.Galati,
G.Missale,
P.Fowler,
H.J.Schlicht,
A.Vitiello,
and
R.C.Chesnut
(1993).
Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein.
|
| |
J Virol,
67,
2376-2380.
|
|
|
|
|
|
|
A.Compston
(1993).
Inflammation and the brain.
|
| |
Mol Chem Neuropathol,
19,
47-64.
|
|
|
|
|
|
|
A.G.Geiser,
J.J.Letterio,
A.B.Kulkarni,
S.Karlsson,
A.B.Roberts,
and
M.B.Sporn
(1993).
Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype.
|
| |
Proc Natl Acad Sci U S A,
90,
9944-9948.
|
|
|
|
|
|
|
A.Geluk,
D.G.Elferink,
B.L.Slierendregt,
K.E.van Meijgaarden,
R.R.de Vries,
T.H.Ottenhoff,
and
R.E.Bontrop
(1993).
Evolutionary conservation of major histocompatibility complex-DR/peptide/T cell interactions in primates.
|
| |
J Exp Med,
177,
979-987.
|
|
|
|
|
|
|
A.L.Hughes,
M.K.Hughes,
and
D.I.Watkins
(1993).
Contrasting roles of interallelic recombination at the HLA-A and HLA-B loci.
|
| |
Genetics,
133,
669-680.
|
|
|
|
|
|
|
A.Marozzi,
R.Meneveri,
G.Bunone,
C.De Santis,
L.Lopalco,
A.Beretta,
A.Agresti,
A.G.Siccardi,
G.Della Valle,
and
E.Ginelli
(1993).
Expression of beta 2m-free HLA class I heavy chains in neuroblastoma cell lines.
|
| |
Scand J Immunol,
37,
661-667.
|
|
|
|
|
|
|
A.Tulp,
and
D.J.Verwoerd
(1993).
Thermostability analysis of major histocompatibility complex class I molecules by temperature gradient gel electrophoresis.
|
| |
Eur J Immunol,
23,
2030-2033.
|
|
|
|
|
|
|
B.Frangoulis,
B.Urbero,
and
M.Pla
(1993).
Allogeneic recognition of class I molecules: anti-H-2Ld repertoire of H-2b mice includes T cells recognizing mutant class II H-2b (Abm12) molecules.
|
| |
Eur J Immunol,
23,
1884-1888.
|
|
|
|
|
|
|
B.Frangoulis,
M.Reboul,
A.Rocca,
and
M.Pla
(1993).
Cross-reactivity among evolutionarily distant major histocompatibility complex class I molecules (HLA-B27 and H-2Kk) revealed by xenoreactive T lymphocytes.
|
| |
Eur J Immunol,
23,
338-342.
|
|
|
|
|
|
|
B.H.O'Neil,
Y.Kawakami,
N.P.Restifo,
J.R.Bennink,
J.W.Yewdell,
and
S.A.Rosenberg
(1993).
Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLA.
|
| |
J Immunol,
151,
1410-1418.
|
|
|
|
|
|
|
B.L.Slierendregt,
M.Kenter,
N.Otting,
J.Anholts,
M.Jonker,
and
R.E.Bontrop
(1993).
Major histocompatibility complex class II haplotypes in a breeding colony of chimpanzees (Pan troglodytes).
|
| |
Tissue Antigens,
42,
55-61.
|
|
|
|
|
|
|
C.Delarbre,
P.Kourilsky,
and
G.Gachelin
(1993).
Diversity of exon 2 of major histocompatibility complex class I genes in wild mice.
|
| |
Immunogenetics,
38,
71-73.
|
|
|
|
|
|
|
C.R.Wang,
and
K.F.Lindahl
(1993).
HMT, encoded by H-2M3, is a neoclassical major histocompatibility class I antigen.
|
| |
Proc Natl Acad Sci U S A,
90,
2784-2788.
|
|
|
|
|
|
|
D.Faustman
(1993).
Mechanisms of autoimmunity in type I diabetes.
|
| |
J Clin Immunol,
13,
1-7.
|
|
|
|
|
|
|
D.H.Margulies,
M.Corr,
L.F.Boyd,
and
S.N.Khilko
(1993).
MHC class I/peptide interactions: binding specificity and kinetics.
|
| |
J Mol Recognit,
6,
59-69.
|
|
|
|
|
|
|
D.M.Ojcius,
F.Godeau,
J.P.Abastado,
J.L.Casanova,
and
P.Kourilsky
(1993).
Real-time measurement of antigenic peptide binding to empty and preloaded single-chain major histocompatibility complex class I molecules.
|
| |
Eur J Immunol,
23,
1118-1124.
|
|
|
|
|
|
|
E.F.Hounsell,
and
M.J.Davies
(1993).
Role of protein glycosylation in immune regulation.
|
| |
Ann Rheum Dis,
52,
S22-S29.
|
|
|
|
|
|
|
E.Wiertz,
J.van Gaans-van den Brink,
P.Hoogerhout,
and
J.Poolman
(1993).
Microheterogeneity in the recognition of a HLA-DR2-restricted T cell epitope from a meningococcal outer membrane protein.
|
| |
Eur J Immunol,
23,
232-239.
|
|
|
|
|
|
|
G.Missale,
A.Redeker,
J.Person,
P.Fowler,
S.Guilhot,
H.J.Schlicht,
C.Ferrari,
and
F.V.Chisari
(1993).
HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
|
| |
J Exp Med,
177,
751-762.
|
|
|
|
|
|
|
H.C.Guo,
D.R.Madden,
M.L.Silver,
T.S.Jardetzky,
J.C.Gorga,
J.L.Strominger,
and
D.C.Wiley
(1993).
Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705.
|
| |
Proc Natl Acad Sci U S A,
90,
8053-8057.
|
|
|
|
|
|
|
H.G.Rammensee,
K.Falk,
and
O.Rötzschke
(1993).
MHC molecules as peptide receptors.
|
| |
Curr Opin Immunol,
5,
35-44.
|
|
|
|
|
|
|
H.Ono,
F.Figueroa,
C.O'hUigin,
and
J.Klein
(1993).
Cloning of the beta 2-microglobulin gene in the zebrafish.
|
| |
Immunogenetics,
38,
1.
|
|
|
|
|
|
|
H.W.Nijman,
J.G.Houbiers,
M.P.Vierboom,
S.H.van der Burg,
J.W.Drijfhout,
J.D'Amaro,
P.Kenemans,
C.J.Melief,
and
W.M.Kast
(1993).
Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes.
|
| |
Eur J Immunol,
23,
1215-1219.
|
|
|
|
|
|
|
J.A.Goss,
M.A.Alexander-Miller,
J.Gorka,
M.W.Flye,
J.M.Connolly,
and
T.H.Hansen
(1993).
Specific prolongation of allograft survival by a T-cell-receptor-derived peptide.
|
| |
Proc Natl Acad Sci U S A,
90,
9872-9876.
|
|
|
|
|
|
|
J.A.Goss,
R.Pyo,
M.W.Flye,
J.M.Connolly,
and
T.H.Hansen
(1993).
Major histocompatibility complex-specific prolongation of murine skin and cardiac allograft survival after in vivo depletion of V beta+ T cells.
|
| |
J Exp Med,
177,
35-44.
|
|
|
|
|
|
|
J.C.Steele,
T.Stankovic,
and
P.H.Gallimore
(1993).
Production and characterization of human proliferative T-cell clones specific for human papillomavirus type 1 E4 protein.
|
| |
J Virol,
67,
2799-2806.
|
|
|
|
|
|
|
J.D.Altman,
P.A.Reay,
and
M.M.Davis
(1993).
Formation of functional peptide complexes of class II major histocompatibility complex proteins from subunits produced in Escherichia coli.
|
| |
Proc Natl Acad Sci U S A,
90,
10330-10334.
|
|
|
|
|
|
|
J.D.Domena,
K.Azumi,
W.B.Bias,
and
P.Parham
(1993).
B*1401 encodes the B64 antigen: the B64 and B65 splits of B14 differ only at residue 11, a buried amino acid.
|
| |
Tissue Antigens,
41,
110-111.
|
|
|
|
|
|
|
J.Dal Porto,
T.E.Johansen,
B.Catipović,
D.J.Parfiit,
D.Tuveson,
U.Gether,
S.Kozlowski,
D.T.Fearon,
and
J.P.Schneck
(1993).
A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations.
|
| |
Proc Natl Acad Sci U S A,
90,
6671-6675.
|
|
|
|
|
|
|
J.F.Zagury,
J.Bernard,
A.Achour,
A.Astgen,
A.Lachgar,
L.Fall,
C.Carelli,
W.Issing,
J.P.Mbika,
and
O.Picard
(1993).
Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
|
| |
Proc Natl Acad Sci U S A,
90,
7573-7577.
|
|
|
|
|
|
|
J.J.Neefjes,
G.J.Hämmerling,
and
F.Momburg
(1993).
Folding and assembly of major histocompatibility complex class I heterodimers in the endoplasmic reticulum of intact cells precedes the binding of peptide.
|
| |
J Exp Med,
178,
1971-1980.
|
|
|
|
|
|
|
J.J.Neefjes,
J.Dierx,
and
H.L.Ploegh
(1993).
The effect of anchor residue modifications on the stability of major histocompatibility complex class I-peptide interactions.
|
| |
Eur J Immunol,
23,
840-845.
|
|
|
|
|
|
|
J.L.Muñoz,
W.P.Parks,
S.M.Wolinsky,
B.T.Korber,
and
C.Hutto
(1993).
HIV-1 reverse transcriptase. A diversity generator and quasispecies regulator.
|
| |
Ann N Y Acad Sci,
693,
65-70.
|
|
|
|
|
|
|
J.M.Brooks,
R.J.Murray,
W.A.Thomas,
M.G.Kurilla,
and
A.B.Rickinson
(1993).
Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
|
| |
J Exp Med,
178,
879-887.
|
|
|
|
|
|
|
J.M.Kelly,
S.J.Sterry,
S.Cose,
S.J.Turner,
J.Fecondo,
S.Rodda,
P.J.Fink,
and
F.R.Carbone
(1993).
Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant.
|
| |
Eur J Immunol,
23,
3318-3326.
|
|
|
|
|
|
|
J.Nikolić-Zugić,
and
R.Dyall
(1993).
Positive selection of the T-cell repertoire is affected by mutations in the peptide-binding site of MHC class I molecules.
|
| |
Ann N Y Acad Sci,
681,
16-24.
|
|
|
|
|
|
|
J.P.Abastado,
D.M.Ojcius,
A.Casrouge,
P.Yeh,
T.N.Schumacher,
H.L.Ploegh,
and
P.Kourilsky
(1993).
A soluble, single-chain Kd molecule produced by yeast selects a peptide repertoire indistinguishable from that of cell-surface-associated Kd.
|
| |
Eur J Immunol,
23,
1776-1783.
|
|
|
|
|
|
|
J.Stagsted,
C.Mapelli,
C.Meyers,
B.W.Matthews,
C.B.Anfinsen,
A.Goldstein,
and
L.Olsson
(1993).
Amino acid residues essential for biological activity of a peptide derived from a major histocompatibility complex class I antigen.
|
| |
Proc Natl Acad Sci U S A,
90,
7686-7690.
|
|
|
|
|
|
|
J.Sutton,
S.Rowland-Jones,
W.Rosenberg,
D.Nixon,
F.Gotch,
X.M.Gao,
N.Murray,
A.Spoonas,
P.Driscoll,
and
M.Smith
(1993).
A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.
|
| |
Eur J Immunol,
23,
447-453.
|
|
|
|
|
|
|
K.Falk,
O.Rötzschke,
B.Grahovac,
D.Schendel,
S.Stevanović,
V.Gnau,
G.Jung,
J.L.Strominger,
and
H.G.Rammensee
(1993).
Allele-specific peptide ligand motifs of HLA-C molecules.
|
| |
Proc Natl Acad Sci U S A,
90,
12005-12009.
|
|
|
|
|
|
|
L.Adorini,
J.C.Guéry,
G.Rodriguez-Tarduchy,
and
S.Trembleau
(1993).
Selective immunosuppression.
|
| |
Trends Pharmacol Sci,
14,
178-182.
|
|
|
|
|
|
|
L.Franksson,
M.Petersson,
R.Kiessling,
and
K.Kärre
(1993).
Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells.
|
| |
Eur J Immunol,
23,
2606-2613.
|
|
|
|
|
|
|
L.García-Buey,
M.López-Botet,
A.García-Sánchez,
M.A.Balboa,
J.Aramburu,
C.García-Monzón,
A.Acevedo,
and
R.Moreno-Otero
(1993).
Variability in the expression of a beta 2-microglobulin epitope on hepatocytes in chronic type C hepatitis on treatment with interferon.
|
| |
Hepatology,
17,
372-382.
|
|
|
|
|
|
|
L.Imberti,
A.Sottini,
and
D.Primi
(1993).
T cell repertoire and autoimmune diseases.
|
| |
Immunol Res,
12,
149-167.
|
|
|
|
|
|
|
L.Lopalco,
C.De Santis,
R.Meneveri,
R.Longhi,
E.Ginelli,
F.Grassi,
A.G.Siccardi,
and
A.Beretta
(1993).
Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I alpha 1 peptide-binding domain.
|
| |
Eur J Immunol,
23,
2016-2021.
|
|
|
|
|
|
|
L.Shen,
G.P.Mazzara,
S.O.DiSciullo,
D.L.Panicali,
and
N.L.Letvin
(1993).
Immunization with lentivirus-like particles elicits a potent SIV-specific recall cytotoxic T-lymphocyte response in rhesus monkeys.
|
| |
AIDS Res Hum Retroviruses,
9,
129-132.
|
|
|
|
|
|
|
M.A.Ossevoort,
A.J.Sijts,
K.J.van Veen,
F.Momburg,
G.J.Hämmerling,
A.Seelig,
G.W.Butcher,
J.C.Howard,
W.M.Kast,
and
C.J.Melief
(1993).
Differential effect of transporter Tap 2 gene introduction into RMA-S cells on viral antigen processing.
|
| |
Eur J Immunol,
23,
3082-3088.
|
|
|
|
|
|
|
M.Corr,
L.F.Boyd,
E.A.Padlan,
and
D.H.Margulies
(1993).
H-2Dd exploits a four residue peptide binding motif.
|
| |
J Exp Med,
178,
1877-1892.
|
|
|
|
|
|
|
M.D.Crew
(1993).
Genes of the major histocompatibility complex and the evolutionary genetics of lifespan.
|
| |
Genetica,
91,
225-238.
|
|
|
|
|
|
|
M.J.Bijlmakers,
J.J.Neefjes,
E.H.Wojcik-Jacobs,
and
H.L.Ploegh
(1993).
The assembly of H2-Kb class I molecules translated in vitro requires oxidized glutathione and peptide.
|
| |
Eur J Immunol,
23,
1305-1313.
|
|
|
|
|
|
|
M.J.Smith,
T.Basora,
J.E.Kieran,
and
M.C.Nieto
(1993).
Alteration within a discrete region of the H-2Ld alpha 1 helix upon association with human beta 2 microglobulin.
|
| |
Immunol Cell Biol,
71,
145-149.
|
|
|
|
|
|
|
M.Kasahara,
E.C.McKinney,
M.F.Flajnik,
and
T.Ishibashi
(1993).
The evolutionary origin of the major histocompatibility complex: polymorphism of class II alpha chain genes in the cartilaginous fish.
|
| |
Eur J Immunol,
23,
2160-2165.
|
|
|
|
|
|
|
M.Lobigs,
and
A.Müllbacher
(1993).
Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.
|
| |
Proc Natl Acad Sci U S A,
90,
2676-2680.
|
|
|
|
|
|
|
M.M.Davis,
and
Y.Chien
(1993).
Topology and affinity of T-cell receptor mediated recognition of peptide-MHC complexes.
|
| |
Curr Opin Immunol,
5,
45-49.
|
|
|
|
|
|
|
M.Matsui,
C.E.Hioe,
and
J.A.Frelinger
(1993).
Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones.
|
| |
Proc Natl Acad Sci U S A,
90,
674-678.
|
|
|
|
|
|
|
M.Teitell,
H.Holcombe,
H.Cheroutre,
C.J.Aldrich,
I.Stroynowski,
J.Forman,
and
M.Kronenberg
(1993).
The alpha 3 domain of the Qa-2 molecule is defective for CD8 binding and cytotoxic T lymphocyte activation.
|
| |
J Exp Med,
178,
2139-2145.
|
|
|
|
|
|
|
N.Kato,
A.Kikuchi,
K.Kano,
K.Egawa,
and
M.Takiguchi
(1993).
Molecular analysis of a novel HLA-A33 subtype associated with HLA-B44.
|
| |
Tissue Antigens,
41,
211-213.
|
|
|
|
|
|
|
N.Killeen,
S.Sawada,
and
D.R.Littman
(1993).
Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4.
|
| |
EMBO J,
12,
1547-1553.
|
|
|
|
|
|
|
P.Parham
(1993).
Disease resistance: good news from Gambia.
|
| |
Curr Biol,
3,
223-225.
|
|
|
|
|
|
|
R.A.Colbert,
S.L.Rowland-Jones,
A.J.McMichael,
and
J.A.Frelinger
(1993).
Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
|
| |
Proc Natl Acad Sci U S A,
90,
6879-6883.
|
|
|
|
|
|
|
R.C.Williams,
C.C.Malone,
T.Kenny,
and
D.Robbins
(1993).
Monoclonal IgM rheumatoid factors generated from synovial B cells of rheumatoid arthritis patients react with beta 2-microglobulin. Monoclonal RF react with beta 2m.
|
| |
Autoimmunity,
16,
103-114.
|
|
|
|
|
|
|
R.Lahesmaa,
M.Skurnik,
and
P.Toivanen
(1993).
Molecular mimicry: any role in the pathogenesis of spondyloarthropathies?
|
| |
Immunol Res,
12,
193-208.
|
|
|
|
|
|
|
R.M.Chicz,
R.G.Urban,
J.C.Gorga,
D.A.Vignali,
W.S.Lane,
and
J.L.Strominger
(1993).
Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.
|
| |
J Exp Med,
178,
27-47.
|
|
|
|
|
|
|
R.N.Germain
(1993).
Seeing double.
|
| |
Curr Biol,
3,
586-589.
|
|
|
|
|
|
|
R.P.Perrillo
(1993).
Interferon in the management of chronic hepatitis B.
|
| |
Dig Dis Sci,
38,
577-593.
|
|
|
|
|
|
|
R.R.Olson,
J.J.Reuter,
and
K.Scalf
(1993).
Cell surface expression and function of an HLA class II molecule with class I domain configuration.
|
| |
J Exp Med,
178,
731-735.
|
|
|
|
|
|
|
S.Demaria,
and
Y.Bushkin
(1993).
CD8 and beta 2-microglobulin-free MHC class I molecules in T cell immunoregulation.
|
| |
Int J Clin Lab Res,
23,
61-69.
|
|
|
|
|
|
|
S.Gattoni-Celli,
L.Calorini,
H.R.Byers,
T.Etoh,
Z.Wang,
and
S.Ferrone
(1993).
Abnormalities in HLA class I antigen expression by melanoma cells: structural characterization and functional implications.
|
| |
J Invest Dermatol,
100,
226S-230S.
|
|
|
|
|
|
|
S.H.Oh,
K.Fleischhauer,
and
S.Y.Yang
(1993).
Isoelectric focusing subtypes of HLA-A can be defined by oligonucleotide typing.
|
| |
Tissue Antigens,
41,
135-142.
|
|
|
|
|
|
|
S.L.Rowland-Jones,
S.H.Powis,
J.Sutton,
I.Mockridge,
F.M.Gotch,
N.Murray,
A.B.Hill,
W.M.Rosenberg,
J.Trowsdale,
and
A.J.McMichael
(1993).
An antigen processing polymorphism revealed by HLA-B8-restricted cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism.
|
| |
Eur J Immunol,
23,
1999-2004.
|
|
|
|
|
|
|
S.Moriwaki,
B.S.Korn,
Y.Ichikawa,
L.van Kaer,
and
S.Tonegawa
(1993).
Amino acid substitutions in the floor of the putative antigen-binding site of H-2T22 affect recognition by a gamma delta T-cell receptor.
|
| |
Proc Natl Acad Sci U S A,
90,
11396-11400.
|
|
|
|
|
|
|
S.Rojo,
F.García,
J.A.Villadangos,
and
J.A.López de Castro
(1993).
Changes in the repertoire of peptides bound to HLA-B27 subtypes and to site-specific mutants inside and outside pocket B.
|
| |
J Exp Med,
177,
613-620.
|
|
|
|
|
|
|
T.Cotner
(1993).
Factors governing the binding and recognition of foreign and self-peptides by MHC class II.
|
| |
Autoimmunity,
16,
57-67.
|
|
|
|
|
|
|
T.Elliott,
M.Smith,
P.Driscoll,
and
A.McMichael
(1993).
Peptide selection by class I molecules of the major histocompatibility complex.
|
| |
Curr Biol,
3,
854-866.
|
|
|
|
|
|
|
T.J.Braciale
(1993).
Naked DNA and vaccine design.
|
| |
Trends Microbiol,
1,
323.
|
|
|
|
|
|
|
T.L.Garber,
A.L.Hughes,
N.L.Letvin,
J.W.Templeton,
and
D.I.Watkins
(1993).
Sequence and evolution of cattle MHC class I cDNAs: concerted evolution has not taken place in cattle.
|
| |
Immunogenetics,
38,
11-20.
|
|
|
|
|
|
|
T.M.Fu,
R.H.Bonneau,
M.J.Tevethia,
and
S.S.Tevethia
(1993).
Simian virus 40 T antigen as a carrier for the expression of cytotoxic T-lymphocyte recognition epitopes.
|
| |
J Virol,
67,
6866-6871.
|
|
|
|
|
|
|
T.W.Hermiston,
R.A.Tripp,
T.Sparer,
L.R.Gooding,
and
W.S.Wold
(1993).
Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes.
|
| |
J Virol,
67,
5289-5298.
|
|
|
|
|
|
|
T.W.Mak
(1993).
The T-cell antigen receptor enters its second decade.
|
| |
Scand J Immunol,
38,
209-211.
|
|
|
|
|
|
|
U.Blank,
B.Boitel,
D.Mège,
M.Ermonval,
and
O.Acuto
(1993).
Analysis of tetanus toxin peptide/DR recognition by human T cell receptors reconstituted into a murine T cell hybridoma.
|
| |
Eur J Immunol,
23,
3057-3065.
|
|
|
|
|
|
|
U.Hurtenbach,
E.Lier,
L.Adorini,
and
Z.A.Nagy
(1993).
Prevention of autoimmune diabetes in non-obese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide.
|
| |
J Exp Med,
177,
1499-1504.
|
|
|
|
|
|
|
U.Sezerman,
S.Vajda,
J.Cornette,
and
C.DeLisi
(1993).
Toward computational determination of peptide-receptor structure.
|
| |
Protein Sci,
2,
1827-1843.
|
|
|
|
|
|
|
V.Barnaba
(1993).
Immunopathologic effect of antigen recognition.
|
| |
Allergy,
48,
137-141.
|
|
|
|
|
|
|
V.Lepage,
L.U.Lamm,
and
D.Charron
(1993).
Molecular aspects of HLA class II and some autoimmune diseases.
|
| |
Eur J Immunogenet,
20,
153-164.
|
|
|
|
|
|
|
W.H.Hildebrand,
J.D.Domena,
and
P.Parham
(1993).
Primary structure shows HLA-B59 to be a hybrid of HLA-B55 and HLA-B51, and not a subtype of HLA-B8.
|
| |
Tissue Antigens,
41,
190-195.
|
|
|
|
|
|
|
Y.Itoh,
K.Ogasawara,
and
K.Onoé
(1993).
Fine analysis of recognition sites of monoclonal antibodies, 1B7 and 1E4, using L cell transfectants of recombinant mouse MHC class II genes.
|
| |
Eur J Immunogenet,
20,
23-27.
|
|
|
|
|
|
|
Z.Wang,
Y.Cao,
A.P.Albino,
R.A.Zeff,
A.Houghton,
and
S.Ferrone
(1993).
Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA.
|
| |
J Clin Invest,
91,
684-692.
|
|
|
|
|
|
|
A.D.Beyers,
L.L.Spruyt,
and
A.F.Williams
(1992).
Multimolecular associations of the T-cell antigen receptor.
|
| |
Trends Cell Biol,
2,
253-255.
|
|
|
|
|
|
|
A.G.Grandea,
and
M.J.Bevan
(1992).
Single-residue changes in class I major histocompatibility complex molecules stimulate responses to self peptides.
|
| |
Proc Natl Acad Sci U S A,
89,
2794-2798.
|
|
|
|
|
|
|
A.Geluk,
W.Bloemhoff,
R.R.De Vries,
and
T.H.Ottenhoff
(1992).
Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules.
|
| |
Eur J Immunol,
22,
107-113.
|
|
|
|
|
|
|
A.J.Muller,
A.M.Pendergast,
M.H.Havlik,
L.Puil,
T.Pawson,
and
O.N.Witte
(1992).
A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction.
|
| |
Mol Cell Biol,
12,
5087-5093.
|
|
|
|
|
|
|
A.M.Knight,
G.B.Harrison,
R.J.Pease,
P.J.Robinson,
and
P.J.Dyson
(1992).
Biochemical analysis of the mouse mammary tumor virus long terminal repeat product. Evidence for the molecular structure of an endogenous superantigen.
|
| |
Eur J Immunol,
22,
879-882.
|
|
|
|
|
|
|
A.Martin,
and
T.F.Davies
(1992).
T cells and human autoimmune thyroid disease: emerging data show lack of need to invoke suppressor T cell problems.
|
| |
Thyroid,
2,
247-261.
|
|
|
|
|
|
|
B.Catipović,
J.Dal Porto,
M.Mage,
T.E.Johansen,
and
J.P.Schneck
(1992).
Major histocompatibility complex conformational epitopes are peptide specific.
|
| |
J Exp Med,
176,
1611-1618.
|
|
|
|
|
|
|
B.Gopalakrishnan,
and
B.P.Roques
(1992).
Do antigenic peptides have a unique sense of direction inside the MHC binding groove? A molecular modelling study.
|
| |
FEBS Lett,
303,
224-228.
|
|
|
|
|
|
|
C.Cayrol,
F.Moro,
E.Sommer,
J.Tkaczuk,
E.Ohayon,
and
A.Cambon-Thomsen
(1992).
New polymorphic HLA-DR epitopes recognized by three monoclonal antibodies produced against DR103 transfected L cells.
|
| |
Tissue Antigens,
40,
197-203.
|
|
|
|
|
|
|
C.G.Drake,
and
B.L.Kotzin
(1992).
Superantigens: biology, immunology, and potential role in disease.
|
| |
J Clin Immunol,
12,
149-162.
|
|
|
|
|
|
|
C.Sibille,
K.Gould,
G.Hämmerling,
and
A.Townsend
(1992).
A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly.
|
| |
Eur J Immunol,
22,
433-440.
|
|
|
|
|
|
|
C.Vincent,
J.Chanard,
V.Caudwell,
S.Lavaud,
T.Wong,
and
J.P.Revillard
(1992).
Kinetics of 125I-beta 2-microglobulin turnover in dialyzed patients.
|
| |
Kidney Int,
42,
1434-1443.
|
|
|
|
|
|
|
D.A.Lawlor,
and
P.Parham
(1992).
Structure of CD8 alpha and beta chains of the orangutan: novel patterns of mRNA splicing encoding hingeless polypeptides.
|
| |
Immunogenetics,
36,
121-125.
|
|
|
|
|
|
|
D.C.Wraith,
D.E.Smilek,
and
S.Webb
(1992).
MHC-binding peptides for immunotherapy of experimental autoimmune disease.
|
| |
J Autoimmun,
5,
103-113.
|
|
|
|
|
|
|
D.Grossberger,
and
P.Parham
(1992).
Reptilian class I major histocompatibility complex genes reveal conserved elements in class I structure.
|
| |
Immunogenetics,
36,
166-174.
|
|
|
|
|
|
|
D.H.Margulies
(1992).
Peptides tailored to perfection?
|
| |
Curr Biol,
2,
211-213.
|
|
|
|
|
|
|
D.J.Leahy,
R.Axel,
and
W.A.Hendrickson
(1992).
Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 A resolution.
|
| |
Cell,
68,
1145-1162.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
D.N.Garboczi,
D.T.Hung,
and
D.C.Wiley
(1992).
HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.
|
| |
Proc Natl Acad Sci U S A,
89,
3429-3433.
|
|
|
|
|
|
|
D.Pardoll,
and
A.Carrera
(1992).
Thymic selection.
|
| |
Curr Opin Immunol,
4,
162-165.
|
|
|
|
|
|
|
D.Rognan,
N.Zimmermann,
G.Jung,
and
G.Folkers
(1992).
Molecular dynamics study of a complex between the human histocompatibility antigen HLA-A2 and the IMP58-66 nonapeptide from influenza virus matrix protein.
|
| |
Eur J Biochem,
208,
101-113.
|
|
|
|
|
|
|
E.J.Baas,
H.M.van Santen,
M.J.Kleijmeer,
H.J.Geuze,
P.J.Peters,
and
H.L.Ploegh
(1992).
Peptide-induced stabilization and intracellular localization of empty HLA class I complexes.
|
| |
J Exp Med,
176,
147-156.
|
|
|
|
|
|
|
E.Joly,
and
M.B.Oldstone
(1992).
Neuronal cells are deficient in loading peptides onto MHC class I molecules.
|
| |
Neuron,
8,
1185-1190.
|
|
|
|
|
|
|
E.Thorsby,
and
K.S.Rønningen
(1992).
Role of HLA genes in predisposition to develop insulin-dependent diabetes mellitus.
|
| |
Ann Med,
24,
523-531.
|
|
|
|
|
|
|
F.Plata
(1992).
Implications of HIV-specific cytotoxic T lymphocytes in AIDS.
|
| |
Biotherapy,
5,
31-45.
|
|
|
|
|
|
|
G.M.van Bleek,
and
S.G.Nathenson
(1992).
Presentation of antigenic peptides by MHC class I molecules.
|
| |
Trends Cell Biol,
2,
202-207.
|
|
|
|
|
|
|
G.Tuchscherer,
C.Servis,
G.Corradin,
U.Blum,
J.Rivier,
and
M.Mutter
(1992).
Total chemical synthesis, characterization, and immunological properties of an MHC class I model using the TASP concept for protein de novo design.
|
| |
Protein Sci,
1,
1377-1386.
|
|
|
|
|
|
|
H.A.Gjersten,
K.E.Lundin,
W.W.Kwok,
G.T.Nepom,
and
E.Thorsby
(1992).
Allorecognition of HLA-DQw8 molecules: influence of single amino acid substitutions.
|
| |
Tissue Antigens,
39,
95-98.
|
|
|
|
|
|
|
H.Browne,
M.Churcher,
and
T.Minson
(1992).
Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted.
|
| |
J Virol,
66,
6784-6787.
|
|
|
|
|
|
|
H.Burkhardt,
T.Yan,
B.Bröker,
A.Beck-Sickinger,
R.Holmdahl,
K.Von der Mark,
and
F.Emmrich
(1992).
Antibody binding to a collagen type-II epitope gives rise to an inhibitory peptide for autoreactive T cells.
|
| |
Eur J Immunol,
22,
1063-1067.
|
|
|
|
|
|
|
H.D.Hunt,
T.I.Munitz,
and
L.R.Pease
(1992).
Alloreactive cytotoxic T lymphocytes recognize epitopes determined by both the alpha helices and beta sheets of the class I peptide binding site.
|
| |
J Exp Med,
175,
821-829.
|
|
|
|
|
|
|
H.J.Wallny,
O.Rötzschke,
K.Falk,
G.Hämmerling,
and
H.G.Rammensee
(1992).
Gene transfer experiments imply instructive role of major histocompatibility complex class I molecules in cellular peptide processing.
|
| |
Eur J Immunol,
22,
655-659.
|
|
|
|
|
|
|
H.Kaneoka,
K.C.Hsu,
Y.Takeda,
G.C.Sharp,
and
R.W.Hoffman
(1992).
Molecular genetic analysis of HLA-DR and HLA-DQ genes among anti-U1-70-kd autoantibody positive connective tissue disease patients.
|
| |
Arthritis Rheum,
35,
83-94.
|
|
|
|
|
|
|
J.Fangmann,
R.Dalchau,
G.J.Sawyer,
C.A.Priestley,
and
J.W.Fabre
(1992).
T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection.
|
| |
Eur J Immunol,
22,
1525-1530.
|
|
|
|
|
|
|
J.Fangmann,
R.Dalchau,
and
J.W.Fabre
(1992).
Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.
|
| |
J Exp Med,
175,
1521-1529.
|
|
|
|
|
|
|
J.Hammer,
B.Takacs,
and
F.Sinigaglia
(1992).
Identification of a motif for HLA-DR1 binding peptides using M13 display libraries.
|
| |
J Exp Med,
176,
1007-1013.
|
|
|
|
|
|
|
J.J.Neefjes,
and
H.L.Ploegh
(1992).
Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance alpha beta heterodimers in endosomes.
|
| |
EMBO J,
11,
411-416.
|
|
|
|
|
|
|
J.J.Neefjes,
L.Smit,
M.Gehrmann,
and
H.L.Ploegh
(1992).
The fate of the three subunits of major histocompatibility complex class I molecules.
|
| |
Eur J Immunol,
22,
1609-1614.
|
|
|
|
|
|
|
J.Tormo,
E.Stadler,
T.Skern,
H.Auer,
O.Kanzler,
C.Betzel,
D.Blaas,
and
I.Fita
(1992).
Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2.
|
| |
Protein Sci,
1,
1154-1161.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
J.Zemmour,
J.E.Gumperz,
W.H.Hildebrand,
F.E.Ward,
S.G.Marsh,
R.C.Williams,
and
P.Parham
(1992).
The molecular basis for reactivity of anti-Cw1 and anti-Cw3 alloantisera with HLA-B46 haplotypes.
|
| |
Tissue Antigens,
39,
249-257.
|
|
|
|
|
|
|
J.Zemmour,
and
P.Parham
(1992).
Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C.
|
| |
J Exp Med,
176,
937-950.
|
|
|
|
|
|
|
K.Deres,
T.N.Schumacher,
K.H.Wiesmüller,
S.Stevanović,
G.Greiner,
G.Jung,
and
H.L.Ploegh
(1992).
Preferred size of peptides that bind to H-2 Kb is sequence dependent.
|
| |
Eur J Immunol,
22,
1603-1608.
|
|
|
|
|
|
|
K.Hashimoto,
T.Nakanishi,
and
Y.Kurosawa
(1992).
Identification of a shark sequence resembling the major histocompatibility complex class I alpha 3 domain.
|
| |
Proc Natl Acad Sci U S A,
89,
2209-2212.
|
|
|
|
|
|
|
K.Hatae,
A.Kimura,
R.Okubo,
H.Watanabe,
H.A.Erlich,
K.Ueda,
Y.Nishimura,
and
T.Sasazuki
(1992).
Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended HLA haplotype.
|
| |
Eur J Immunol,
22,
1899-1905.
|
|
|
|
|
|
|
K.L.Rock,
L.Rothstein,
and
B.Benacerraf
(1992).
Analysis of the association of peptides of optimal length to class I molecules on the surface of cells.
|
| |
Proc Natl Acad Sci U S A,
89,
8918-8922.
|
|
|
|
|
|
|
K.Shibata,
M.Imarai,
G.M.van Bleek,
S.Joyce,
and
S.G.Nathenson
(1992).
Vesicular stomatitis virus antigenic octapeptide N52-59 is anchored into the groove of the H-2Kb molecule by the side chains of three amino acids and the main-chain atoms of the amino terminus.
|
| |
Proc Natl Acad Sci U S A,
89,
3135-3139.
|
|
|
|
|
|
|
L.A.Rosenthal,
K.K.Klyczek,
and
K.J.Blank
(1992).
Interferon-alpha/beta, pentoxifylline, and caffeine synergize with interferon-gamma to induce major histocompatibility complex class I expression on a constitutively class I-negative murine tumor cell line.
|
| |
J Interferon Res,
12,
403-410.
|
|
|
|
|
|
|
L.Adorini
(1992).
Inhibition of T cell activation by MHC blockade: a possible strategy for immunointervention in autoimmune diseases.
|
| |
J Autoimmun,
5,
73-81.
|
|
|
|
|
|
|
L.J.Stern,
and
D.C.Wiley
(1992).
The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide.
|
| |
Cell,
68,
465-477.
|
|
|
|
|
|
|
L.Jaffe,
E.J.Robertson,
and
E.K.Bikoff
(1992).
Developmental failure of chimeric embryos expressing high levels of H-2Dd transplantation antigens.
|
| |
Proc Natl Acad Sci U S A,
89,
5927-5931.
|
|
|
|
|
|
|
L.L.Lanier,
and
J.H.Phillips
(1992).
Natural killer cells.
|
| |
Curr Opin Immunol,
4,
38-42.
|
|
|
|
|
|
|
L.MacLean
(1992).
HLA-B27 subtypes: implications for the spondyloarthropathies.
|
| |
Ann Rheum Dis,
51,
929-931.
|
|
|
|
|
|
|
L.N.Gastinel,
N.E.Simister,
and
P.J.Bjorkman
(1992).
Expression and crystallization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules.
|
| |
Proc Natl Acad Sci U S A,
89,
638-642.
|
|
|
|
|
|
|
L.Van Kaer,
P.G.Ashton-Rickardt,
H.L.Ploegh,
and
S.Tonegawa
(1992).
TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells.
|
| |
Cell,
71,
1205-1214.
|
|
|
|
|
|
|
M.B.Oldstone,
A.Tishon,
R.Geckeler,
H.Lewicki,
and
J.L.Whitton
(1992).
A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: implications for vaccination.
|
| |
Proc Natl Acad Sci U S A,
89,
2752-2755.
|
|
|
|
|
|
|
M.Baines,
and
A.Ebringer
(1992).
HLA and disease.
|
| |
Mol Aspects Med,
13,
263-378.
|
|
|
|
|
|
|
M.Cochet,
C.Pannetier,
A.Regnault,
S.Darche,
C.Leclerc,
and
P.Kourilsky
(1992).
Molecular detection and in vivo analysis of the specific T cell response to a protein antigen.
|
| |
Eur J Immunol,
22,
2639-2647.
|
|
|
|
|
|
|
M.Corr,
L.F.Boyd,
S.R.Frankel,
S.Kozlowski,
E.A.Padlan,
and
D.H.Margulies
(1992).
Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex.
|
| |
J Exp Med,
176,
1681-1692.
|
|
|
|
|
|
|
M.D.Walkinshaw
(1992).
Protein targets for structure-based drug design.
|
| |
Med Res Rev,
12,
317-372.
|
|
|
|
|
|
|
M.Kasahara,
M.Vazquez,
K.Sato,
E.C.McKinney,
and
M.F.Flajnik
(1992).
Evolution of the major histocompatibility complex: isolation of class II A cDNA clones from the cartilaginous fish.
|
| |
Proc Natl Acad Sci U S A,
89,
6688-6692.
|
|
|
|
|
|
|
M.del Val,
H.Hengel,
H.Häcker,
U.Hartlaub,
T.Ruppert,
P.Lucin,
and
U.H.Koszinowski
(1992).
Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment.
|
| |
J Exp Med,
176,
729-738.
|
|
|
|
|
|
|
N.A.Lee,
D.Y.Loh,
and
E.Lacy
(1992).
CD8 surface levels alter the fate of alpha/beta T cell receptor-expressing thymocytes in transgenic mice.
|
| |
J Exp Med,
175,
1013-1025.
|
|
|
|
|
|
|
N.S.Braunstein,
D.A.Weber,
X.C.Wang,
E.O.Long,
and
D.Karp
(1992).
Sequences in both class II major histocompatibility complex alpha and beta chains contribute to the binding of the superantigen toxic shock syndrome toxin 1.
|
| |
J Exp Med,
175,
1301-1305.
|
|
|
|
|
|
|
N.Takahata,
Y.Satta,
and
J.Klein
(1992).
Polymorphism and balancing selection at major histocompatibility complex loci.
|
| |
Genetics,
130,
925-938.
|
|
|
|
|
|
|
O.Rötzschke,
K.Falk,
S.Stevanović,
G.Jung,
and
H.G.Rammensee
(1992).
Peptide motifs of closely related HLA class I molecules encompass substantial differences.
|
| |
Eur J Immunol,
22,
2453-2456.
|
|
|
|
|
|
|
P.Cresswell
(1992).
Chemistry and functional role of the invariant chain.
|
| |
Curr Opin Immunol,
4,
87-92.
|
|
|
|
|
|
|
P.Flomenberg,
J.Szmulewicz,
E.Gutierrez,
and
H.Lupatkin
(1992).
Role of the adenovirus E3-19k conserved region in binding major histocompatibility complex class I molecules.
|
| |
J Virol,
66,
4778-4783.
|
|
|
|
|
|
|
P.I.Terasaki,
S.Takemoto,
M.S.Park,
and
B.Clark
(1992).
Landsteiner Award. HLA epitope matching.
|
| |
Transfusion,
32,
775-786.
|
|
|
|
|
|
|
P.J.Fairchild,
and
D.C.Wraith
(1992).
Peptide-MHC interaction in autoimmunity.
|
| |
Curr Opin Immunol,
4,
748-753.
|
|
|
|
|
|
|
P.L.McGeer,
H.Akiyama,
T.Kawamata,
T.Yamada,
D.G.Walker,
and
T.Ishii
(1992).
Immunohistochemical localization of beta-amyloid precursor protein sequences in Alzheimer and normal brain tissue by light and electron microscopy.
|
| |
J Neurosci Res,
31,
428-442.
|
|
|
|
|
|
|
P.Parham
(1992).
Typing for class I HLA polymorphism: past, present, and future.
|
| |
Eur J Immunogenet,
19,
347-359.
|
|
|
|
|
|
|
S.C.Hong,
A.Chelouche,
R.H.Lin,
D.Shaywitz,
N.S.Braunstein,
L.Glimcher,
and
C.A.Janeway
(1992).
An MHC interaction site maps to the amino-terminal half of the T cell receptor alpha chain variable domain.
|
| |
Cell,
69,
999.
|
|
|
|
|
|
|
S.D.Husbands,
G.Schönrich,
B.Arnold,
P.R.Chandler,
E.Simpson,
K.L.Philpott,
P.Tomlinson,
L.O'Reilly,
A.Cooke,
and
A.L.Mellor
(1992).
Expression of major histocompatibility complex class I antigens at low levels in the thymus induces T cell tolerance via a non-deletional mechanism.
|
| |
Eur J Immunol,
22,
2655-2661.
|
|
|
|
|
|
|
S.E.Buxton,
R.J.Benjamin,
C.Clayberger,
P.Parham,
and
A.M.Krensky
(1992).
Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B ("45") pocket of HLA-B27.
|
| |
J Exp Med,
175,
809-820.
|
|
|
|
|
|
|
T.Elliott,
J.Elvin,
V.Cerundolo,
H.Allen,
and
A.Townsend
(1992).
Structural requirements for the peptide-induced conformational change of free major histocompatibility complex class I heavy chains.
|
| |
Eur J Immunol,
22,
2085-2091.
|
|
|
|
|
|
|
T.Klausen,
K.Amris,
and
P.Helin
(1992).
Ulcerative colitis complicating seronegative HLA-A2-B27 rheumatoid arthritis with sacroiliitis.
|
| |
Ann Rheum Dis,
51,
1009-1011.
|
|
|
|
|
|
|
U.Moebius,
L.K.Clayton,
S.Abraham,
A.Diener,
J.J.Yunis,
S.C.Harrison,
and
E.L.Reinherz
(1992).
Human immunodeficiency virus gp120 binding C'C" ridge of CD4 domain 1 is also involved in interaction with class II major histocompatibility complex molecules.
|
| |
Proc Natl Acad Sci U S A,
89,
12008-12012.
|
|
|
|
|
|
|
V.Jewtoukoff,
S.Amzazi,
R.Lebar,
M.A.Bach,
and
P.N.Marche
(1992).
T-cell receptor identification of an oligodendrocyte-specific autoreactive cytotoxic T-cell clone without self restriction.
|
| |
Scand J Immunol,
36,
893-898.
|
|
|
|
|
|
|
V.Lam,
L.J.Thomas,
D.A.Kostyal,
and
R.E.Humphreys
(1992).
Highly conserved, potential cleavage sites about the desetopes of MHC class I and class II molecules.
|
| |
Tissue Antigens,
39,
26-31.
|
|
|
|
|
|
|
W.C.Breau,
W.J.Atwood,
and
L.C.Norkin
(1992).
Class I major histocompatibility proteins are an essential component of the simian virus 40 receptor.
|
| |
J Virol,
66,
2037-2045.
|
|
|
|
|
|
|
W.Zhang,
A.C.Young,
M.Imarai,
S.G.Nathenson,
and
J.C.Sacchettini
(1992).
Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition.
|
| |
Proc Natl Acad Sci U S A,
89,
8403-8407.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
X.Zhou,
L.Berg,
U.M.Motal,
and
M.Jondal
(1992).
In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides.
|
| |
J Immunol Methods,
153,
193-200.
|
|
|
|
|
|
|
X.Zhou,
U.M.Abdel Motal,
L.Berg,
and
M.Jondal
(1992).
In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides.
|
| |
Eur J Immunol,
22,
3085-3090.
|
|
|
|
|
|
|
Y.Zevering,
F.Amante,
A.Smillie,
J.Currier,
G.Smith,
R.A.Houghten,
and
M.F.Good
(1992).
High frequency of malaria-specific T cells in non-exposed humans.
|
| |
Eur J Immunol,
22,
689-696.
|
|
|
|
|
|
|
A.Asahina,
S.Akazaki,
H.Nakagawa,
S.Kuwata,
K.Tokunaga,
Y.Ishibashi,
and
T.Juji
(1991).
Specific nucleotide sequence of HLA-C is strongly associated with psoriasis vulgaris.
|
| |
J Invest Dermatol,
97,
254-258.
|
|
|
|
|
|
|
A.Guha,
N.Dainiak,
and
R.E.Cone
(1991).
Inhibition of major histocompatibility complex class I antigen shedding up-regulates the surface expression of class I antigens on the lymphocyte cell surface.
|
| |
Ann N Y Acad Sci,
628,
354-361.
|
|
|
|
|
|
|
A.Herman,
N.Labrecque,
J.Thibodeau,
P.Marrack,
J.W.Kappler,
and
R.P.Sekaly
(1991).
Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR.
|
| |
Proc Natl Acad Sci U S A,
88,
9954-9958.
|
|
|
|
|
|
|
A.J.Feeney
(1991).
Junctional sequences of fetal T cell receptor beta chains have few N regions.
|
| |
J Exp Med,
174,
115-124.
|
|
|
|
|
|
|
A.L.Hughes
(1991).
Independent gene duplications, not concerted evolution, explain relationships among class I MHC genes of murine rodents.
|
| |
Immunogenetics,
33,
367-373.
|
|
|
|
|
|
|
A.M.Krensky
(1991).
Molecular basis of transplant rejection and acceptance.
|
| |
Pediatr Nephrol,
5,
422-427.
|
|
|
|
|
|
|
A.M.Little,
and
P.Parham
(1991).
The HLA-Bw75 subtype of B15: molecular characterization and comparison with crossreacting antigens.
|
| |
Tissue Antigens,
38,
186-190.
|
|
|
|
|
|
|
A.M.Pullen,
J.Bill,
R.T.Kubo,
P.Marrack,
and
J.W.Kappler
(1991).
Analysis of the interaction site for the self superantigen Mls-1a on T cell receptor V beta.
|
| |
J Exp Med,
173,
1183-1192.
|
|
|
|
|
|
|
A.Nikaein,
C.Phillips,
S.C.Gilbert,
D.Savino,
A.Silverman,
M.J.Stone,
and
A.Menter
(1991).
Characterization of skin-infiltrating lymphocytes in patients with psoriasis.
|
| |
J Invest Dermatol,
96,
3-9.
|
|
|
|
|
|
|
A.R.Castaño,
and
J.A.López de Castro
(1991).
Structure of the HLA-A*0204 antigen, found in South American Indians. Spatial clustering of HLA-A2 subtype polymorphism.
|
| |
Immunogenetics,
34,
281-285.
|
|
|
|
|
|
|
A.Rocca,
A.Samaan,
C.Michel,
D.Besluau,
L.Degos,
and
M.Pla
(1991).
H-2 influence on the production of real but not of apparent H-2-specific antibodies induced by the association of syngeneic class I heavy chains with bovine beta 2-microglobulin.
|
| |
Eur J Immunogenet,
18,
367-378.
|
|
|
|
|
|
|
B.N.Beck,
A.E.Nilson,
M.P.Bell,
C.G.Chase,
and
D.J.McKean
(1991).
The contribution of beta-strand residues to serologic epitopes on the A beta k polypeptide.
|
| |
Immunogenetics,
33,
409-412.
|
|
|
|
|
|
|
B.S.Nepom,
U.Malhotra,
D.A.Schwarz,
J.W.Nettles,
J.G.Schaller,
and
P.Concannon
(1991).
HLA and T cell receptor polymorphisms in pauciarticular-onset juvenile rheumatoid arthritis.
|
| |
Arthritis Rheum,
34,
1260-1267.
|
|
|
|
|
|
|
C.D.Platsoucas
(1991).
Human autologous tumor-specific T cells in malignant melanoma.
|
| |
Cancer Metastasis Rev,
10,
151-176.
|
|
|
|
|
|
|
C.J.Kelly,
D.A.Roth,
and
C.M.Meyers
(1991).
Immune recognition and response to the renal interstitium.
|
| |
Kidney Int,
39,
518-530.
|
|
|
|
|
|
|
C.K.Weber,
D.J.Shaffer,
and
C.L.Sidman
(1991).
Unexpected behavior of H2Kb mutant DNAs in denaturing gradient gel electrophoresis.
|
| |
Nucleic Acids Res,
19,
3331-3335.
|
|
|
|
|
|
|
C.Knobloch,
S.F.Goldmann,
and
W.Friedrich
(1991).
Self-nonself discrimination and repertoire selection of human T cells differentiated in an HLA-semiallogeneic environment following bone marrow transplantation for severe combined immunodeficiency.
|
| |
Eur J Immunol,
21,
2479-2487.
|
|
|
|
|
|
|
C.R.Wang,
B.E.Loveland,
and
K.F.Lindahl
(1991).
H-2M3 encodes the MHC class I molecule presenting the maternally transmitted antigen of the mouse.
|
| |
Cell,
66,
335-345.
|
|
|
|
|
|
|
C.V.Harding
(1991).
Pathways of antigen processing.
|
| |
Curr Opin Immunol,
3,
3-9.
|
|
|
|
|
|
|
C.Wills
(1991).
Maintenance of multiallelic polymorphism at the MHC region.
|
| |
Immunol Rev,
124,
165-220.
|
|
|
|
|
|
|
D.A.Lawlor,
E.Warren,
P.Taylor,
and
P.Parham
(1991).
Gorilla class I major histocompatibility complex alleles: comparison to human and chimpanzee class I.
|
| |
J Exp Med,
174,
1491-1509.
|
|
|
|
|
|
|
D.A.Schmitt,
D.Hanau,
J.P.Cazenave,
and
T.Bieber
(1991).
Are CD1a antigens on Langerhans cells empty class I-like molecules that come out in the cold?
|
| |
J Invest Dermatol,
97,
160-161.
|
|
|
|
|
|
|
D.Brändle,
K.Bürki,
V.A.Wallace,
U.H.Rohrer,
T.W.Mak,
B.Malissen,
H.Hengartner,
and
H.Pircher
(1991).
Involvement of both T cell receptor V alpha and V beta variable region domains and alpha chain junctional region in viral antigen recognition.
|
| |
Eur J Immunol,
21,
2195-2202.
|
|
|
|
|
|
|
D.C.Benjamin
(1991).
Molecular approaches to the study of B cell epitopes.
|
| |
Int Rev Immunol,
7,
149-164.
|
|
|
|
|
|
|
D.C.DeNagel,
and
S.K.Pierce
(1991).
Heat shock proteins and immune responses: an early view.
|
| |
Immunol Res,
10,
66-78.
|
|
|
|
|
|
|
D.G.Marsh,
and
S.K.Huang
(1991).
Molecular genetics of human immune responsiveness to pollen allergens.
|
| |
Clin Exp Allergy,
21,
168-172.
|
|
|
|
|
|
|
D.Kabelitz,
M.L.da Silva Lobo,
and
K.Pechhold
(1991).
Perspectives in transplantation immunology 1991.
|
| |
Klin Wochenschr,
69,
623-628.
|
|
|
|
|
|
|
E.K.Bikoff,
G.R.Otten,
and
E.J.Robertson
(1991).
Defective assembly of class I major histocompatibility complex molecules in an embryonic cell line.
|
| |
Eur J Immunol,
21,
1997-2004.
|
|
|
|
|
|
|
E.K.Bikoff,
L.Jaffe,
R.K.Ribaudo,
G.R.Otten,
R.N.Germain,
and
E.J.Robertson
(1991).
MHC class I surface expression in embryo-derived cell lines inducible with peptide or interferon.
|
| |
Nature,
354,
235-238.
|
|
|
|
|
|
|
E.Mottez,
C.Jaulin,
F.Godeau,
J.Choppin,
J.P.Levy,
and
P.Kourilsky
(1991).
A single-chain murine class I major transplantation antigen.
|
| |
Eur J Immunol,
21,
467-471.
|
|
|
|
|
|
|
E.T.Baldwin,
I.T.Weber,
R.St Charles,
J.C.Xuan,
E.Appella,
M.Yamada,
K.Matsushima,
B.F.Edwards,
G.M.Clore,
and
A.M.Gronenborn
(1991).
Crystal structure of interleukin 8: symbiosis of NMR and crystallography.
|
| |
Proc Natl Acad Sci U S A,
88,
502-506.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
F.C.Arnett
(1991).
Immunogenetic features of some cases of immune-mediated skin diseases.
|
| |
J Autoimmun,
4,
97.
|
|
|
|
|
|
|
F.Healy,
C.Drouet,
P.Romero,
C.Jaulin,
and
J.L.Maryanski
(1991).
Conversion of a self peptide sequence into a Kd-restricted neo-antigen by a Tyr substitution.
|
| |
J Exp Med,
174,
1657-1660.
|
|
|
|
|
|
|
F.Lévy,
R.Larsson,
and
S.Kvist
(1991).
Translocation of peptides through microsomal membranes is a rapid process and promotes assembly of HLA-B27 heavy chain and beta 2-microglobulin translated in vitro.
|
| |
J Cell Biol,
115,
959-970.
|
|
|
|
|
|
|
F.Latron,
R.Moots,
J.B.Rothbard,
T.P.Garrett,
J.L.Strominger,
and
A.McMichael
(1991).
Positioning of a peptide in the cleft of HLA-A2 by complementing amino acid changes.
|
| |
Proc Natl Acad Sci U S A,
88,
11325-11329.
|
|
|
|
|
|
|
F.Nadimi,
J.Moreno,
F.Momburg,
A.Heuser,
S.Fuchs,
L.Adorini,
and
G.J.Hämmerling
(1991).
Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain.
|
| |
Eur J Immunol,
21,
1255-1263.
|
|
|
|
|
|
|
F.R.Carbone
(1991).
Conformational constraints involved in MHC class I restricted antigen presentation.
|
| |
Int Rev Immunol,
7,
129-138.
|
|
|
|
|
|
|
F.Rippmann,
W.R.Taylor,
J.B.Rothbard,
and
N.M.Green
(1991).
A hypothetical model for the peptide binding domain of hsp70 based on the peptide binding domain of HLA.
|
| |
EMBO J,
10,
1053-1059.
|
|
|
|
|
|
|
G.M.van Bleek,
and
S.G.Nathenson
(1991).
The structure of the antigen-binding groove of major histocompatibility complex class I molecules determines specific selection of self-peptides.
|
| |
Proc Natl Acad Sci U S A,
88,
11032-11036.
|
|
|
|
|
|
|
G.Schönrich,
U.Kalinke,
F.Momburg,
M.Malissen,
A.M.Schmitt-Verhulst,
B.Malissen,
G.J.Hämmerling,
and
B.Arnold
(1991).
Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction.
|
| |
Cell,
65,
293-304.
|
|
|
|
|
|
|
H.C.Ertl,
B.Dietzschold,
and
L.Otvos
(1991).
T helper cell epitope of rabies virus nucleoprotein defined by tri- and tetrapeptides.
|
| |
Eur J Immunol,
21,
1.
|
|
|
|
|
|
|
H.DerSimonian,
H.Band,
and
M.B.Brenner
(1991).
Increased frequency of T cell receptor V alpha 12.1 expression on CD8+ T cells: evidence that V alpha participates in shaping the peripheral T cell repertoire.
|
| |
J Exp Med,
174,
639-648.
|
|
|
|
|
|
|
H.Lowenstein
(1991).
New and improved vaccines for the 1990s.
|
| |
Clin Exp Allergy,
21,
227-231.
|
|
|
|
|
|
|
H.W.Davidson,
P.A.Reid,
A.Lanzavecchia,
and
C.Watts
(1991).
Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes.
|
| |
Cell,
67,
105-116.
|
|
|
|
|
|
|
J.D.Weissman,
and
D.S.Singer
(1991).
Striking similarities between the regulatory mechanisms governing yeast mating-type genes and mammalian major histocompatibility complex genes.
|
| |
Mol Cell Biol,
11,
4228-4234.
|
|
|
|
|
|
|
J.Elvin,
V.Cerundolo,
T.Elliott,
and
A.Townsend
(1991).
A quantitative assay of peptide-dependent class I assembly.
|
| |
Eur J Immunol,
21,
2025-2031.
|
|
|
|
|
|
|
J.J.Neefjes,
T.N.Schumacher,
and
H.L.Ploegh
(1991).
Assembly and intracellular transport of major histocompatibility complex molecules.
|
| |
Curr Opin Cell Biol,
3,
601-609.
|
|
|
|
|
|
|
J.K.Russell,
C.H.Pontzer,
and
H.M.Johnson
(1991).
Both alpha-helices along the major histocompatibility complex binding cleft are required for staphylococcal enterotoxin A function.
|
| |
Proc Natl Acad Sci U S A,
88,
7228-7232.
|
|
|
|
|
|
|
J.L.Casanova,
P.Romero,
C.Widmann,
P.Kourilsky,
and
J.L.Maryanski
(1991).
T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire.
|
| |
J Exp Med,
174,
1371-1383.
|
|
|
|
|
|
|
J.Nikolić-Zugić,
and
F.R.Carbone
(1991).
Peptide presentation by class-I major histocompatibility complex molecules.
|
| |
Immunol Res,
10,
54-65.
|
|
|
|
|
|
|
J.P.Morgenstern,
I.J.Griffith,
A.W.Brauer,
B.L.Rogers,
J.F.Bond,
M.D.Chapman,
and
M.C.Kuo
(1991).
Amino acid sequence of Fel dI, the major allergen of the domestic cat: protein sequence analysis and cDNA cloning.
|
| |
Proc Natl Acad Sci U S A,
88,
9690-9694.
|
|
|
|
|
|
|
J.X.She,
S.A.Boehme,
T.W.Wang,
F.Bonhomme,
and
E.K.Wakeland
(1991).
Amplification of major histocompatibility complex class II gene diversity by intraexonic recombination.
|
| |
Proc Natl Acad Sci U S A,
88,
453-457.
|
|
|
|
|
|
|
K.C.Kuijpers,
P.Treep-Van Leeuwen,
F.Miedema,
and
C.J.Lucas
(1991).
Allo-cross-reactivity of a human neuraminidase-specific T cell clone dependent on presentation of an endogenous B cell-specific antigen.
|
| |
Eur J Immunol,
21,
1453-1460.
|
|
|
|
|
|
|
K.Dornmair,
B.R.Clark,
and
H.M.McConnell
(1991).
In vitro peptide binding to the heavy chain of the class I molecule of the major histocompatibility complex molecule HLA-A2.
|
| |
Proc Natl Acad Sci U S A,
88,
1335-1338.
|
|
|
|
|
|
|
K.F.Lindahl
(1991).
Minor histocompatibility antigens.
|
| |
Trends Genet,
7,
219-224.
|
|
|
|
|
|
|
K.Falk,
O.Rötzschke,
K.Deres,
J.Metzger,
G.Jung,
and
H.G.Rammensee
(1991).
Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast.
|
| |
J Exp Med,
174,
425-434.
|
|
|
|
|
|
|
K.Fleischhauer,
N.A.Kernan,
B.Dupont,
and
S.Y.Yang
(1991).
The two major subtypes of HLA-B44 differ for a single amino acid in codon 156.
|
| |
Tissue Antigens,
37,
133-137.
|
|
|
|
|
|
|
K.L.Rock,
S.Gamble,
L.Rothstein,
and
B.Benacerraf
(1991).
Reassociation with beta 2-microglobulin is necessary for Db class I major histocompatibility complex binding of an exogenous influenza peptide.
|
| |
Proc Natl Acad Sci U S A,
88,
301-304.
|
|
|
|
|
|
|
K.L.Rock,
S.Gamble,
L.Rothstein,
C.Gramm,
and
B.Benacerraf
(1991).
Dissociation of beta 2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface.
|
| |
Cell,
65,
611-620.
|
|
|
|
|
|
|
K.P.Kane,
L.A.Sherman,
and
M.F.Mescher
(1991).
Exogenous beta 2-microglobulin is required for antigenic peptide binding to isolated class I major histocompatibility complex molecules.
|
| |
Eur J Immunol,
21,
2289-2292.
|
|
|
|
|
|
|
L.Van Kaer,
M.Wu,
Y.Ichikawa,
K.Ito,
M.Bonneville,
S.Ostrand-Rosenberg,
D.B.Murphy,
and
S.Tonegawa
(1991).
Recognition of MHC TL gene products by gamma delta T cells.
|
| |
Immunol Rev,
120,
89.
|
|
|
|
|
|
|
M.B.Oldstone
(1991).
Molecular anatomy of viral persistence.
|
| |
J Virol,
65,
6381-6386.
|
|
|
|
|
|
|
M.B.Zaleski
(1991).
Cell-surface molecules in the regulation of immune responsiveness.
|
| |
Immunol Invest,
20,
103-131.
|
|
|
|
|
|
|
M.Edidin,
and
I.Stroynowski
(1991).
Differences between the lateral organization of conventional and inositol phospholipid-anchored membrane proteins. A further definition of micrometer scale membrane domains.
|
| |
J Cell Biol,
112,
1143-1150.
|
|
|
|
|
|
|
M.F.Flajnik,
C.Canel,
J.Kramer,
and
M.Kasahara
(1991).
Which came first, MHC class I or class II?
|
| |
Immunogenetics,
33,
295-300.
|
|
|
|
|
|
|
M.K.Kuhner,
D.A.Lawlor,
P.D.Ennis,
and
P.Parham
(1991).
Gene conversion in the evolution of the human and chimpanzee MHC class I loci.
|
| |
Tissue Antigens,
38,
152-164.
|
|
|
|
|
|
|
M.Schulz,
P.Aichele,
R.Schneider,
T.H.Hansen,
R.M.Zinkernagel,
and
H.Hengartner
(1991).
Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide.
|
| |
Eur J Immunol,
21,
1181-1185.
|
|
|
|
|
|
|
M.Srinivasan,
E.W.Marsh,
and
S.K.Pierce
(1991).
Characterization of naturally processed antigen bound to major histocompatibility complex class II molecules.
|
| |
Proc Natl Acad Sci U S A,
88,
7928-7932.
|
|
|
|
|
|
|
M.Teitell,
M.F.Mescher,
C.A.Olson,
D.R.Littman,
and
M.Kronenberg
(1991).
The thymus leukemia antigen binds human and mouse CD8.
|
| |
J Exp Med,
174,
1131-1138.
|
|
|
|
|
|
|
O.Rötzschke,
K.Falk,
S.Faath,
and
H.G.Rammensee
(1991).
On the nature of peptides involved in T cell alloreactivity.
|
| |
J Exp Med,
174,
1059-1071.
|
|
|
|
|
|
|
P.A.Moss,
R.J.Moots,
W.M.Rosenberg,
S.J.Rowland-Jones,
H.C.Bodmer,
A.J.McMichael,
and
J.I.Bell
(1991).
Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide.
|
| |
Proc Natl Acad Sci U S A,
88,
8987-8990.
|
|
|
|
|
|
|
P.Borgulya,
H.Kishi,
U.Müller,
J.Kirberg,
and
H.von Boehmer
(1991).
Development of the CD4 and CD8 lineage of T cells: instruction versus selection.
|
| |
EMBO J,
10,
913-918.
|
|
|
|
|
|
|
P.Dellabona,
B.Y.Wei,
N.Gervois,
C.Benoist,
and
D.Mathis
(1991).
A single amino acid substitution in the Ak molecule fortuitously provokes an alloresponse.
|
| |
Eur J Immunol,
21,
209-213.
|
|
|
|
|
|
|
P.Méndez-Samperio,
and
L.Jiménez-Zamudio
(1991).
Peptide competition at the level of MHC-binding sites using T cell clones from a rheumatoid arthritis patient.
|
| |
J Autoimmun,
4,
795-806.
|
|
|
|
|
|
|
P.Parham
(1991).
A stressful relationship.
|
| |
Trends Biochem Sci,
16,
357-358.
|
|
|
|
|
|
|
P.Romero,
G.Corradin,
I.F.Luescher,
and
J.L.Maryanski
(1991).
H-2Kd-restricted antigenic peptides share a simple binding motif.
|
| |
J Exp Med,
174,
603-612.
|
|
|
|
|
|
|
P.Salomon,
A.Pizzimenti,
A.Panja,
A.Reisman,
and
L.Mayer
(1991).
The expression and regulation of class II antigens in normal and inflammatory bowel disease peripheral blood monocytes and intestinal epithelium.
|
| |
Autoimmunity,
9,
141-149.
|
|
|
|
|
|
|
P.W.Hedrick,
T.S.Whittam,
and
P.Parham
(1991).
Heterozygosity at individual amino acid sites: extremely high levels for HLA-A and -B genes.
|
| |
Proc Natl Acad Sci U S A,
88,
5897-5901.
|
|
|
|
|
|
|
R.F.Willkens,
G.T.Nepom,
C.R.Marks,
J.W.Nettles,
and
B.S.Nepom
(1991).
Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the "shared epitope" hypothesis.
|
| |
Arthritis Rheum,
34,
43-47.
|
|
|
|
|
|
|
R.Giorda,
E.Turco,
and
M.Trucco
(1991).
Full length beta chain cDNAs of DQw9 and DQw8 molecules encode proteins that differ only at amino acid 57.
|
| |
Immunogenetics,
33,
404-408.
|
|
|
|
|
|
|
R.Lechler,
and
G.Lombardi
(1991).
Structural aspects of allorecognition.
|
| |
Curr Opin Immunol,
3,
715-721.
|
|
|
|
|
|
|
R.Lippé,
E.Luke,
Y.T.Kuah,
C.Lomas,
and
W.A.Jefferies
(1991).
Adenovirus infection inhibits the phosphorylation of major histocompatibility complex class I proteins.
|
| |
J Exp Med,
174,
1159-1166.
|
|
|
|
|
|
|
R.Patarca,
F.Y.Wei,
M.V.Iregui,
and
H.Cantor
(1991).
Differential induction of interferon gamma gene expression after activation of CD4+ T cells by conventional antigen and Mls superantigen.
|
| |
Proc Natl Acad Sci U S A,
88,
2736-2739.
|
|
|
|
|
|
|
R.Tampé,
D.Tyvoll,
and
H.M.McConnell
(1991).
Reactions of the subunits of the class II major histocompatibility complex molecule IAd.
|
| |
Proc Natl Acad Sci U S A,
88,
10667-10670.
|
|
|
|
|
|
|
S.Fleury,
D.Lamarre,
S.Meloche,
S.E.Ryu,
C.Cantin,
W.A.Hendrickson,
and
R.P.Sekaly
(1991).
Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site.
|
| |
Cell,
66,
1037-1049.
|
|
|
|
|
|
|
S.J.Ono,
H.C.Liou,
R.Davidon,
J.L.Strominger,
and
L.H.Glimcher
(1991).
Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos.
|
| |
Proc Natl Acad Sci U S A,
88,
4309-4312.
|
|
|
|
|
|
|
S.J.Ono,
V.Bazil,
M.Sugawara,
and
J.L.Strominger
(1991).
An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP.
|
| |
J Exp Med,
173,
629-637.
|
|
|
|
|
|
|
S.J.Powis,
J.C.Howard,
and
G.W.Butcher
(1991).
The major histocompatibility complex class II-linked cim locus controls the kinetics of intracellular transport of a classical class I molecule.
|
| |
J Exp Med,
173,
913-921.
|
|
|
|
|
|
|
S.Ohno
(1991).
Many peptide fragments of alien antigens are homologous with host proteins, thus canalizing T-cell responses.
|
| |
Proc Natl Acad Sci U S A,
88,
3065-3068.
|
|
|
|
|
|
|
S.S.Chen
(1991).
What determines an antigen-specific IgE isotypic response? A hypothesis.
|
| |
Scand J Immunol,
34,
519-529.
|
|
|
|
|
|
|
T.H.Ottenhoff,
J.B.Haanen,
A.Geluk,
T.Mutis,
B.K.Ab,
J.E.Thole,
W.C.van Schooten,
P.J.van den Elsen,
and
R.R.de Vries
(1991).
Regulation of mycobacterial heat-shock protein-reactive T cells by HLA class II molecules: lessons from leprosy.
|
| |
Immunol Rev,
121,
171-191.
|
|
|
|
|
|
|
T.J.Tsomides,
B.D.Walker,
and
H.N.Eisen
(1991).
An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein.
|
| |
Proc Natl Acad Sci U S A,
88,
11276-11280.
|
|
|
|
|
|
|
T.Ohta
(1991).
Role of diversifying selection and gene conversion in evolution of major histocompatibility complex loci.
|
| |
Proc Natl Acad Sci U S A,
88,
6716-6720.
|
|
|
|
|
|
|
T.Ohta
(1991).
Multigene families and the evolution of complexity.
|
| |
J Mol Evol,
33,
34-41.
|
|
|
|
|
|
|
T.P.Levine,
and
B.M.Chain
(1991).
The cell biology of antigen processing.
|
| |
Crit Rev Biochem Mol Biol,
26,
439-473.
|
|
|
|
|
|
|
V.Cerundolo,
T.Elliott,
J.Elvin,
J.Bastin,
H.G.Rammensee,
and
A.Townsend
(1991).
The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules.
|
| |
Eur J Immunol,
21,
2069-2075.
|
|
|
|
|
|
|
W.J.Storkus,
R.D.Salter,
J.Alexander,
F.E.Ward,
R.E.Ruiz,
P.Cresswell,
and
J.R.Dawson
(1991).
Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2.
|
| |
Proc Natl Acad Sci U S A,
88,
5989-5992.
|
|
|
|
|
|
|
W.R.Heath,
K.P.Kane,
M.F.Mescher,
and
L.A.Sherman
(1991).
Alloreactive T cells discriminate among a diverse set of endogenous peptides.
|
| |
Proc Natl Acad Sci U S A,
88,
5101-5105.
|
|
|
|
|
|
|
W.R.Heath,
and
L.A.Sherman
(1991).
Cell-type-specific recognition of allogeneic cells by alloreactive cytotoxic T cells: a consequence of peptide-dependent allorecognition.
|
| |
Eur J Immunol,
21,
153-159.
|
|
|
|
|
|
|
W.R.Lie,
N.B.Myers,
J.M.Connolly,
J.Gorka,
D.R.Lee,
and
T.H.Hansen
(1991).
The specific binding of peptide ligand to Ld class I major histocompatibility complex molecules determines their antigenic structure.
|
| |
J Exp Med,
173,
449-459.
|
|
|
|
|
|
|
A.Finnegan,
B.W.Needleman,
and
R.J.Hodes
(1990).
Function of autoreactive T cells in immune responses.
|
| |
Immunol Rev,
116,
15-31.
|
|
|
|
|
|
|
A.Hiraiwa,
K.Yamanaka,
W.W.Kwok,
E.M.Mickelson,
S.Masewicz,
J.A.Hansen,
S.F.Radka,
and
G.T.Nepom
(1990).
Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis.
|
| |
Proc Natl Acad Sci U S A,
87,
8051-8055.
|
|
|
|
|
|
|
A.Lernmark,
H.Bärmeier,
S.Dube,
W.Hagopian,
A.E.Karlsen,
H.Markholst,
C.Wilson,
and
R.Wassmuth
(1990).
Molecular analysis of the pathogenesis of beta-cell destruction in insulin-dependent diabetes mellitus.
|
| |
West J Med,
153,
499-502.
|
|
|
|
|
|
|
A.Townsend,
T.Elliott,
V.Cerundolo,
L.Foster,
B.Barber,
and
A.Tse
(1990).
Assembly of MHC class I molecules analyzed in vitro.
|
| |
Cell,
62,
285-295.
|
|
|
|
|
|
|
A.V.Bogdanova,
T.V.Cherednikova,
T.A.Egorov,
E.G.Harutyunyan,
N.A.Kurochkina,
V.S.Lamzin,
A.P.Savitskiy,
I.A.Shumilin,
and
V.O.Popov
(1990).
Mapping of the immunodominant regions of the NAD-dependent formate dehydrogenase.
|
| |
FEBS Lett,
260,
297-300.
|
|
|
|
|
|
|
B.D.Schwartz
(1990).
Infectious agents, immunity, and rheumatic diseases.
|
| |
Arthritis Rheum,
33,
457-465.
|
|
|
|
|
|
|
B.M.Carreno,
R.W.Anderson,
J.E.Coligan,
and
W.E.Biddison
(1990).
HLA-B37 and HLA-A2.1 molecules bind largely nonoverlapping sets of peptides.
|
| |
Proc Natl Acad Sci U S A,
87,
3420-3424.
|
|
|
|
|
|
|
B.N.Beck,
and
D.J.McKean
(1990).
Mapping T cell receptor epitopes on the A beta polypeptide.
|
| |
Immunol Res,
9,
47-56.
|
|
|
|
|
|
|
B.P.Chen,
J.Rothbard,
and
P.Parham
(1990).
Apparent lack of MHC restriction in binding of class I HLA molecules to solid-phase peptides.
|
| |
J Exp Med,
172,
931-936.
|
|
|
|
|
|
|
C.Ewing,
R.Ebringer,
G.Tribbick,
and
H.M.Geysen
(1990).
Antibody activity in ankylosing spondylitis sera to two sites on HLA B27.1 at the MHC groove region (within sequence 65-85), and to a Klebsiella pneumoniae nitrogenase reductase peptide (within sequence 181-199).
|
| |
J Exp Med,
171,
1635-1647.
|
|
|
|
|
|
|
C.M.Weyand,
and
J.J.Goronzy
(1990).
Disease-associated human histocompatibility leukocyte antigen determinants in patients with seropositive rheumatoid arthritis. Functional role in antigen-specific and allogeneic T cell recognition.
|
| |
J Clin Invest,
85,
1051-1057.
|
|
|
|
|
|
|
C.V.Harding,
and
E.R.Unanue
(1990).
Cellular mechanisms of antigen processing and the function of class I and II major histocompatibility complex molecules.
|
| |
Cell Regul,
1,
499-509.
|
|
|
|
|
|
|
D.A.Lawlor,
E.Warren,
F.E.Ward,
and
P.Parham
(1990).
Comparison of class I MHC alleles in humans and apes.
|
| |
Immunol Rev,
113,
147-185.
|
|
|
|
|
|
|
D.C.Wraith,
D.E.Smilek,
D.J.Mitchell,
L.Steinman,
and
H.O.McDevitt
(1990).
T cell recognition in experimental autoimmune encephalomyelitis: prospects for immune intervention with synthetic peptides.
|
| |
Int Rev Immunol,
6,
37-47.
|
|
|
|
|
|
|
D.D.Eckels
(1990).
Alloreactivity: allogeneic presentation of endogenous peptide or direct recognition of MHC polymorphism? A review.
|
| |
Tissue Antigens,
35,
49-55.
|
|
|
|
|
|
|
D.E.Geraghty,
X.H.Wei,
H.T.Orr,
and
B.H.Koller
(1990).
Human leukocyte antigen F (HLA-F). An expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element.
|
| |
J Exp Med,
171,
1.
|
|
|
|
|
|
|
D.E.Smilek,
C.B.Lock,
and
H.O.McDevitt
(1990).
Antigen recognition and peptide-mediated immunotherapy in autoimmune disease.
|
| |
Immunol Rev,
118,
37-71.
|
|
|
|
|
|
|
D.E.Staunton,
M.L.Dustin,
H.P.Erickson,
and
T.A.Springer
(1990).
The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus.
|
| |
Cell,
61,
243-254.
|
|
|
|
|
|
|
D.Hanau,
D.A.Schmitt,
T.Bieber,
D.Schmitt,
and
J.P.Cazenave
(1990).
Possible mechanism of action of CD1a antigens.
|
| |
J Invest Dermatol,
95,
503-505.
|
|
|
|
|
|
|
D.J.Charron,
P.Hermans,
V.Lotteau,
B.Merlu,
F.Amesland,
P.Turmel,
and
L.Tevton
(1990).
Interisotypic alpha- and beta-chain assembly as a source of HLA class-II diversity.
|
| |
Immunol Res,
9,
234-243.
|
|
|
|
|
|
|
D.M.Roberts,
M.Guenthert,
and
R.Rodewald
(1990).
Isolation and characterization of the Fc receptor from the fetal yolk sac of the rat.
|
| |
J Cell Biol,
111,
1867-1876.
|
|
|
|
|
|
|
E.A.Padlan
(1990).
On the nature of antibody combining sites: unusual structural features that may confer on these sites an enhanced capacity for binding ligands.
|
| |
Proteins,
7,
112-124.
|
|
|
|
|
|
|
E.K.Wakeland,
S.Boehme,
and
J.X.She
(1990).
The generation and maintenance of MHC class II gene polymorphism in rodents.
|
| |
Immunol Rev,
113,
207-226.
|
|
|
|
|
|
|
E.K.Wakeland,
S.Boehme,
J.X.She,
C.C.Lu,
R.A.McIndoe,
I.Cheng,
Y.Ye,
and
W.K.Potts
(1990).
Ancestral polymorphisms of MHC class II genes: divergent allele advantage.
|
| |
Immunol Res,
9,
115-122.
|
|
|
|
|
|
|
E.Schnabl,
H.Stockinger,
O.Majdic,
H.Gaugitsch,
I.J.Lindley,
D.Maurer,
A.Hajek-Rosenmayr,
and
W.Knapp
(1990).
Activated human T lymphocytes express MHC class I heavy chains not associated with beta 2-microglobulin.
|
| |
J Exp Med,
171,
1431-1442.
|
|
|
|
|
|
|
F.Hochstenbach,
and
M.B.Brenner
(1990).
Newly identified gamma delta and beta delta T-cell receptors.
|
| |
J Clin Immunol,
10,
1.
|
|
|
|
|
|
|
G.C.Miescher,
N.S.Liao,
R.K.Lees,
H.R.MacDonald,
and
D.H.Raulet
(1990).
Selective expression of V delta 6 genes by B2A2- CD4- CD8- T cell receptor gamma/delta thymocytes.
|
| |
Eur J Immunol,
20,
41-45.
|
|
|
|
|
|
|
G.Kroemer,
A.Bernot,
G.Béhar,
A.M.Chaussé,
L.N.Gastinel,
F.Guillemot,
I.Park,
P.Thoraval,
R.Zoorob,
and
C.Auffray
(1990).
Molecular genetics of the chicken MHC: current status and evolutionary aspects.
|
| |
Immunol Rev,
113,
119-145.
|
|
|
|
|
|
|
G.M.Pfaffenbach,
R.W.Melvold,
and
S.G.Nathenson
(1990).
Biochemical analysis of related, independently arising histocompatibility mutants: bm17 and KB-98 enlarge the "bg series" of H-2Kb mutants.
|
| |
Biochem Genet,
28,
433-441.
|
|
|
|
|
|
|
G.Siu,
E.A.Springer,
and
S.M.Hedrick
(1990).
The biology of the T-cell antigen receptor and its role in the skin immune system.
|
| |
J Invest Dermatol,
94,
91S.
|
|
|
|
|
|
|
G.Soldevila,
M.Doshi,
R.James,
S.P.Lake,
R.Sutton,
D.Gray,
G.F.Bottazzo,
and
R.Pujol-Borrell
(1990).
HLA DR, DP, DQ induction in human islet beta cells by the cytokine combination IFN-gamma + TNF-alpha.
|
| |
Autoimmunity,
6,
307-317.
|
|
|
|
|
|
|
G.T.Nepom
(1990).
Mutagenesis and expression of putative class II susceptibility genes: a "reverse immunogenetics" approach to analysis of HLA and disease.
|
| |
Autoimmunity,
7,
189-199.
|
|
|
|
|
|
|
H.Heinrichs,
and
H.T.Orr
(1990).
HLA non-A,B,C class I genes: their structure and expression.
|
| |
Immunol Res,
9,
265-274.
|
|
|
|
|
|
|
H.Jacobs,
H.Von Boehmer,
C.J.Melief,
and
A.Berns
(1990).
Mutations in the major histocompatibility complex class I antigen-presenting groove affect both negative and positive selection of T cells.
|
| |
Eur J Immunol,
20,
2333-2337.
|
|
|
|
|
|
|
I.Khalil,
L.d'Auriol,
M.Gobet,
L.Morin,
V.Lepage,
I.Deschamps,
M.S.Park,
L.Degos,
F.Galibert,
and
J.Hors
(1990).
A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus.
|
| |
J Clin Invest,
85,
1315-1319.
|
|
|
|
|
|
|
J.B.Rothbard,
and
R.Busch
(1990).
Interactions between immunogenic peptides and HLA-DR molecules.
|
| |
Immunol Res,
9,
178-189.
|
|
|
|
|
|
|
J.Choppin,
F.Martinon,
E.Gomard,
E.Bahraoui,
F.Connan,
M.Bouillot,
and
J.P.Lévy
(1990).
Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptides.
|
| |
J Exp Med,
172,
889-899.
|
|
|
|
|
|
|
J.Colombani
(1990).
Conserved and variable structures in HLA class I molecules: a review.
|
| |
Tissue Antigens,
35,
103-113.
|
|
|
|
|
|
|
J.J.Neefjes,
M.L.De Bruijn,
C.J.Boog,
J.D.Nieland,
J.Boes,
C.J.Melief,
and
H.L.Ploegh
(1990).
N-linked glycan modification on antigen-presenting cells restores an allospecific cytotoxic T cell response.
|
| |
J Exp Med,
171,
583-588.
|
|
|
|
|
|
|
J.J.Neefjes,
V.Stollorz,
P.J.Peters,
H.J.Geuze,
and
H.L.Ploegh
(1990).
The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route.
|
| |
Cell,
61,
171-183.
|
|
|
|
|
|
|
J.Kaufman,
K.Skjoedt,
and
J.Salomonsen
(1990).
The MHC molecules of nonmammalian vertebrates.
|
| |
Immunol Rev,
113,
83.
|
|
|
|
|
|
|
J.Kaufman
(1990).
Evolution of the MHC: lessons from the nonmammalian vertebrates.
|
| |
Immunol Res,
9,
123-134.
|
|
|
|
|
|
|
J.L.Maryanski,
A.S.Verdini,
P.C.Weber,
F.R.Salemme,
and
G.Corradin
(1990).
Competitor analogs for defined T cell antigens: peptides incorporating a putative binding motif and polyproline or polyglycine spacers.
|
| |
Cell,
60,
63-72.
|
|
|
|
|
|
|
J.M.Connolly,
T.H.Hansen,
A.L.Ingold,
and
T.A.Potter
(1990).
Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T-cell receptor recognize the same class I molecule.
|
| |
Proc Natl Acad Sci U S A,
87,
2137-2141.
|
|
|
|
|
|
|
J.Nikolić-Zugić,
and
F.R.Carbone
(1990).
The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant.
|
| |
Eur J Immunol,
20,
2431-2437.
|
|
|
|
|
|
|
J.Peccoud,
P.Dellabona,
P.Allen,
C.Benoist,
and
D.Mathis
(1990).
Delineation of antigen contact residues on an MHC class II molecule.
|
| |
EMBO J,
9,
4215-4223.
|
|
|
|
|
|
|
J.Stagsted,
G.M.Reaven,
T.Hansen,
A.Goldstein,
and
L.Olsson
(1990).
Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen.
|
| |
Cell,
62,
297-307.
|
|
|
|
|
|
|
K.Hashimoto,
T.Nakanishi,
and
Y.Kurosawa
(1990).
Isolation of carp genes encoding major histocompatibility complex antigens.
|
| |
Proc Natl Acad Sci U S A,
87,
6863-6867.
|
|
|
|
|
|
|
K.Ito,
L.Van Kaer,
M.Bonneville,
S.Hsu,
D.B.Murphy,
and
S.Tonegawa
(1990).
Recognition of the product of a novel MHC TL region gene (27b) by a mouse gamma delta T cell receptor.
|
| |
Cell,
62,
549-561.
|
|
|
|
|
|
|
K.L.Rock,
L.E.Rothstein,
S.R.Gamble,
and
B.Benacerraf
(1990).
Reassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptides.
|
| |
Proc Natl Acad Sci U S A,
87,
7517-7521.
|
|
|
|
|
|
|
K.Ohya,
K.Kondo,
and
S.Mizuno
(1990).
Polymorphism in the human class I MHC locus HLA-E in Japanese.
|
| |
Immunogenetics,
32,
205-209.
|
|
|
|
|
|
|
K.Ozawa,
F.Saka,
I.Kitabayashi,
T.Imai,
E.Soeda,
A.Israel,
G.Gachelin,
and
K.Yokoyama
(1990).
Comparison of the promoter regions of H-2Kb and H-2Kbm1 class I MHC genes.
|
| |
Nucleic Acids Res,
18,
4185-4190.
|
|
|
|
|
|
|
K.Sturmhöfel,
and
G.J.Hämmerling
(1990).
Reconstitution of H-2 class I expression by gene transfection decreases susceptibility to natural killer cells of an EL4 class I loss variant.
|
| |
Eur J Immunol,
20,
171-177.
|
|
|
|
|
|
|
L.Adorini,
and
Z.Nagy
(1990).
Inhibition of T cell activation by MHC blockade.
|
| |
Int Rev Immunol,
6,
23-35.
|
|
|
|
|
|
|
L.R.Smith,
and
A.N.Theofilopoulos
(1990).
Sequence of I-E genes from autoimmune New Zealand white mice.
|
| |
Arthritis Rheum,
33,
583-586.
|
|
|
|
|
|
|
M.Barbu
(1990).
Molecular cloning of cDNAs that encode the chicken P0 protein: evidence for early expression in avians.
|
| |
J Neurosci Res,
25,
143-151.
|
|
|
|
|
|
|
M.Bouillot,
J.Choppin,
and
J.P.Levy
(1990).
Definition of epitopes on HLA class I molecules by polyclonal antipeptide sera.
|
| |
Immunogenetics,
32,
68-71.
|
|
|
|
|
|
|
M.H.Nissen,
P.Roepstorff,
L.Thim,
B.Dunbar,
and
J.E.Fothergill
(1990).
Limited proteolysis of beta 2-microglobulin at Lys-58 by complement component C1s.
|
| |
Eur J Biochem,
189,
423-429.
|
|
|
|
|
|
|
M.Kuhner,
S.Watts,
W.Klitz,
G.Thomson,
and
R.S.Goodenow
(1990).
Gene conversion in the evolution of both the H-2 and Qa class I genes of the murine major histocompatibility complex.
|
| |
Genetics,
126,
1115-1126.
|
|
|
|
|
|
|
M.S.Kruskall
(1990).
The major histocompatibility complex: the value of extended haplotypes in the analysis of associated immune diseases and disorders.
|
| |
Yale J Biol Med,
63,
477-486.
|
|
|
|
|
|
|
M.Srinivasan,
and
S.K.Pierce
(1990).
Isolation of a functional antigen-Ia complex.
|
| |
Proc Natl Acad Sci U S A,
87,
919-922.
|
|
|
|
|
|
|
M.Y.Chang,
C.Kowal,
L.R.Marzullo,
T.J.Briner,
M.L.Gefter,
and
B.Diamond
(1990).
Genetic recombination in the alpha 2 domain of the E alpha chain yields an Ed molecule with altered T cell activation.
|
| |
Eur J Immunol,
20,
2571-2576.
|
|
|
|
|
|
|
N.Tsuchiya,
G.Husby,
R.C.Williams,
H.Stieglitz,
P.E.Lipsky,
and
R.D.Inman
(1990).
Autoantibodies to the HLA-B27 sequence cross-react with the hypothetical peptide from the arthritis-associated Shigella plasmid.
|
| |
J Clin Invest,
86,
1193-1203.
|
|
|
|
|
|
|
P.A.Cazenave,
P.N.Marche,
E.Jouvin-Marche,
D.Voegtlé,
F.Bonhomme,
A.Bandeira,
and
A.Coutinho
(1990).
V beta 17 gene polymorphism in wild-derived mouse strains: two amino acid substitutions in the V beta 17 region greatly alter T cell receptor specificity.
|
| |
Cell,
63,
717-728.
|
|
|
|
|
|
|
P.Cresswell,
J.S.Blum,
J.E.Davis,
and
M.S.Marks
(1990).
Transport and expression of HLA class-II glycoproteins.
|
| |
Immunol Res,
9,
190-199.
|
|
|
|
|
|
|
P.D.Ennis,
J.Zemmour,
R.D.Salter,
and
P.Parham
(1990).
Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification.
|
| |
Proc Natl Acad Sci U S A,
87,
2833-2837.
|
|
|
|
|
|
|
P.Dellabona,
J.Peccoud,
J.Kappler,
P.Marrack,
C.Benoist,
and
D.Mathis
(1990).
Superantigens interact with MHC class II molecules outside of the antigen groove.
|
| |
Cell,
62,
1115-1121.
|
|
|
|
|
|
|
P.Parham
(1990).
Recognition of antigen and alloantigen by T cells: a common mechanism?
|
| |
Trends Biochem Sci,
15,
79-81.
|
|
|
|
|
|
|
P.R.Wolf,
and
R.G.Cook
(1990).
The TL region gene 37 encodes a Qa-1 antigen.
|
| |
J Exp Med,
172,
1795-1804.
|
|
|
|
|
|
|
R.Bragado,
P.Lauzurica,
D.López,
and
J.A.López de Castro
(1990).
T cell receptor V beta gene usage in a human alloreactive response. Shared structural features among HLA-B27-specific T cell clones.
|
| |
J Exp Med,
171,
1189-1204.
|
|
|
|
|
|
|
R.Bujdoso,
G.Harkiss,
J.Hopkins,
and
I.McConnell
(1990).
Afferent lymph dendritic cells: a model for antigen capture and presentation in vivo.
|
| |
Int Rev Immunol,
6,
177-186.
|
|
|
|
|
|
|
R.E.Bontrop,
D.G.Elferink,
N.Otting,
M.Jonker,
and
R.R.de Vries
(1990).
Major histocompatibility complex class II-restricted antigen presentation across a species barrier: conservation of restriction determinants in evolution.
|
| |
J Exp Med,
172,
53-59.
|
|
|
|
|
|
|
R.E.Tigelaar,
J.M.Lewis,
and
P.R.Bergstresser
(1990).
TCR gamma/delta+ dendritic epidermal T cells as constituents of skin-associated lymphoid tissue.
|
| |
J Invest Dermatol,
94,
58S-63S.
|
|
|
|
|
|
|
R.Gabathuler,
F.Lévy,
and
S.Kvist
(1990).
Requirements for the association of adenovirus type 2 E3/19K wild-type and mutant proteins with HLA antigens.
|
| |
J Virol,
64,
3679-3685.
|
|
|
|
|
|
|
R.Lechler,
and
G.Lombardi
(1990).
The structural basis of alloreactivity.
|
| |
Immunol Res,
9,
135-146.
|
|
|
|
|
|
|
R.Mantegazza,
J.R.Oksenberg,
F.Baggi,
C.Antozzi,
M.T.Illeni,
G.Pellegris,
F.Cornelio,
and
L.Steinman
(1990).
Increased incidence of certain TCR and HLA genes associated with myasthenia gravis in Italians.
|
| |
J Autoimmun,
3,
431-440.
|
|
|
|
|
|
|
R.S.Kalish
(1990).
The use of human T-lymphocyte clones to study T-cell function in allergic contact dermatitis to urushiol.
|
| |
J Invest Dermatol,
94,
108S-111S.
|
|
|
|
|
|
|
R.W.Karr,
W.Yu,
R.Watts,
K.S.Evans,
and
E.Celis
(1990).
The role of polymorphic HLA-DR beta chain residues in presentation of viral antigens to T cells.
|
| |
J Exp Med,
172,
273-283.
|
|
|
|
|
|
|
S.B.Sorger,
and
S.M.Hedrick
(1990).
Highly conserved T-cell receptor junctional regions. Evidence for selection at the protein and the DNA level.
|
| |
Immunogenetics,
31,
118-122.
|
|
|
|
|
|
|
S.Fraga,
E.San-Fabian,
S.Thornton,
and
B.Singh
(1990).
Prediction of the secondary structure and functional sites of major histocompatibility complex molecules.
|
| |
J Mol Recognit,
3,
65-73.
|
|
|
|
|
|
|
S.Gilfillan,
S.Aiso,
S.A.Michie,
and
H.O.McDevitt
(1990).
Immune deficiency due to high copy numbers of an Ak beta transgene.
|
| |
Proc Natl Acad Sci U S A,
87,
7319-7323.
|
|
|
|
|
|
|
S.M.Shawar,
R.G.Cook,
J.R.Rodgers,
and
R.R.Rich
(1990).
Specialized functions of MHC class I molecules. I. An N-formyl peptide receptor is required for construction of the class I antigen Mta.
|
| |
J Exp Med,
171,
897-912.
|
|
|
|
|
|
|
T.E.Feltkamp
(1990).
HLA and uveitis.
|
| |
Int Ophthalmol,
14,
327-333.
|
|
|
|
|
|
|
T.J.Elliott,
and
H.N.Eisen
(1990).
Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule.
|
| |
Proc Natl Acad Sci U S A,
87,
5213-5217.
|
|
|
|
|
|
|
T.N.Schumacher,
M.T.Heemels,
J.J.Neefjes,
W.M.Kast,
C.J.Melief,
and
H.L.Ploegh
(1990).
Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.
|
| |
Cell,
62,
563-567.
|
|
|
|
|
|
|
T.S.Jardetzky,
J.C.Gorga,
R.Busch,
J.Rothbard,
J.L.Strominger,
and
D.C.Wiley
(1990).
Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding.
|
| |
EMBO J,
9,
1797-1803.
|
|
|
|
|
|
|
U.Gross,
J.H.Chen,
D.H.Kono,
and
D.T.Yu
(1990).
A ribosomal protein of Yersinia pseudotuberculosis having partial epitope identity with HLA-B27.
|
| |
Autoimmunity,
7,
267-277.
|
|
|
|
|
|
|
V.J.Disesa
(1990).
The basic science of heart transplantation: important immune cell surface molecules.
|
| |
J Card Surg,
5,
26-38.
|
|
|
|
|
|
|
W.A.Jefferies,
and
H.G.Burgert
(1990).
E3/19K from adenovirus 2 is an immunosubversive protein that binds to a structural motif regulating the intracellular transport of major histocompatibility complex class I proteins.
|
| |
J Exp Med,
172,
1653-1664.
|
|
|
|
|
|
|
W.K.Potts,
and
E.K.Wakeland
(1990).
Evolution of diversity at the major histocompatibility complex.
|
| |
Trends Ecol Evol,
5,
181-187.
|
|
|
|
|
|
|
W.R.Mayr
(1990).
HLA 1990.
|
| |
Blut,
61,
207-212.
|
|
|
|
|
|
|
W.W.Kwok,
E.Mickelson,
S.Masewicz,
E.C.Milner,
J.Hansen,
and
G.T.Nepom
(1990).
Polymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition.
|
| |
J Exp Med,
171,
85-95.
|
|
|
|
|
|
|
Y.Li,
P.Szabo,
M.A.Robinson,
B.Dong,
and
D.N.Posnett
(1990).
Allelic variations in the human T cell receptor V beta 6.7 gene products.
|
| |
J Exp Med,
171,
221-230.
|
|
|
|
|
|
|
Y.Yanagi,
R.Maekawa,
T.Cook,
O.Kanagawa,
and
M.B.Oldstone
(1990).
Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.
|
| |
J Virol,
64,
5919-5926.
|
|
|
|
|
|
|
A.Hiraiwa,
C.E.Seyfried,
G.T.Nepom,
and
E.C.Milner
(1989).
Sequence analysis of HLA class II domains: characterization of the DQw3 family of DQB genes.
|
| |
Immunogenetics,
29,
186-190.
|
|
|
|
|
|
|
A.K.Jonsson,
L.Andersson,
and
L.Rask
(1989).
Selection for polymorphism in the antigen recognition site of major histocompatibility complex class II molecules.
|
| |
Scand J Immunol,
30,
409-417.
|
|
|
|
|
|
|
A.L.Cunningham,
and
J.R.Noble
(1989).
Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.
|
| |
J Clin Invest,
83,
490-496.
|
|
|
|
|
|
|
A.M.Livingstone,
S.J.Powis,
A.G.Diamond,
G.W.Butcher,
and
J.C.Howard
(1989).
A trans-acting major histocompatibility complex-linked gene whose alleles determine gain and loss changes in the antigenic structure of a classical class I molecule.
|
| |
J Exp Med,
170,
777-795.
|
|
|
|
|
|
|
A.Svejgaard,
and
L.P.Ryder
(1989).
HLA and insulin-dependent diabetes: an overview.
|
| |
Genet Epidemiol,
6,
1.
|
|
|
|
|
|
|
A.Vanbuskirk,
B.L.Crump,
E.Margoliash,
and
S.K.Pierce
(1989).
A peptide binding protein having a role in antigen presentation is a member of the HSP70 heat shock family.
|
| |
J Exp Med,
170,
1799-1809.
|
|
|
|
|
|
|
A.Zurbriggen,
and
R.S.Fujinami
(1989).
Immunity to viruses.
|
| |
Curr Opin Immunol,
1,
427-430.
|
|
|
|
|
|
|
B.P.Wordsworth,
J.S.Lanchbury,
L.I.Sakkas,
K.I.Welsh,
G.S.Panayi,
and
J.I.Bell
(1989).
HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region.
|
| |
Proc Natl Acad Sci U S A,
86,
10049-10053.
|
|
|
|
|
|
|
C.A.Janeway,
J.Yagi,
P.J.Conrad,
M.E.Katz,
B.Jones,
S.Vroegop,
and
S.Buxser
(1989).
T-cell responses to Mls and to bacterial proteins that mimic its behavior.
|
| |
Immunol Rev,
107,
61-88.
|
|
|
|
|
|
|
C.A.Müller,
G.Engler-Blum,
V.Gekeler,
I.Steiert,
E.Weiss,
and
H.Schmidt
(1989).
Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6.
|
| |
Immunogenetics,
30,
200-207.
|
|
|
|
|
|
|
C.A.Olson,
L.C.Williams,
E.McLaughlin-Taylor,
and
M.McMillan
(1989).
Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes.
|
| |
Proc Natl Acad Sci U S A,
86,
1031-1035.
|
|
|
|
|
|
|
C.B.Davis,
J.M.Buerstedde,
D.J.McKean,
P.P.Jones,
H.O.McDevitt,
and
D.C.Wraith
(1989).
The role of polymorphic I-Ak beta chain residues in presentation of a peptide from myelin basic protein.
|
| |
J Exp Med,
169,
2239-2244.
|
|
|
|
|
|
|
C.E.Rudd,
P.Anderson,
C.Morimoto,
M.Streuli,
and
S.F.Schlossman
(1989).
Molecular interactions, T-cell subsets and a role of the CD4/CD8:p56lck complex in human T-cell activation.
|
| |
Immunol Rev,
111,
225-266.
|
|
|
|
|
|
|
C.J.Boog,
J.J.Neefjes,
J.Boes,
H.L.Ploegh,
and
C.J.Melief
(1989).
Specific immune responses restored by alteration in carbohydrate chains of surface molecules on antigen-presenting cells.
|
| |
Eur J Immunol,
19,
537-542.
|
|
|
|
|
|
|
C.M.Graham,
B.C.Barnett,
I.Hartlmayr,
D.S.Burt,
R.Faulkes,
J.J.Skehel,
and
D.B.Thomas
(1989).
The structural requirements for class II (I-Ad)-restricted T cell recognition of influenza hemagglutinin: B cell epitopes define T cell epitopes.
|
| |
Eur J Immunol,
19,
523-528.
|
|
|
|
|
|
|
C.Winkler,
A.Schultz,
S.Cevario,
and
S.O'Brien
(1989).
Genetic characterization of FLA, the cat major histocompatibility complex.
|
| |
Proc Natl Acad Sci U S A,
86,
943-947.
|
|
|
|
|
|
|
C.Y.Okada,
and
I.L.Weissman
(1989).
Relative V beta transcript levels in thymus and peripheral lymphoid tissues from various mouse strains. Inverse correlation of I-E and Mls expression with relative abundance of several V beta transcripts in peripheral lymphoid tissues.
|
| |
J Exp Med,
169,
1703-1719.
|
|
|
|
|
|
|
D.C.Wraith,
H.O.McDevitt,
L.Steinman,
and
H.Acha-Orbea
(1989).
T cell recognition as the target for immune intervention in autoimmune disease.
|
| |
Cell,
57,
709-715.
|
|
|
|
|
|
|
D.Isaacs
(1989).
Immunity to viruses.
|
| |
Arch Dis Child,
64,
1649-1652.
|
|
|
|
|
|
|
D.L.Hamilos
(1989).
Antigen presenting cells.
|
| |
Immunol Res,
8,
98.
|
|
|
|
|
|
|
D.R.Martin,
and
R.G.Miller
(1989).
In vivo administration of histoincompatible lymphocytes leads to rapid functional deletion of cytotoxic T lymphocyte precursors.
|
| |
J Exp Med,
170,
679-690.
|
|
|
|
|
|
|
D.S.Singer,
L.J.Parent,
and
M.A.Kolber
(1989).
Ethanol: an enhancer of transplantation antigen expression.
|
| |
Alcohol Clin Exp Res,
13,
480-484.
|
|
|
|
|
|
|
E.A.Padlan,
E.W.Silverton,
S.Sheriff,
G.H.Cohen,
S.J.Smith-Gill,
and
D.R.Davies
(1989).
Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex.
|
| |
Proc Natl Acad Sci U S A,
86,
5938-5942.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
E.K.Bikoff,
and
L.A.Eckhardt
(1989).
Presentation of IgG2a antigens to class II-restricted T cells by stably transfected B lymphoma cells.
|
| |
Eur J Immunol,
19,
1903-1909.
|
|
|
|
|
|
|
E.Thorsby,
K.E.Lundin,
K.S.Rønningen,
L.M.Sollid,
and
F.Vartdal
(1989).
Molecular basis and functional importance of some disease-associated HLA polymorphisms.
|
| |
Tissue Antigens,
34,
39-49.
|
|
|
|
|
|
|
F.Calabi,
J.M.Jarvis,
L.Martin,
and
C.Milstein
(1989).
Two classes of CD1 genes.
|
| |
Eur J Immunol,
19,
285-292.
|
|
|
|
|
|
|
F.Kievits,
J.Wijffels,
W.Lokhorst,
and
P.Ivanyi
(1989).
Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
|
| |
Proc Natl Acad Sci U S A,
86,
617-620.
|
|
|
|
|
|
|
F.Kievits,
J.Wijffels,
W.Lokhorst,
W.J.Boerenkamp,
and
P.Ivanyi
(1989).
HLA expression and function in single and double HLA-B27-transgenic mice.
|
| |
Tissue Antigens,
34,
50-63.
|
|
|
|
|
|
|
G.G.Capps,
M.Van Kampen,
C.L.Ward,
and
M.C.Zúñiga
(1989).
Endocytosis of the class I major histocompatibility antigen via a phorbol myristate acetate-inducible pathway is a cell-specific phenomenon and requires the cytoplasmic domain.
|
| |
J Cell Biol,
108,
1317-1329.
|
|
|
|
|
|
|
G.J.Hämmerling,
T.Hunt,
O.Dill,
and
J.Moreno
(1989).
Cytotoxic T lymphocyte recognition of HLA-A2 antigens in normal and HLA-Cw3-transgenic mice.
|
| |
Eur J Immunol,
19,
599-604.
|
|
|
|
|
|
|
G.Lombardi,
S.Sidhu,
J.R.Batchelor,
and
R.I.Lechler
(1989).
Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptides.
|
| |
Proc Natl Acad Sci U S A,
86,
4190-4194.
|
|
|
|
|
|
|
G.Sterkers,
J.M.Tiercy,
D.Zeliszewski,
J.P.Levy,
and
B.Mach
(1989).
Characterization of three functional sites in alpha beta 1 DR of DRw13. All three sites are potentially involved in major histocompatibility complex-peptide interaction.
|
| |
Eur J Immunol,
19,
1585-1590.
|
|
|
|
|
|
|
H.Epstein,
L.J.Kennedy,
and
N.Holmes
(1989).
An Oriental HLA-A2 subtype is closely related to a subset of Caucasoid HLA-A2 alleles.
|
| |
Immunogenetics,
29,
112-116.
|
|
|
|
|
|
|
H.Epstein,
R.Hardy,
J.S.May,
M.H.Johnson,
and
N.Holmes
(1989).
Expression and function of HLA-A2.1 in transgenic mice.
|
| |
Eur J Immunol,
19,
1575-1583.
|
|
|
|
|
|
|
H.J.Schlicht,
and
H.Schaller
(1989).
The secretory core protein of human hepatitis B virus is expressed on the cell surface.
|
| |
J Virol,
63,
5399-5404.
|
|
|
|
|
|
|
H.Pohla,
W.Kuon,
P.Tabaczewski,
C.Doerner,
and
E.H.Weiss
(1989).
Allelic variation in HLA-B and HLA-C sequences and the evolution of the HLA-B alleles.
|
| |
Immunogenetics,
29,
297-307.
|
|
|
|
|
|
|
H.Stieglitz,
S.Fosmire,
and
P.Lipsky
(1989).
Identification of a 2-Md plasmid from Shigella flexneri associated with reactive arthritis.
|
| |
Arthritis Rheum,
32,
937-946.
|
|
|
|
|
|
|
H.Takahashi,
R.Houghten,
S.D.Putney,
D.H.Margulies,
B.Moss,
R.N.Germain,
and
J.A.Berzofsky
(1989).
Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein.
|
| |
J Exp Med,
170,
2023-2035.
|
|
|
|
|
|
|
J.A.Trapani,
S.Mizuno,
S.H.Kang,
S.Y.Yang,
and
B.Dupont
(1989).
Molecular mapping of a new public HLA class I epitope shared by all HLA-B and HLA-C antigens and defined by a monoclonal antibody.
|
| |
Immunogenetics,
29,
25-32.
|
|
|
|
|
|
|
J.B.Keeney,
and
T.H.Hansen
(1989).
Cis-acting elements determine the locus-specific shutoff of class I major histocompatibility genes in murine S49 lymphoma sublines.
|
| |
Proc Natl Acad Sci U S A,
86,
6288-6292.
|
|
|
|
|
|
|
J.B.Rothbard,
R.M.Pemberton,
H.C.Bodmer,
B.A.Askonas,
and
W.R.Taylor
(1989).
Identification of residues necessary for clonally specific recognition of a cytotoxic T cell determinant.
|
| |
EMBO J,
8,
2321-2328.
|
|
|
|
|
|
|
J.Bill,
F.Ronchese,
R.N.Germain,
and
E.Palmer
(1989).
The contribution of mutant amino acids to alloantigenicity.
|
| |
J Exp Med,
170,
739-750.
|
|
|
|
|
|
|
J.Bill,
J.Yagüe,
V.B.Appel,
J.White,
G.Horn,
H.A.Erlich,
and
E.Palmer
(1989).
Molecular genetic analysis of 178 I-Abm12-reactive T cells.
|
| |
J Exp Med,
169,
115-133.
|
|
|
|
|
|
|
J.C.Gorga,
A.Dong,
M.C.Manning,
R.W.Woody,
W.S.Caughey,
and
J.L.Strominger
(1989).
Comparison of the secondary structures of human class I and class II major histocompatibility complex antigens by Fourier transform infrared and circular dichroism spectroscopy.
|
| |
Proc Natl Acad Sci U S A,
86,
2321-2325.
|
|
|
|
|
|
|
J.Deisenhofer,
and
H.Michel
(1989).
Nobel lecture. The photosynthetic reaction centre from the purple bacterium Rhodopseudomonas viridis.
|
| |
EMBO J,
8,
2149-2170.
|
|
|
|
|
|
|
J.H.Hurley,
P.E.Thorsness,
V.Ramalingam,
N.H.Helmers,
D.E.Koshland,
and
R.M.Stroud
(1989).
Structure of a bacterial enzyme regulated by phosphorylation, isocitrate dehydrogenase.
|
| |
Proc Natl Acad Sci U S A,
86,
8635-8639.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
J.Harpprecht,
K.Olde,
E.Westphal,
and
W.Müller-Ruchholtz
(1989).
Serological mapping of HLA-epitopes with monoclonal antibodies and its interpretation by sequenced HLA-molecules.
|
| |
Tissue Antigens,
34,
170-178.
|
|
|
|
|
|
|
J.L.Maryanski,
J.P.Abastado,
H.R.MacDonald,
and
P.Kourilsky
(1989).
Intradomain H-2Kd/Dd recombinants define the same regions as crucial for recognition by alloreactive or major histocompatibility complex-restricted cytolytic T cells.
|
| |
Eur J Immunol,
19,
193-196.
|
|
|
|
|
|
|
J.L.Urban,
S.J.Horvath,
and
L.Hood
(1989).
Autoimmune T cells: immune recognition of normal and variant peptide epitopes and peptide-based therapy.
|
| |
Cell,
59,
257-271.
|
|
|
|
|
|
|
J.L.Whitton,
A.Tishon,
H.Lewicki,
J.Gebhard,
T.Cook,
M.Salvato,
E.Joly,
and
M.B.Oldstone
(1989).
Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity.
|
| |
J Virol,
63,
4303-4310.
|
|
|
|
|
|
|
J.Longley,
J.Kraus,
M.Alonso,
and
R.Edelson
(1989).
Molecular cloning of CD1a (T6), a human epidermal dendritic cell marker related to class I MHC molecules.
|
| |
J Invest Dermatol,
92,
628-631.
|
|
|
|
|
|
|
J.P.Banga,
P.S.Barnett,
D.Mahadevan,
and
A.M.McGregor
(1989).
Immune recognition of antigen and its relevance to autoimmune disease: recent advances at the molecular level.
|
| |
Eur J Clin Invest,
19,
107-116.
|
|
|
|
|
|
|
J.R.Lamb,
A.B.Kay,
and
R.E.O'Hehir
(1989).
HLA class II restriction specificity of Dermatophagoides spp. reactive T lymphocyte clones that support IgE synthesis.
|
| |
Clin Exp Allergy,
19,
389-393.
|
|
|
|
|
|
|
J.S.Spencer,
and
R.T.Kubo
(1989).
Mixed isotype class II antigen expression. A novel class II molecule is expressed on a murine B cell lymphoma.
|
| |
J Exp Med,
169,
625-640.
|
|
|
|
|
|
|
J.Santos-Aguado,
M.A.Crimmins,
S.J.Mentzer,
S.J.Burakoff,
and
J.L.Strominger
(1989).
Alloreactivity studied with mutants of HLA-A2.
|
| |
Proc Natl Acad Sci U S A,
86,
8936-8940.
|
|
|
|
|
|
|
J.Schneck,
T.Munitz,
J.E.Coligan,
W.L.Maloy,
D.H.Margulies,
and
A.Singer
(1989).
Inhibition of allorecognition by an H-2Kb-derived peptide is evidence for a T-cell binding region on a major histocompatibility complex molecule.
|
| |
Proc Natl Acad Sci U S A,
86,
8516-8520.
|
|
|
|
|
|
|
J.Schneck,
W.L.Maloy,
J.E.Coligan,
and
D.H.Margulies
(1989).
Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC.
|
| |
Cell,
56,
47-55.
|
|
|
|
|
|
|
J.W.Becker,
H.P.Erickson,
S.Hoffman,
B.A.Cunningham,
and
G.M.Edelman
(1989).
Topology of cell adhesion molecules.
|
| |
Proc Natl Acad Sci U S A,
86,
1088-1092.
|
|
|
|
|
|
|
J.White,
A.Herman,
A.M.Pullen,
R.Kubo,
J.W.Kappler,
and
P.Marrack
(1989).
The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice.
|
| |
Cell,
56,
27-35.
|
|
|
|
|
|
|
J.Yamamoto,
M.Tanabe,
M.Minami,
K.Kano,
and
M.Takiguchi
(1989).
Allo-class I-reactive CD4-CD8- T cell hybridomas recognize the conformational change of class I molecule resulting from the exchange of the alpha 3 domain.
|
| |
Eur J Immunol,
19,
1861-1865.
|
|
|
|
|
|
|
K.A.Brorson,
S.Richards,
S.W.Hunt,
H.Cheroutre,
K.F.Lindahl,
and
L.Hood
(1989).
Analysis of a new class I gene mapping to the Hmt region of the mouse.
|
| |
Immunogenetics,
30,
273-283.
|
|
|
|
|
|
|
K.A.Brorson,
S.W.Hunt,
T.Hunkapiller,
Y.H.Sun,
H.Cheroutre,
D.A.Nickerson,
and
L.Hood
(1989).
Comparison of exon 5 sequences from 35 class I genes of the BALB/c mouse.
|
| |
J Exp Med,
170,
1837-1858.
|
|
|
|
|
|
|
K.Kato,
B.Dupont,
and
S.Y.Yang
(1989).
Localization of nucleotide sequence which determines Mongoloid subtype of HLA-B13.
|
| |
Immunogenetics,
29,
117-120.
|
|
|
|
|
|
|
K.M.Hui
(1989).
Re-expression of major histocompatibility complex (MHC) class I molecules on malignant tumor cells and its effect on host-tumor interaction.
|
| |
Bioessays,
11,
22-26.
|
|
|
|
|
|
|
L.A.Baxter-Lowe,
J.B.Hunter,
J.T.Casper,
and
J.Gorski
(1989).
HLA gene amplification and hybridization analysis of polymorphism. HLA matching for bone marrow transplantation of a patient with HLA-deficient severe combined immunodeficiency syndrome.
|
| |
J Clin Invest,
84,
613-618.
|
|
|
|
|
|
|
L.Cianetti,
U.Testa,
L.Scotto,
R.La Valle,
A.Simeone,
G.Boccoli,
G.Giannella,
C.Peschle,
and
E.Boncinelli
(1989).
Three new class I HLA alleles: structure of mRNAs and alternative mechanisms of processing.
|
| |
Immunogenetics,
29,
80-91.
|
|
|
|
|
|
|
M.A.Vega,
and
J.L.Strominger
(1989).
Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules.
|
| |
Proc Natl Acad Sci U S A,
86,
2688-2692.
|
|
|
|
|
|
|
M.C.Nieto,
E.S.Song,
D.McKinney,
M.McMillan,
and
R.S.Goodenow
(1989).
The association of H-2Ld with human beta-2 microglobulin induces localized conformational changes in the alpha-1 and -2 superdomain.
|
| |
Immunogenetics,
30,
361-369.
|
|
|
|
|
|
|
M.Cochet,
A.Casrouge,
A.M.Dumont,
C.Transy,
F.Baleux,
W.L.Maloy,
J.E.Coligan,
P.A.Cazenave,
and
P.Kourilsky
(1989).
A new cell surface molecule closely related to mouse class I transplantation antigens.
|
| |
Eur J Immunol,
19,
1927-1931.
|
|
|
|
|
|
|
M.F.Kagnoff,
J.I.Harwood,
T.L.Bugawan,
and
H.A.Erlich
(1989).
Structural analysis of the HLA-DR, -DQ, and -DP alleles on the celiac disease-associated HLA-DR3 (DRw17) haplotype.
|
| |
Proc Natl Acad Sci U S A,
86,
6274-6278.
|
|
|
|
|
|
|
M.J.Irwin,
W.R.Heath,
and
L.A.Sherman
(1989).
Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response.
|
| |
J Exp Med,
170,
1091-1101.
|
|
|
|
|
|
|
M.L.Hedley,
S.W.Hunt,
K.A.Brorson,
J.S.Andris,
L.Hood,
J.Forman,
and
P.W.Tucker
(1989).
Analysis of D2d: a D-region class I gene.
|
| |
Immunogenetics,
29,
359-365.
|
|
|
|
|
|
|
M.Pierres,
S.Marchetto,
P.Naquet,
D.Landais,
J.Peccoud,
C.Benoist,
and
D.Mathis
(1989).
I-A alpha polymorphic residues that determine alloreactive T cell recognition.
|
| |
J Exp Med,
169,
1655-1668.
|
|
|
|
|
|
|
M.Z.Atassi,
M.Yoshioka,
and
G.S.Bixler
(1989).
T cells specific for alpha-beta interface regions of hemoglobin recognize the isolated subunit but not the tetramer and indicate presentation without processing.
|
| |
Proc Natl Acad Sci U S A,
86,
6729-6733.
|
|
|
|
|
|
|
N.K.Mehra,
and
V.Taneja
(1989).
HLA, immune response and disease.
|
| |
Indian J Pediatr,
56,
171-179.
|
|
|
|
|
|
|
P.Brown,
R.L.Spooner,
and
A.J.Clark
(1989).
Cloning and characterization of a BoLA class I cDNA clone.
|
| |
Immunogenetics,
29,
58-60.
|
|
|
|
|
|
|
P.G.Natali,
M.R.Nicotra,
A.Bigotti,
I.Venturo,
L.Marcenaro,
P.Giacomini,
and
C.Russo
(1989).
Selective changes in expression of HLA class I polymorphic determinants in human solid tumors.
|
| |
Proc Natl Acad Sci U S A,
86,
6719-6723.
|
|
|
|
|
|
|
P.Kourilsky,
and
J.M.Claverie
(1989).
MHC restriction, alloreactivity, and thymic education: a common link?
|
| |
Cell,
56,
327-329.
|
|
|
|
|
|
|
R.Abe,
M.Foo-Phillips,
and
R.J.Hodes
(1989).
Analysis of Mlsc genetics. A novel instance of genetic redundancy.
|
| |
J Exp Med,
170,
1059-1073.
|
|
|
|
|
|
|
R.C.Duke
(1989).
Self recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens.
|
| |
J Exp Med,
170,
59-71.
|
|
|
|
|
|
|
R.Hohlfeld
(1989).
Neurological autoimmune disease and the trimolecular complex of T-lymphocytes.
|
| |
Ann Neurol,
25,
531-538.
|
|
|
|
|
|
|
R.W.Vaughan,
A.G.Demaine,
and
K.I.Welsh
(1989).
A DQA1 allele is strongly associated with idiopathic membranous nephropathy.
|
| |
Tissue Antigens,
34,
261-269.
|
|
|
|
|
|
|
R.Winchester
(1989).
Genetics of autoimmune diseases.
|
| |
Curr Opin Immunol,
1,
701-707.
|
|
|
|
|
|
|
S.P.Balk,
P.A.Bleicher,
and
C.Terhorst
(1989).
Isolation and characterization of a cDNA and gene coding for a fourth CD1 molecule.
|
| |
Proc Natl Acad Sci U S A,
86,
252-256.
|
|
|
|
|
|
|
S.Wadsworth,
K.Yui,
and
M.I.Greene
(1989).
Major histocompatibility complex class I-specific cytolytic T cells, derived from gld mice, lacking Thy-1, CD4, and CD8.
|
| |
Proc Natl Acad Sci U S A,
86,
1018-1022.
|
|
|
|
|
|
|
S.Watts,
A.C.Davis,
B.Gaut,
C.Wheeler,
L.Hill,
and
R.S.Goodenow
(1989).
Organization and structure of the Qa genes of the major histocompatibility complex of the C3H mouse: implications for Qa function and class I evolution.
|
| |
EMBO J,
8,
1749-1759.
|
|
|
|
|
|
|
S.Watts,
A.C.Davis,
and
R.S.Goodenow
(1989).
Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci.
|
| |
Immunogenetics,
29,
355-357.
|
|
|
|
|
|
|
T.Hansen,
A.Bratlie,
B.Johansen,
and
K.Hannestad
(1989).
Two cytotoxic human-human hybridoma antibodies to HLA: TrAH10 (anti A3.1) and TrAG2 (anti B7, Bw42).
|
| |
Tissue Antigens,
33,
520-530.
|
|
|
|
|
|
|
T.J.Braciale,
M.T.Sweetser,
L.A.Morrison,
D.J.Kittlesen,
and
V.L.Braciale
(1989).
Class I major histocompatibility complex-restricted cytolytic T lymphocytes recognize a limited number of sites on the influenza hemagglutinin.
|
| |
Proc Natl Acad Sci U S A,
86,
277-281.
|
|
|
|
|
|
|
T.Matsunaga,
and
U.Dahl
(1989).
What was wrong with the T-cell receptor gamma/delta heterodimer? Divergence of the T-cell receptor alpha/beta and gamma/delta heterodimers.
|
| |
Scand J Immunol,
30,
511-517.
|
|
|
|
|
|
|
W.E.Biddison,
R.W.Anderson,
E.P.Cowan,
R.V.Turner,
J.E.Coligan,
K.Hannestad,
T.Hansen,
and
W.L.Maloy
(1989).
Structural studies of an HLA-A03 alloantigenic epitope defined by a human hybridoma antibody.
|
| |
Immunogenetics,
30,
54-57.
|
|
|
|
|
|
|
W.J.Burlingham,
S.S.Ceman,
and
R.DeMars
(1989).
Secretion and cell surface expression of IgG1 are impaired in human B lymphoblasts that lack HLA-A, -B, and -C antigens.
|
| |
Proc Natl Acad Sci U S A,
86,
8005-8009.
|
|
|
|
|
|
|
W.L.Vasmel,
E.J.Sijts,
C.J.Leupers,
E.A.Matthews,
and
C.J.Melief
(1989).
Primary virus-induced lymphomas evade T cell immunity by failure to express viral antigens.
|
| |
J Exp Med,
169,
1233-1254.
|
|
|
|
|
|
|
W.N.Khan,
A.Osterman,
and
S.Hammarström
(1989).
Molecular cloning and expression of cDNA for a carcinoembryonic antigen-related fetal liver glycoprotein.
|
| |
Proc Natl Acad Sci U S A,
86,
3332-3336.
|
|
|
|
|
|
|
Y.W.Choi,
B.Kotzin,
L.Herron,
J.Callahan,
P.Marrack,
and
J.Kappler
(1989).
Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.
|
| |
Proc Natl Acad Sci U S A,
86,
8941-8945.
|
|
|
|
|
|
|
A.Bradbury,
K.T.Belt,
T.M.Neri,
C.Milstein,
and
F.Calabi
(1988).
Mouse CD1 is distinct from and co-exists with TL in the same thymus.
|
| |
EMBO J,
7,
3081-3086.
|
|
|
|
|
|
|
A.J.McMichael,
F.M.Gotch,
J.Santos-Aguado,
and
J.L.Strominger
(1988).
Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes.
|
| |
Proc Natl Acad Sci U S A,
85,
9194-9198.
|
|
|
|
|
|
|
A.Lanzavecchia
(1988).
Clonal sketches of the immune response.
|
| |
EMBO J,
7,
2945-2951.
|
|
|
|
|
|
|
A.M.Pullen,
P.Marrack,
and
J.W.Kappler
(1988).
The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens.
|
| |
Nature,
335,
796-801.
|
|
|
|
|
|
|
B.M.Chain,
P.M.Kaye,
and
M.A.Shaw
(1988).
The biochemistry and cell biology of antigen processing.
|
| |
Immunol Rev,
106,
33-58.
|
|
|
|
|
|
|
B.S.Fox
(1988).
Interaction of major histocompatibility complex molecules with immunogenic peptides.
|
| |
Curr Opin Immunol,
1,
103-106.
|
|
|
|
|
|
|
C.J.Melief,
C.J.Boog,
W.L.Vasmel,
J.Boes,
A.C.Voordouw,
and
W.M.Kast
(1988).
Dendritic cells and antigen presentation in the regulation of cytotoxic T lymphocyte responses against viruses and transplantation antigens.
|
| |
Ann N Y Acad Sci,
532,
280-291.
|
|
|
|
|
|
|
C.V.Harding,
F.Leyva-Cobian,
and
E.R.Unanue
(1988).
Mechanisms of antigen processing.
|
| |
Immunol Rev,
106,
77-92.
|
|
|
|
|
|
|
D.D.Eckels,
J.Gorski,
J.Rothbard,
and
J.R.Lamb
(1988).
Peptide-mediated modulation of T-cell allorecognition.
|
| |
Proc Natl Acad Sci U S A,
85,
8191-8195.
|
|
|
|
|
|
|
D.H.Kono,
J.L.Urban,
S.J.Horvath,
D.G.Ando,
R.A.Saavedra,
and
L.Hood
(1988).
Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice.
|
| |
J Exp Med,
168,
213-227.
|
|
|
|
|
|
|
D.Jaraquemada,
B.Galocha,
P.Aparicio,
S.Rojo,
V.Calvo,
and
J.A.López de Castro
(1988).
Modulation on immunogenicity by HLA-B27 subtype polymorphism.
|
| |
Eur J Immunol,
18,
1945-1950.
|
|
|
|
|
|
|
D.R.Katz
(1988).
Antigen presentation, antigen-presenting cells and antigen processing.
|
| |
Curr Opin Immunol,
1,
213-219.
|
|
|
|
|
|
|
D.W.Mann,
E.McLaughlin-Taylor,
R.B.Wallace,
and
J.Forman
(1988).
An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes.
|
| |
J Exp Med,
168,
307-324.
|
|
|
|
|
|
|
E.McLaughlin-Taylor,
C.G.Miyada,
M.McMillan,
and
R.B.Wallace
(1988).
Direct demonstration of critical amino acid residues required for cytotoxic T-lymphocyte allorecognition of H-2 class I antigens.
|
| |
Proc Natl Acad Sci U S A,
85,
3085-3089.
|
|
|
|
|
|
|
E.O.Long
(1988).
Processing requirements for presentation of antigens to T lymphocytes.
|
| |
Curr Opin Immunol,
1,
98.
|
|
|
|
|
|
|
E.S.Song,
R.Linsk,
C.A.Olson,
M.McMillan,
and
R.S.Goodenow
(1988).
Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule.
|
| |
Proc Natl Acad Sci U S A,
85,
1927-1931.
|
|
|
|
|
|
|
F.Gotch,
A.McMichael,
and
J.Rothbard
(1988).
Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site.
|
| |
J Exp Med,
168,
2045-2057.
|
|
|
|
|
|
|
F.Guillemot,
A.Billault,
O.Pourquié,
G.Béhar,
A.M.Chaussé,
R.Zoorob,
G.Kreibich,
and
C.Auffray
(1988).
A molecular map of the chicken major histocompatibility complex: the class II beta genes are closely linked to the class I genes and the nucleolar organizer.
|
| |
EMBO J,
7,
2775-2785.
|
|
|
|
|
|
|
F.Mazerolles,
A.Durandy,
D.Piatier-Tonneau,
D.Charron,
L.Montagnier,
C.Auffray,
and
A.Fischer
(1988).
Immunosuppressive properties of synthetic peptides derived from CD4 and HLA-DR antigens.
|
| |
Cell,
55,
497-504.
|
|
|
|
|
|
|
F.R.Carbone,
M.W.Moore,
J.M.Sheil,
and
M.J.Bevan
(1988).
Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.
|
| |
J Exp Med,
167,
1767-1779.
|
|
|
|
|
|
|
G.T.Nepom
(1988).
Genetics and disease association of the major histocompatibility complex.
|
| |
Curr Opin Immunol,
1,
107-111.
|
|
|
|
|
|
|
H.M.Cooper,
G.Corradin,
and
Y.Paterson
(1988).
The heme moiety of cytochrome c is an autoreactive Ir gene-restricted T cell epitope.
|
| |
J Exp Med,
168,
1127-1143.
|
|
|
|
|
|
|
H.M.Grey,
A.Sette,
and
S.Buus
(1988).
Structural characteristics of peptides required for their interaction with IAd.
|
| |
Ann N Y Acad Sci,
546,
72-79.
|
|
|
|
|
|
|
I.Engel,
and
S.M.Hedrick
(1988).
Site-directed mutations in the VDJ junctional region of a T cell receptor beta chain cause changes in antigenic peptide recognition.
|
| |
Cell,
54,
473-484.
|
|
|
|
|
|
|
J.A.Berzofsky,
S.J.Brett,
H.Z.Streicher,
and
H.Takahashi
(1988).
Antigen processing for presentation to T lymphocytes: function, mechanisms, and implications for the T-cell repertoire.
|
| |
Immunol Rev,
106,
5.
|
|
|
|
|
|
|
J.A.Berzofsky
(1988).
Structural basis of antigen recognition by T lymphocytes. Implications for vaccines.
|
| |
J Clin Invest,
82,
1811-1817.
|
|
|
|
|
|
|
J.B.Rothbard,
R.I.Lechler,
K.Howland,
V.Bal,
D.D.Eckels,
R.Sekaly,
E.O.Long,
W.R.Taylor,
and
J.R.Lamb
(1988).
Structural model of HLA-DR1 restricted T cell antigen recognition.
|
| |
Cell,
52,
515-523.
|
|
|
|
|
|
|
J.D.Taurog,
and
F.A.el-Zaatari
(1988).
In vitro mutagenesis of HLA-B27. Substitution of an unpaired cysteine residue in the alpha 1 domain causes loss of antibody-defined epitopes.
|
| |
J Clin Invest,
82,
987-992.
|
|
|
|
|
|
|
J.F.Miller,
and
J.D.Watson
(1988).
Intracellular recognition events eliminate self-reactive T cells.
|
| |
Scand J Immunol,
28,
389-395.
|
|
|
|
|
|
|
J.H.Brown,
T.Jardetzky,
M.A.Saper,
B.Samraoui,
P.J.Bjorkman,
and
D.C.Wiley
(1988).
A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.
|
| |
Nature,
332,
845-850.
|
|
|
|
|
|
|
J.M.Buerstedde,
L.R.Pease,
A.E.Nilson,
M.P.Bell,
C.Chase,
G.Buerstedde,
and
D.J.McKean
(1988).
Regulation of murine MHC class II molecule expression. Identification of A beta residues responsible for allele-specific cell surface expression.
|
| |
J Exp Med,
168,
823-837.
|
|
|
|
|
|
|
J.M.Claverie,
P.Kourilsky,
P.Langlade-Demoyen,
A.Chalufour-Prochnicka,
G.Dadaglio,
F.Tekaia,
F.Plata,
and
L.Bougueleret
(1988).
T-immunogenic peptides are constituted of rare sequence patterns. Use in the identification of T epitopes in the human immunodeficiency virus gag protein.
|
| |
Eur J Immunol,
18,
1547-1553.
|
|
|
|
|
|
|
J.M.Connolly,
T.A.Potter,
E.M.Wormstall,
and
T.H.Hansen
(1988).
The Lyt-2 molecule recognizes residues in the class I alpha 3 domain in allogeneic cytotoxic T cell responses.
|
| |
J Exp Med,
168,
325-341.
|
|
|
|
|
|
|
J.M.Vogel,
A.C.Davis,
D.M.McKinney,
M.McMillan,
W.J.Martin,
and
R.S.Goodenow
(1988).
Molecular characterization of the C3HfB/HeN H-2Kkm2 mutation. Implications for the molecular basis of alloreactivity.
|
| |
J Exp Med,
168,
1781-1800.
|
|
|
|
|
|
|
J.W.Fabre
(1988).
"Immune" functions of parenchymal cells might contribute to their susceptibility to rejection.
|
| |
Transpl Int,
1,
165-167.
|
|
|
|
|
|
|
J.Yague,
M.Blackman,
W.Born,
P.Marrack,
J.Kappler,
and
E.Palmer
(1988).
The structure of V alpha and J alpha segments in the mouse.
|
| |
Nucleic Acids Res,
16,
11355-11364.
|
|
|
|
|
|
|
K.P.Kane,
S.A.Goldstein,
and
M.F.Mescher
(1988).
Class I alloantigen is sufficient for cytolytic T lymphocyte binding and transmembrane signaling.
|
| |
Eur J Immunol,
18,
1925-1929.
|
|
|
|
|
|
|
K.T.Hogan,
N.Shimojo,
S.F.Walk,
V.H.Engelhard,
W.L.Maloy,
J.E.Coligan,
and
W.E.Biddison
(1988).
Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.
|
| |
J Exp Med,
168,
725-736.
|
|
|
|
|
|
|
K.Yui,
S.Wadsworth,
A.Yellen,
Y.Hashimoto,
Y.Kokai,
and
M.I.Greene
(1988).
Molecular and functional properties of novel T cell subsets in C3H-gld/gld and nude mice. Implications for thymic and extrathymic maturation.
|
| |
Immunol Rev,
104,
121-155.
|
|
|
|
|
|
|
L.A.Matis
(1988).
Diversity and antigen specificity of the T cell receptor.
|
| |
Curr Opin Immunol,
1,
84-87.
|
|
|
|
|
|
|
L.Adorini,
E.Appella,
G.Doria,
and
Z.A.Nagy
(1988).
Mechanisms influencing the immunodominance of T cell determinants.
|
| |
J Exp Med,
168,
2091-2104.
|
|
|
|
|
|
|
M.A.Khan
(1988).
Ankylosing spondylitis and heterogeneity of HLA-B27.
|
| |
Semin Arthritis Rheum,
18,
134-141.
|
|
|
|
|
|
|
M.B.Oldstone,
J.L.Whitton,
H.Lewicki,
and
A.Tishon
(1988).
Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes.
|
| |
J Exp Med,
168,
559-570.
|
|
|
|
|
|
|
M.Fougereau,
and
C.Schiff
(1988).
Breaking the first circle.
|
| |
Immunol Rev,
105,
69-84.
|
|
|
|
|
|
|
M.J.Santoni,
C.Goridis,
and
J.C.Fontecilla-Camps
(1988).
Molecular modelling of the immunoglobulin-like domains of the neural cell adhesion molecule (NCAM): implications for the positioning of functionally important sugar side chains.
|
| |
J Neurosci Res,
20,
304-310.
|
|
|
|
|
|
|
M.W.Moore,
F.R.Carbone,
and
M.J.Bevan
(1988).
Introduction of soluble protein into the class I pathway of antigen processing and presentation.
|
| |
Cell,
54,
777-785.
|
|
|
|
|
|
|
M.Z.Lai,
S.Y.Huang,
T.J.Briner,
J.G.Guillet,
J.A.Smith,
and
M.L.Gefter
(1988).
T cell receptor gene usage in the response to lambda repressor cI protein. An apparent bias in the usage of a V alpha gene element.
|
| |
J Exp Med,
168,
1081-1097.
|
|
|
|
|
|
|
P.Ajitkumar,
S.S.Geier,
K.V.Kesari,
F.Borriello,
M.Nakagawa,
J.A.Bluestone,
M.A.Saper,
D.C.Wiley,
and
S.G.Nathenson
(1988).
Evidence that multiple residues on both the alpha-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor.
|
| |
Cell,
54,
47-56.
|
|
|
|
|
|
|
P.Aparicio,
D.Jaraquemada,
S.Rojo,
and
J.A.López de Castro
(1988).
Clonal heterogeneity of HLA-B27 cellular allorecognition. Delineation of immunodominant sites.
|
| |
Eur J Immunol,
18,
203-209.
|
|
|
|
|
|
|
P.M.Allen
(1988).
Antigen presentation and autoimmunity.
|
| |
Hepatology,
8,
677-679.
|
|
|
|
|
|
|
P.Marrack,
D.Lo,
R.Brinster,
R.Palmiter,
L.Burkly,
R.H.Flavell,
and
J.Kappler
(1988).
The effect of thymus environment on T cell development and tolerance.
|
| |
Cell,
53,
627-634.
|
|
|
|
|
|
|
P.Parham,
C.E.Lomen,
D.A.Lawlor,
J.P.Ways,
N.Holmes,
H.L.Coppin,
R.D.Salter,
A.M.Wan,
and
P.D.Ennis
(1988).
Nature of polymorphism in HLA-A, -B, and -C molecules.
|
| |
Proc Natl Acad Sci U S A,
85,
4005-4009.
|
|
|
|
|
|
|
R.Castaño,
A.Ezquerra,
N.Doménech,
and
J.A.López de Castro
(1988).
An HLA-A2 population variant with structural polymorphism in the alpha 3 region.
|
| |
Immunogenetics,
27,
345-355.
|
|
|
|
|
|
|
R.F.Siliciano,
T.Lawton,
C.Knall,
R.W.Karr,
P.Berman,
T.Gregory,
and
E.L.Reinherz
(1988).
Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion.
|
| |
Cell,
54,
561-575.
|
|
|
|
|
|
|
R.G.Lorenz,
and
P.M.Allen
(1988).
Direct evidence for functional self-protein/Ia-molecule complexes in vivo.
|
| |
Proc Natl Acad Sci U S A,
85,
5220-5223.
|
|
|
|
|
|
|
R.J.Winchester,
and
P.K.Gregersen
(1988).
The molecular basis of susceptibility to rheumatoid arthritis: the conformational equivalence hypothesis.
|
| |
Springer Semin Immunopathol,
10,
119-139.
|
|
|
|
|
|
|
R.Murray,
C.A.Hutchison,
and
J.A.Frelinger
(1988).
Saturation mutagenesis of a major histocompatibility complex protein domain: identification of a single conserved amino acid important for allorecognition.
|
| |
Proc Natl Acad Sci U S A,
85,
3535-3539.
|
|
|
|
|
|
|
R.Murray,
K.Pederson,
H.Prosser,
D.Muller,
C.A.Hutchison,
and
J.A.Frelinger
(1988).
Random oligonucleotide mutagenesis: application to a large protein coding sequence of a major histocompatibility complex class I gene, H-2DP.
|
| |
Nucleic Acids Res,
16,
9761-9773.
|
|
|
|
|
|
|
R.R.de Vries,
T.H.Ottenhoff,
and
W.C.van Schooten
(1988).
Human leukocyte antigens (HLA) and mycobacterial disease.
|
| |
Springer Semin Immunopathol,
10,
305-318.
|
|
|
|
|
|
|
S.Hemmi,
J.Geliebter,
R.A.Zeff,
R.W.Melvold,
and
S.G.Nathenson
(1988).
Three spontaneous H-2Db mutants are generated by genetic micro-recombination (gene conversion) events. Impact on the H-2-restricted immune responsiveness.
|
| |
J Exp Med,
168,
2319-2335.
|
|
|
|
|
|
|
S.K.Pierce,
J.F.Morris,
M.J.Grusby,
P.Kaumaya,
A.van Buskirk,
M.Srinivasan,
B.Crump,
and
L.A.Smolenski
(1988).
Antigen-presenting function of B lymphocytes.
|
| |
Immunol Rev,
106,
149-180.
|
|
|
|
|
|
|
T.J.Elliott,
and
H.N.Eisen
(1988).
Allorecognition of purified major histocompatibility complex glycoproteins by cytotoxic T lymphocytes.
|
| |
Proc Natl Acad Sci U S A,
85,
2728-2732.
|
|
|
|
|
|
|
W.A.Jefferies,
U.Rüther,
E.F.Wagner,
and
S.Kvist
(1988).
Cytolytic T cells recognize a chimeric MHC class I antigen expressed in influenza A infected transgenic mice.
|
| |
EMBO J,
7,
3423-3431.
|
|
|
|
|
|
|
W.E.Mayer,
M.Jonker,
D.Klein,
P.Ivanyi,
G.van Seventer,
and
J.Klein
(1988).
Nucleotide sequences of chimpanzee MHC class I alleles: evidence for trans-species mode of evolution.
|
| |
EMBO J,
7,
2765-2774.
|
|
|
|
|
|
|
W.V.Williams,
D.B.Weiner,
S.Wadsworth,
and
M.I.Greene
(1988).
The antigen-major histocompatibility complex-T cell receptor interaction. A structural analysis.
|
| |
Immunol Res,
7,
339-350.
|
|
|
|
|
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
 |
Links
